Design and Development of Donor-Acceptor Stenhouse Adducts: A New Visible Light Activated Photochromic Compound by Helmy, Sameh
UC Santa Barbara
UC Santa Barbara Electronic Theses and Dissertations
Title
Design and Development of Donor-Acceptor Stenhouse Adducts: A New Visible Light 
Activated Photochromic Compound
Permalink
https://escholarship.org/uc/item/1zv1q6vn
Author
Helmy, Sameh
Publication Date
2015
 
Peer reviewed|Thesis/dissertation
eScholarship.org Powered by the California Digital Library
University of California
UNIVERSITY OF CALIFORNIA 
Santa Barbara 
 
 
Design and Development of Donor-Acceptor Stenhouse Adducts:  
A New Visible Light Activated Photochromic Compound 
 
 
A dissertation submitted in partial satisfaction of the 
requirements for the degree Doctor of Philosophy 
in Chemistry 
 
by 
 
Sameh Helmy 
 
Committee in charge:  
Professor Javier Read de Alaniz, Chair 
Professor Mattanjah de Vries 
Professor Liming Zhang 
Professor Craig Hawker 
 
June 2015
 The dissertation of Sameh Helmy is approved. 
 
  ____________________________________________  
 Craig Hawker 
 
  ____________________________________________  
 Liming Zhang 
 
  ____________________________________________  
 Mattanjah de Vries 
 
  ____________________________________________  
 Javier Read de Alaniz, Committee Chair 
 
 
April 2015  
  iii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Design and Development of Donor-Acceptor Stenhouse Adducts:  
A New Visible Light Activated Photochromic Compound 
Copyright © 2015 
by 
Sameh Helmy  
  iv 
ACKNOWLEDGEMENTS 
This work is dedicated in loving memory of my mother Abia Mohammed El Tayeb. 
 
I would like to first thank my advisor, Javier Read de Alaniz, for his tireless support and 
guidance. He has taught me far more than chemistry, and helped me develop my beliefs and 
opinions on education and academic research. I am forever indebted for the opportunity you 
have provided me, and the wisdom you have passed along. Thank you for everything. And 
to all of the past and present members of the Read Group: thank you, it has been an honor to 
work and learn with you. 
Second, I would like to thank Dr. Philip Hampton. I have learned more from you over 
the last seven years then I could have ever imagined. You have provided me with countless 
opportunities and endless guidance. I have been blessed to have you as a mentor and hon-
ored to call you my friend. 
I wish to thank the friends who have stood beside me through this experience. Elis, you 
are the sister of my heart, I may not know what the future holds, but I know I can always 
count on you. To Saralynn, Zach, Apoorva, Lauren, Eric, Alex, Corey and Alicia, thanks for 
getting me off the couch and reminding me to have fun, I love you all. 
  v 
VITA OF SAMEH HELMY 
April 2014 
 
EDUCATION 
• Doctorate of Philosophy, Chemistry, University of California, Santa Barbara, CA, April 
2015 
 
• Bachelors of Science, Chemistry, California State University, Channel Islands, May 
2010 
 
PROFESSIONAL EMPLOYMENT 
• June 2012-August 2014: Assistant Program Coordinator, California Alliance for Minori-
ty Participation-Summer Program, Materials Research Laboratory, University of Cali-
fornia, Santa Barbara, CA 
 
• August 2013-March 2015: Teaching Assistant-Organic Chemistry Laboratory, Depart-
ment of Chemistry and Biochemistry, University of California, Santa Barbara, CA 
 
• August 2012-September 2012: Invited Lecturer, School for Scientific Thought, Center 
for Science and Engineering Partnerships, University of California, Santa Barbara, CA 
 
• August 2011-September 2011: Research Mentor, Summer Institute in Mathematics and 
Science, California NanoSystems Institute, University of California, Santa Barbara, CA 
 
• May 2010-June 2010: Research Mentor, CSUCI HSI-STEM Summer Institute, Califor-
nia State University Channel Islands, CA 
 
• May 2010-June 2010: Lecture and Laboratory Instructor, CSUCI HSI-STEM Summer 
Institute, California State University Channel Islands, CA 
 
• August 2009-May 2010: Chemistry and Mathematics Tutor, CSUCI HSI-STEM, Cali-
fornia State University Channel Islands, CA 
 
• May 2009-May 2010: Student Research Assistant, CSUCI Alzheimer’s Institute, Cali-
fornia State University Channel Islands, CA 
 
PUBLICATIONS AND PRESENTATIONS 
• S. Helmy, F. A. Leibfarth, S. Oh, C. Hawker, and J. Read de Alaniz “Visible Light as a 
Stimulus for Organic Catalyst Recycling” Manuscript Submitted to RSC Chem. Comm. 
 
• S. Helmy, S. Oh, F. A. Leibfarth, C. Hawker, and J. Read de Alaniz “Design and Synthe-
sis of Donor-Acceptor Stenhouse Adducts: A Visible Light Photoswitch Derived from 
Furfural” Journal of Organic Chemistry (DOI: 10.1021/jo502206g) 
 
  vi 
• S. Helmy, F. A. Leibfarth, S. Oh, J. E. Poelma, C. Hawker, and J. Read de Alaniz “Pho-
toswitching Using Visible Light: A New Class of Organic Photochromic Molecules” 
Journal of the American Chemical Society (DOI:10.1021/ja503016b) 
 
• S. Helmy, J. Read de Alaniz “Cascade Rearrangement of Activated Furans Gives Access 
to an Undiscovered Photochromic Switch” Invited presentation to the Faculty of the De-
partment of Chemistry, Ain Shams University, Cairo, Egypt at the National Institute for 
Research, Cairo, Egypt; January 5, 2012 
 
• S. Helmy, P. Hampton “Reverse Phase Chromatography of Candy Coatings and the 
Teaching of the Scientific Method”, Presented at the 43rd Western Regional Meeting of 
the ACS, Pasadena, CA, United States, November 10-12, 2011, WRM343 
 
• S. Helmy, H. Baker, and P. Hampton “VIA-CI Project: Remote instrument operation and 
its impact on student learning”, 239th ACS National Meeting, San Francisco, CA, Unit-
ed States, March 21-25, 2010 (2010), CHED-1606 
 
• S. Helmy, and P. Hampton “Novel Routes to the Synthesis and Purification of Water 
Soluble Curcumin Derivatives”, 239th ACS National Meeting, San Francisco, CA, Unit-
ed States, March 21-25, 2010 (2010), ORGN-310 
 
HONORS AND FELLOWSHIPS 
• 2012/13 UCSB MRL Award for Outstanding Service in Undergraduate Mentoring 
 
• 2012/13 UCSB DCB Robert H. DeWolfe Oustanding Teaching Assistant in Organic 
Chemistry (Winter and Spring) 
 
• 2011/12 UCSB DCB Robert H. DeWolfe Oustanding Teaching Assistant in Organic 
Chemistry (Fall and Winter) 
 
• 2010-12 LSAMP Bridges to the Doctorate Fellowship 
 
• 2010/11 UCSB Summer Doctoral Research Incentive Fellowship 
 
• 2010/11 CSU Student Research Competition, First Place Award in Undergraduate Phys-
ical and Mathematical Sciences 
 
• 2009/10 Sage Student Research Award for Excellence in Chemical Research  
 
• 2009/10 Alzheimer’s Institute Research Scholarship Recipient 
 
• 2009/10 Channel Islands Alzheimer’s Institute Summer Research Scholar 
 
  vii 
ABSTRACT 
 
Design and Development of Donor-Acceptor Stenhouse Adducts:  
A New Visible Light Activated Photochromic Compound 
 
by 
 
Sameh Helmy 
 
The development of an easily synthesized, modular, and tunable organic photoswitch 
that responds to visible light has been a long-standing pursuit. Herein we provide a detailed 
account of the design and synthesis of a new class of photochromes based on furfural, 
termed donor−acceptor Stenhouse adducts (DASAs). A wide variety of these derivatives are 
easily prepared from commercially available starting materials, and their photophysical 
properties are shown to be dependent on the substituents of the push−pull system. Analysis 
of the switching behavior provides conditions to access the two structural isomers of the 
DASAs, reversibly switch between them, and use their unique solubility behavior to provide 
dynamic phase-transfer materials. Overall, these negative photochromes respond to visible 
light and heat and display an unprecedented level of structural modularity and tunabilty. We 
demonstrate the considerable potential of DASA photoswitches in two unique and powerful 
applications. First we have applied DASAs for the visible light-initiated recycling of homo-
geneous organic catalysts. This catalyst-photoswitch construct effectively polymerized lac-
tide with control over molecular weight and a low PDI. The visible-light mediated phase 
  viii 
transfer and subsequent recovery of the thiourea catalyst allowed recycling of the organocat-
alyst. Further, the potential of these photoswitches in biological applications is demonstrated 
through the synthesis of a functional amphiphile that displays on-demand light-mediated 
disassembly and cargo release. This one-photon visible light-responsive micellar system 
served as an efficient, on-demand drug delivery system. The efficiency and effectiveness of 
this system was demonstrated in an in-vitro setting, delivering the chemotherapeutic 
paclitaxel only on exposure to visible light. 
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1. Organic Photochromism 
1.1. Historical Perspective 
The phenomenon of photochromism was first reported by Fritsche in 1867, when he ob-
served that a red solution of tetracene 1 bleached on exposure to sunlight, and recolored 
when held in the dark (Figure 1). In 1899, Markwald observed the reversible color change of 
2,3,4,4-tetrachloronapthalen-1(4H)-one 2 in the solid state (Figure 1).1 
 
Figure 1. Organic photochromic molecules reported by Fritsche and Markwald. 
 
In the 150 years since its initial discovery, research in the field of organic photochrom-
ism has occurred in waves.  Until the 1940s, interest in photochromism was steady yet lim-
ited.  It would take the development of advanced analytical techniques (UV-visible, NMR, 
time-resolved spectroscopies and flash photolysis) to drive the boom in synthetic and mech-
anistic studies on photochromism that occurred through 1940-1960.1  It would be during this 
period that Hirshberg, in 1950, coined the term photochromism [from the Greek phos(light) 
and chroma(color)], which is used to this day to describe this behavior. Yet, despite this in-
terest, and early applications such as the photochromic micro imaging process, the photo-
degradation of these compounds limited their potential for applications.  While photochrom-
ism is a nondestructive process, side reactions (primarily oxidation) can occur, leading to 
chemical degradation of the material with concomitant loss of performance over time and 
repeated cycling.  A new renaissance of photochromic research was seen in the 1980s, with 
the discovery of highly fatigue resistant systems, including spirooxazines,2 diarylethenes,3 
O
Cl Cl
Cl
Cl
1 2
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chromenes,4 and their derivatives, which led to commercial applications such as photo-
chromic lenses, optical filters, and optical recording. 
Photochromism is defined as a “reversible transformation of a chemical species induced 
in one or both directions by absorption of electromagnetic radiation between two forms, A 
and B, having different absorption spectra” (Figure 2a). Thus the thermodynamically stable 
form A is transformed to form B, the back reaction of which can occur thermally (type T 
photochromism) or photochemically (type P photochromism).  The overwhelming majority 
of organic photochromic systems involve unimolecular processes of a colorless form A con-
verting to a colored form B.  This is known as positive photochromism. When 
λmax(A)>λmax(B) the processes is termed negative, inverse, or reverse photochromism (Fig-
ure 2b). 
 
Figure 2. Representative spectra of a) normal and b) reverse photochromism. 
 
Over thirteen classes of organic photochromic compounds have been identified (Figure 
3).  Of these the preponderance of research has focused on the three ‘privileged’ classes, spi-
ropyrans/sprioxanzines 3/4, diarylethenes 9, and azo-compounds 13; with efforts primarily 
focused on derivatizing and tailoring these systems to specific applications. Further, only 
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two reports disclose negative photochromism in organic systems, with minimal investigation 
into their properties and no efforts toward application.5,6 
 
Figure 3. Representative members of known classes of organic photochromic compounds 
 
Interest in adaptable and responsive systems has led to significant effort in the chemistry 
of organic photochromic compounds. The ability of organic photochromes to undergo re-
versible spectral and physical property changes has led to applications ranging from energy 
production, chemical sensing, and molecular actuators to biological systems.7 These switch-
es are particularly valuable as their property changes are triggered by light, the most widely 
available, non-invasive and environmentally benign external stimulus. The driving force for 
this focus is the abundant and versatile nature of light as a stimulus, which provides unique 
opportunities for spatial and temporal resolution.  
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Heterocyclic moieties have a rich and potent history in the field of organic photo-
chromism, as demonstrated by the abundance of work devoted to dithienylethenes3,8 9, spi-
ropyrans 3 and spirooxazines 4.2,9 Indeed since their discovery, there has been such a boom 
in the work related to these classes that there exists a plethora of not only primary but also 
secondary literature covering ongoing developments in the control of their properties and 
applications. While these two classes have dominated the field of photochromic heterocy-
cles, recent years have seen the introduction and development of several promising new or-
ganic photochromes and the revival of known, yet underdeveloped, classes. Because the 
“privileged” photochromes have been extensively reviewed, the following section will focus 
on highlighting the new organic photochromes. 
1.2. Recent Advances 
1.2.1. Bridged Imidazole Dimers 
Increasing the switching rates, specifically thermal bleaching, of photochromic systems 
is critical for their adoption in applications such light modulation or optical data processing. 
Abe and coworkers have developed a family of bridged imidazole dimers (BIDs), based on 
the hexaarylbiimidazole (HABI) framework.10 These materials demonstrate instantaneous 
coloration, however, through rational molecular design their half-life of thermal back reac-
tion can be reduced to as low as 35µs. This rapid thermal bleaching allows for precise spa-
tial control over coloration, since the bleaching kinetics exceed diffusion of the colored spe-
cies. As will be discussed, between their ease of synthesis, diverse molecular design and un-
precedented bleaching performance this class of photochromic compounds is promising for 
applications in high performance ophthalmic lenses and revolutionary optical switching de-
vices. 
  5 
1.2.1.1. Background 
Since being first reported in 1960 by Hayashi and Meada, hexaarylbiimidazole (HABI) 
has garnered great attention due to its unique properties.10 HABI is cleaved into a pair of 
2,4,5-triphenylimidazolyl radicals (TPIRs) by various stimuli (light, pressure, or heat); this 
radical pair (RP) thermally recombines to regenerate the original dimer (Scheme 1). Hayashi 
and Meada were the first to specifically observe that in either the solution or solid state, 
HABI developed a deep red-violet color on irradiation, which faded slowly for the solid and 
rapidly in solution. This photochromic behavior is a result of the homolytic cleavage of the 
C-N bond between the two imidazole rings.11 While the photo-induced cleavage of HABI to 
TPIRs occurs near instantaneously, the thermal regeneration of HABI by radical recombina-
tion of TPIRs in solution requires several minutes as radical-radical reactions generally obey 
second order kinetics. Thus while these systems have seen widespread adoption as photo-
initiators for polymerization or imaging materials, their relatively slow rate of thermal 
bleaching has limited their use in photochromic applications.12 
 
Scheme 1. Photochromism of HABI. 
 
To better understand how this radical recombination could be tamed, Abe and coworkers 
examined the behavior of the TPIR derivative tF-BDPI-2Y 21 (1,4-bis(4,5-
diphenylimidazol-2-ylidene), shown in Figure 4.13 tF-BDPI-2Y 21 dimerizes to the photo-
chromic tF-BDPI-2YD 20 at room temperature, this dimer cleaves to the original RP 21 on 
irradiation with 360 nm light (Figure 4). The tF-BDPI-2Y RP 21 is stable in solution at room 
NN NN NN NN
hν
Δ
HABI 17 TPIR 18
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temperature and thermal recombination to tF-BDPI-2YD 20 occurs over two days at room 
temperature in the dark. Thus, a fast thermal bleaching photochromic molecule could be de-
veloped on the basis of a virtual one photon reaction of tF-BDPI-2YD 20, where in this case 
the TPIR-RP 19 would immediately recombine as the RP is restricted in it its diffusion. Abe 
and coworkers used this design principle to develop their Bridged Imidazole Dimer (BID) 
class of photochromic compounds. 
 
Figure 4. Photochromism and virtual one photon cleavage of tF-BDPI-2Y. 
1.2.1.2. Synthesis 
Two major subclasses of BIDs have been developed, naphthalene bridged dimers and 
[2.2]paracyclophane bridged dimers.  As outlined in Scheme 2, the synthesis of naphthalene 
BIDs begins with the cyclocondensation of a 1,2-diaryl-β-diketone 23, aryl aldehyde 22 and 
ammonium acetate, to generate the 2,4,5-triarylimiazole 24.14 Typically the aryl aldehyde 
employed bears a boronic acid or ester moiety to facilitate Suzuki coupling to the naphtha-
lene bridge 25. At this stage the imidazole moieties are oxidized by basic potassium ferricy-
anide in the absence of light generating the bridged radical pair 27, which instantly dimerize 
to the photochromic BID 28. For naphthalene BIDs, structural diversity is introduced in the 
choice of aryl aldehyde and 1,2-diaryl-β-diketone, allowing control over thermal bleaching 
and wavelength of activation.  
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Scheme 2. Synthesis and photochromism of 1,8-bis-TPID-naphthalene. 
 
Further, chiroptical switching can be achieved by using 4-formylnaphthylboronic acid 29 
as one of the two aryl aldehydes employed, Scheme 3.15 Sequential Suzuki coupling of the 
naphthyldiphenyl imidazole 30 to the naphthalene linker 25, followed by coupling to a tri-
phenyl imidazole 24, oxidation and dimerization, provides 1-NDPI-8-TPI-napthalene 34. 
The BIDs produced in this fashion exhibit axial chirality due to the binaphthyl moiety gen-
erated in their synthesis. 
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Scheme 3. Synthesis and photochromism of 1-NDPI-8-TPI-napthalene. 
 
Alternately a di-aldehyde bridging linker can be employed directly in the cyclocondensa-
tion reaction, as is the case with [2.2]paracyclophane bridged derivative pseudogem-bis-
DPI[2.2]PC, Scheme 4.16 Here the synthetic path is highly streamlined compared to the 
preparation of naphthalene-bridged dimers. The initial cyclocondensation occurs between 
the paracyclophane linker 35, 1,2-diaryl-β-diketone 23 and ammonium acetate providing the 
bridged imidazole pair 36, which undergoes oxidation and dimerization to provide the de-
sired BID 38. Here structural diversity is introduced by variations in the 1,2-diaryl-β-
diketones employed. Indeed, the cyclocondensation can be performed step-wise to provide 
asymmetric [2.2]paracyclophane BIDs.17 
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Scheme 4. Synthesis and Photochromism of pseudogem-bis-DPI[2.2]paracyclophane. 
 
The inherent modularity of these synthetic pathways enables rapid structural diversifica-
tion of the BID. Control over thermal bleaching kinetics is affected by the choice of bridging 
linker, while structural and electronic diversification of the TPID moiety can effect the 
thermal bleaching rate through steric control and the wavelength of irradiation that triggers 
formation of the bridged TPIR, respectively. 
1.2.1.3. Photochromism and Related Properties 
1.2.1.3.1. Naphthalene BIDs 
As with all HABI derivatives 1,8-bis-TPID-naphthalene 28 (Scheme 2) is cleaved by 
light to form 1,8-bis-TPIR-naphthalene 27, which displays an intense absorption band with 
λmax = 585 nm and a shoulder band with absorption maximum at ~620 nm extending beyond 
750 nm.14 Combined, these result in a green coloration of the 1,8-bis-TPIR-naphthalene RP 
27 in solution. Unlike HABI 17, the RP of 1,8-bis-TPIR-naphthalene 28 cannot diffuse in 
solution to give free radicals. Compared to the long thermal recombination rates for HABI 
17, which follow second order kinetics, thermal bleaching of 1,8-bis-TPIR-naphthalene 27 
follows first order kinetics with a half-life of 730 ms at room temperature. After this dra-
matic enhancement, a second type of naphthalene bridged dimer, 1-NDPI-8-TPI-napthalene 
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34 (Scheme 3), was prepared, bearing two different TPIR moieties, 2-(1-naphthyl)-4,5-
diphenylimidazoyl radical (NDPIR) and TPIR.18 The colored RP of 1-NDPI-8-TPI-
napthalene 34 gives superposed absorption spectra covering the entire visible range. The 
TPIR moiety giving absorbance from 500 to 600 nm and the NDPIR moiety absorbing from 
550 to 900 nm, in addition to the sharp band at ~ 460 nm, giving 1-NDPIR-8-TPIR-
napthalene 33 a green color in solution. Under continuous UV irradiation 1-NDPI-8-TPI-
napthalene 34 achieves the photostationary colored state rapidly. Thermal bleaching of the 
RP, here again, follows first order kinetics, with a half-life of 230 ms at room temp. Interest-
ingly it is not known why the thermal bleaching kinetics of 1-NDPI-8-TPI-napthalene 34 is 
accelerated over 1,8-bis-TPI-napthalene 28. Still, naphthalene-BIDs were the first photo-
chromic compounds to achieve these remarkable thermal bleaching rates. 
1-NDPI-8-TPI-napthalene 34 is axially chiral resulting from the 1,1`-binaphthyl frame-
work established in its preparation, and crystallographic analysis confirms that both enanti-
omers are present in the racemic crystal. Axially chiral binaphthalenes show large optical 
rotation values and strong circular dichroism (CD), dependent on their dihedral angle. Chi-
roptical switches are chiral molecules whose chiral properties can be modulated using 
light.19 The racemic mixture of 1-NDPI-8-TPI-napthalene 34 was separated by HPLC pro-
vided each enantiomer in 96% ee. As the thermal half-life of 1-NDPIR-8-TPIR-napthalene 
34 is too short to measure its CD spectrum at room temperature, the CD spectra were col-
lected at 200 K to retard the rate of thermal recombination. Consistent with axially chiral 
binaphthyls, 1-NDPI-8-TPI-napthalene 34 exhibits the strong Cotton effect at less than 400 
nm.20 Further, the CD spectrum of the colored form of each enantiomer is different from the 
parent. Each enantiomer of the RP displays mirror image CD bands in the visible region, 
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where the racemic RP absorbs, indicating that the electronic transitions of the radical pair 
are optically active. 
Chiral RPs generated in close proximity, recombine with high stereoselectivity if diffu-
sion of the radical pair can be inhibited, as Stowell et al. have reported.21 For 1-NDPI-8-TPI-
napthalene 34 photo-racemization does not occur as the radical pair is covalently bridged. 
Chiral HPLC analysis confirmed that no racemization occurs from the photochromic reac-
tion. This is the first example of a reversible photogenerated chiral RP. 
1.2.1.3.2. [2.2]paracyclophane BIDs 
While the intensity of coloration and rapid thermal bleaching of naphthalene-BIDs are 
acceptable for applications such as ophthalmic lenses, these rates are still unsatisfactory for 
real-time image processing application. Indeed, on cessation of irradiation of naphthalene-
BIDs, an afterimage persists for ~1 s and can be observed by the naked eye. Thus to further 
increase the thermal bleaching rate, the RP must be more closely spaced together. To 
achieve this a new BID pseudogem-bis-DPI[2.2]paracyclophane 38 (Scheme 4) was de-
signed and prepared, with a paracyclophane bridge that more tightly couples the photogen-
erated RP.16 
On irradiation with 355 nm light, pseudogem-bis-DPI[2.2]PC 38 photochromically trans-
forms to pseudogem-bis-DPIR[2.2]PC 37 developing a blue color in both the solid state and 
in solution. The radical pair displays a sharp absorption band at 400 nm and a broad absorp-
tion from 500 to 900 nm. Again here, the thermal bleaching obeys first order kinetics, the 
RP having a half-life of 33 ms at room temperature. Unlike naphthalene-BIDs, pseudogem-
bis-DPI[2.2]PC 38 does not suffer from an after-image on cessation of irradiation, as com-
plete bleaching in solution is achieved within 200 ms. While it is difficult for the human eye 
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to detect a phenomenon faster than 10 ms, the lifetime of pseudogem-bis-DPIR[2.2]PC 37 is 
in the tens of milliseconds, and can potentially applied to real-time image processing appli-
cations. 
The stability of pseudogem-bis-DPIR[2.2]PC 37 is a result of the inhibition of diffusion 
of the RP. Yet a further acceleration of the thermal bleaching is necessary for practical use 
in fast light modulators. Here a modular approach can be taken in the synthesis of [2.2]PC-
BIDs, allowing for stepwise formation of the imidazole rings. This approach allows for the 
rational design to control the thermal bleaching rate. To further accelerate thermal bleaching 
of [2.2]PC-BIDs, the colored state would need to be destabilized. As shown in Scheme 5 
(below), pseudogem-DPI-PI[2.2]PC 43 couples a diphenylimidazole group with a phenan-
throimidazole group bridged by the PC linker.17 Here steric repulsion between the rigid phe-
nanthroimidazole group and the phenyl rings of the DPI moiety destabilize the RP (42). In-
deed on irradiation with UV light no color change is observed for a solution of pseudogem-
DPI-PI[2.2]PC 43 at room temperature, while at liquid nitrogen temperatures the solution 
changes from clear to blue when irradiated. Here thermal back reaction of the photogenerat-
ed pseudogem-DPIR-PIR[2.2]PC 42 exceeds the ability of the naked eye to detect coloration 
at room temperature. The absorption of pseudogem-DPIR-PIR[2.2]PC 42 displays a sharp 
absorption at 400 nm and broad absorption from 450 to 1000 nm, nearly identical to that of 
pseudogem-bis-DPI[2.2]PC 38. In contrast the half-life of thermal bleaching for pseudogem-
DPIR-PIR[2.2]PC 42 is 35 µs at room temperature, a 1000 fold acceleration over 
pseudogem-bis-DPI[2.2]PC 38 while maintaining its optical density in the colored state. 
This behavior demonstrates that destabilizing the nascent RP can dramatically enhance the 
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thermal bleaching rate. This approach is not limited to using the steric effect, as an electron-
ic effect can be introduced by substituents in appropriately selected 1,2-diaryl-β-diketones.22 
 
Scheme 5. Synthesis and Photochromism of pseudogem-DPIR-PIR[2.2]PC. 
 
While these accelerations are a remarkable achievement, as the thermal bleaching rate 
increases the color of the photostationary equilibrium becomes lighter, due to the difficulty 
in increasing the stationary concentration of the colored species. A possible approach to 
overcome this limitation is to improve the sensitivity of the colorless state to a broader spec-
trum of irradiation. In regards to the first generation [2.2]PC-BID (38), its photosensitivity is 
poor as it lacks a sufficient absorption band in the UVA region of irradiation. To increase 
the photosensitivity of [2.2]PC-BIDs,  pseudogem-bis-TMDPI[2.2]PC 44 was developed 
which undergoes photochromic reaction under sunlight.22 
 
Figure 5. [2.2]PC-BIDs with enhanced photosensitivity. 
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The two imidazole rings of pseudogem-bis-TMDPI[2.2]PC 44, ImA (red) and ImB 
(blue), are inequivalent in their electronic nature. As shown in Figure 5, ImA is a planar, 
resonant moiety with bond lengths typical of a 6π system with electron-donating properties. 
In contrast, ImB bears an sp3 carbon connecting to ImA and two localized C=N double 
bonds. ImB’s structure is consistent with a 4π electronic system having electron-
withdrawing properties. Based on TDDFT, the absorption of pseudogem-bis-TMDPI[2.2]PC 
44 is attributed to intramolecular charge-transfer from ImA to ImB. To further understand 
the nature of the CT characteristics and the photochromic behavior of pseudogem-bis-
TMDPI[2.2]PC 44, two related derivatives were prepared and examined to ascertain the mo-
lecular design principles for enhancing photosensitivity.23 
Pseudogem-DPI-TMDPI[2.2]PC 45 and pseudogem-TMDPI-DPI[2.2]PC 46 are shown 
in Figure 5. In pseudogem-DPI-TMDPI[2.2]PC 45 the dimethoxyphenyl groups are attached 
to electron withdrawing ImB and in pseudogem-TMDPI-DPI[2.2]PC 46 they are attached to 
electron donating ImA. pseudogem-DPI-TMDPI[2.2]PC 45 exhibits the desired UVA ab-
sorption band, where pseudogem-TMDPI-DPI[2.2]PC 46 does not. In pseudogem-TMDPI-
DPI[2.2]PC 46, the intramolecular CT transition form the electron donating dimethoxy-
phenyl substituents to electron withdrawing ImB is predicted to have a small oscillator 
strength, as there is little overlap between the molecular orbitals delocalized over the di-
methoxyphenyl rings and ImB. Thus photosensitivity is enhanced by electron donating sub-
stituents attached to the phenyl rings of electron withdrawing ImB. Oxidation of the precur-
sor of both pseudogem-DPI-TMDPI[2.2]PC 45 and pseudogem-TMDPI-DPI[2.2]PC 46 
gives a mixture of the two compounds. While both pseudogem-DPI-TMDPI[2.2]PC 45 and 
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pseudogem-TMDPI-DPI[2.2]PC 46 undergo photochromic reaction, repeated cycling of ei-
ther isomer in its pure state ultimately regenerates a mixture of the two species.  
The rapid thermal bleaching of bridged imidazole dimers allows for precise spatial con-
trol over coloration, since the bleaching kinetics exceed diffusion of the colored species. Be-
tween their ease of synthesis, diverse molecular design and unprecedented bleaching per-
formance Abe and coworkers have used rational design to develop a class of photochromic 
compounds that are promising for applications in high performance ophthalmic lenses and 
revolutionary optical switching devices. 
1.2.2. Chromene Based Systems 
Photochromic benzo and naphthopyrans (Figure 6: 47-50), commonly referred to as 
chromenes, have been widely applied as reversible coloring agents for ophthalmic lenses 
since the early 1990s. The studies by several companies to develop benzo and naphthopy-
rans that offer complementary colors (from yellow to orange) to the more established indo-
linospironaphthoxazines (blue) led to a great number of patents published through out that 
decade. In recent years, there has been a renewed interest in this class of organic photo-
chromic compound, specifically, in controlling the rate of thermal bleaching, and improving 
the synthetic routes to access these materials. Several strategies to meet these ends have 
been developed and led to unique discoveries regarding this class. 
 
Figure 6. Photochromic chromenes. 
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1.2.2.1. Background 
From their initial discovery in the 1960s through the mid 1980s, research on photo-
chromic benzo (47) and naphthopyrans (48-50) (Figure 5) was limited and their use in appli-
cations rare.4 These limitations were primarily due to the early literature on chromenes being 
rife with misinformation. Specifically, Wizinger and Wenning incorrectly reported the syn-
thesis of 3,3-diphenyl-3H-naphtho[2,1-b]pyran 49 from 2-hydroxy-1-naphthaldehyde 51 and  
diphenylethylene 52.24 This error would be corrected 20 years later when Livingston and 
coworkers identified the product as 8,8,10,10-tetraphenyl-7a,9,10,10a-tetrahydro-8H-
cyclopenta[b]naphtho[1,2-d]furan 53, Scheme 6.25  
 
Scheme 6. Synthesis and misidentification of 8,8,10,10-tetraphenyl-7a,9,10,10a-tetrahydro-
8H-cyclopenta[b]naphtho[1,2-d]furan. 
 
Unfortunately in 1954, six years prior to this correction, Hirshberg and Fischer would 
report that naphtho[1,2-d]furan 53, the compound assumed to be 3,3-diphenyl-3H-
naphtho[2,1-b]pyran 49, was not photochromic.26 Finally in 1966, Becker and Michl report-
ed the photochromism of 2H-1-benzopyrans, investigating over 25 derivatives, and present-
ing for the first time some of the effects of structural variation on photochromic behavior.27 
In the mid 1970s, Padwa and coworkers would provide valuable insights into the structural 
considerations that affected fatigue resistance in chromenes.28 
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Traditionally benzopyrans exhibit weak photochromic behavior and have received little 
attention.27 Naphthopyrans exhibit more intense color and increased lifetimes, which are fur-
ther improved by gem diaryl substitution adjacent to the pyran oxygen. Of the three isomeric 
naphthopyrans, the linear 2H-naphtho[2,3-b]pyran 48 exhibits negligible photochromic be-
havior at ambient temperature, as the photochromic reaction disrupts the aromaticity of both 
rings of the naphthalene fragment. The angular isomers, 2H-naphtho[1,2-b]pyran 50 and 
3H-naphtho[2,1-b]pyran 49, display good to excellent photochromic response under ambient 
conditions.4 The major differences between the two angular isomers being that the open 
form tautomer of the [1,2-b] isomer absorbs more strongly, exhibits two absorption bands in 
the visible region, and has a significantly longer lifetime after continuous irradiation. 
1.2.2.2. Synthesis 
The older more traditional synthetic routes for benzopyrans can generally be applied to 
the synthesis naphthopyrans and will be considered together. The reaction of aryl Grignard 
reagents with coumarins, while effective, results in significant byproduct formation and low 
to moderate yields, Scheme 7A.29 2,2-Dialkyl and 2-alkyl-2-aryl-benzopyrans are easily 
prepared by the reduction and dehydration of dihydrobenzopyran-4-ones, which are readily 
obtained from 2`-hydroxyacetophenones and ketones, Scheme 7B.30 However, this route is 
ineffective for the preparation of 2,2-diaryl-benzopyrans as the initial condensation reaction, 
between the acetophenone and a diaryl-ketone, suffers from extremely low yields even when 
t-butoxide used as the condensing reagent.31 
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Scheme 7. Classic synthetic routes for the preparation of photochromic chromenes. 
 
The reaction of α,β-unsaturated aldehydes with dilithiated o-bromophenols, followed by 
acid catalyzed cyclization provides photochromic chromenes in moderate to good yield and 
is only limited by substituent compatibility during the initial lithiation, Scheme 8.32 Similar-
ly, the reaction between lithiated heterocycles and o-hydroxynaphthaldehydes provides fac-
ile access to more structurally complex naphthopyrans.33 
 
Scheme 8. Lithiation-addition-cyclization strategy for the synthesis of photochromic 
chromenes 
 
However, the most direct route to naphthopyrans is the thermal rearrangement of naph-
thyl-propargyl ethers 65 (Scheme 9).34 A modified, one pot protocol that has dominated the 
synthesis of diaryl-naphthopyrans is the acid catalyzed reaction between 1,1-diaryl-
propargyl alcohols 64 and naphthols 63, where the naphthyl-propargyl ether 65 is generated 
in situ.35 This method is also compatible with hydroxyl-substituted heterocycles.  Early ex-
amples of this synthesis were plagued with byproducts. Interception of the propargyl carbo-
cation by a nucleophilic site on the naphthol generates propenylidenenaphthalenones 67 
sometimes as the sole product of the reaction.36 Additionally, α,β-unsaturated aldehydes are 
O
O
O O
OH
PhPhPh
Ph
PhMgBr
+
A
49
68%
55
11%
B
O
OH O
O
R
R O
OH
R
R O R
R
R2C=O, PhMe,
pyrrolidine, reflux
NaBH4, EtOH,
reflux
4-TsOH, PhMe,
reflux
54
56 57 58 47
OH
Br OH
OH
Ph
Ph
O
Ph Ph
i) 2 eq. n-BuLi, Et2O
ii)
4-TsOH, PhMe,
60 oC
Ph
O Ph
H
59 60 61 50
  19 
common byproducts arising from the Meyer-Schuster or Rupe rearrangement of the propar-
gyl alcohol. Gabbutt et al. developed the use of 4-nitrophenol as an additive to suppress the-
se side reactions and increase yields,36 while Carreira and Zhao have demonstrated that the 
addition of (MeO)3CH provides the desired photochromic chromenes in greater the 85% 
yield.37 
 
Scheme 9. Acid catalyzed one-pot synthesis of photochromic naphthopyrans. 
1.2.2.3. Photochromism and Related Properties 
Upon irradiation, chromenes undergo 6π electrocyclic ring opening of the colorless py-
ran isomer to generate the colored quinoidal isomer which can exist in four isomeric con-
formations, Figure 7.38 The heterolytic bond C-O bond cleavage leads to the non-planar cis-
cis (CC) isomer, 68 or 72. The CC isomer can either collapse back to the closed form or un-
dergo rotation about the C-C single bond to generate the trans-cis (TC) isomer, 69 or 73. 
This bond rotation occurs within 10 ps, and thus it is the TC isomer that is accessed on the 
nanosecond to second time scale. Absorption of a second photon by the TC isomer results in 
geometrical isomerization to the trans-trans (TT) isomer, 70 or 74, which is the most stable 
conformation of quinoidal chromene isomers. As the TT isomer is the product of two-
photon absorption, its formation is minimal in flash photolysis, but it accumulates to a large 
degree under continuous irradiation. Rotation of the C-C single bond of the TT isomer leads 
to formation of the cis-trans (CT) isomer, 71 or 75. Population of the CT isomer is believed 
to be unlikely as the significant steric interactions dramatically increase energy. 
OH
O O
R1 R2
Acid Catalyst,
PhMe, refluxHO R1
R2
R1 R2
+
O
R2R1
63 64 65 66 67
  20 
 
Figure 7. Ring-opened naphthopyran quinoidal isomers. 
 
There is a well-documented difference in the coloration and lifetime of the 2H-
naphtho[1,2-b]pyran 50 relative to the 3H-naphtho[2,1-b]pyran 49, with the former having 
both more intense coloration and a longer lifetime.4 Analysis of the TC and TT quinoidal 
structural isomers for each of these derivatives rationalizes this difference. As can be seen in 
Figure 8, for the [1,2-b] isomer 50 there is little to no steric interactions between any 4-H 
and 5-H in the TC conformation 69 or 3-H and 5-H in the TT conformation 70, thus permit-
ting both of these states to be readily populated, depending on the length of irradiation. In 
contrast, in the [2,1-b] isomer 49 there is considerable steric interaction between 1-H and 
10-H in the TC conformation 73 and 2-H and 10-H in the TT conformation 74. These steric 
interactions result in a destabilization of the both states and an overall decrease in there pop-
ulations during irradiation, with this effect being significantly more pronounced in the TT 
conformation 74. 
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Figure 8. Steric interactions in naphthopyran quinoidal isomers. 
 
The performance of 3H-naphtho[2,1-b]pyrans 76 can be modulated through the judicious 
selection of substituents on the aryl groups in position 3.35 As shown in Table 1, electron-
donating groups in the para position result in a bathochromic shift in the absorbance of the 
quinoid, while electron-withdrawing groups cause a hypsochromic shift in absorbance. Fur-
ther, very precise variation in the absorbance and rate of thermal bleaching can be afforded 
through the use of amino substituents.  Abe and coworkers have show that substitution at 
position 2 and/or 10 can dramatically accelerate thermal fade rates of 3H-naphtho[2,1-
b]pyrans 76 by increasing steric interactions in the quinoid isomers.39 
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Table 1. Spectroscopic and photochromic properties of some 3H-naphtho[2,1-b]pyrans 
 
R1 R2 R3 R4 λmax (nm) τ1/2 
H H H H 430 34 min 
H p-MeO H H 458 - 
p-MeO p-MeO H H 475 - 
p-F p-F H H 428 - 
H p-CF3 H H 422 - 
p-MeO p-NMe2 H H 512 - 
p-NMe2 p-NMe2 H H 544 - 
H H Br H 455 1.4 min 
H H H Br 415 2.5 ms 
H H Br Br 415 0.80 ms 
H H phenyl phenyl 430 5.1 µs 
H H H pyrene 452 46 µs 
 
Under steady state irradiation, similar to that encountered in ophthalmic lens applications, 
there is a greater equilibrium concentration of the open form of 2H-naphtho[1,2-b]pyrans 76 
compared to 3H-naphtho[2,1-b]pyrans 77, as described previously. This results in both in-
creased coloration and slow rates of thermal bleaching. While the former is a beneficial 
property the later is not. For ophthalmic lenses strong coloration should be coupled with rap-
id fade rates. One strategy to increase fade rates has been to install substituents at position 5 
on the periphery of the naphthopyran, as seen for the derivatives examined in Table 2.40 
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Table 2. Spectroscopic and photochromic properties of some 2H-naphtho[1,2-b]pyrans. 
 
R1 R2 λmax (nm) τ1/2 (s) 
CO2Et H 493 3 
CO2Me 6-OMe 502 73 
CO2Et 7-OMe 508 3 
CO2Me 8-OMe 480 11 
CO2Et 9-OMe 505 3 
CO2Me 10-OMe 485 21 
 
In recent years Moorthy and coworkers have explored the effect of incorporating a 
chromene into a [2.2]paracyclophane scaffold, Figure 9.41,42 While the parent benzopyran 47 
does not demonstrate photochromism at ambient temperature, benzopyrans constrained to 
the [2.2]paracyclophane framework exhibit photochromism at room temperature as a result 
of through space π−π delocalization, the phane effect.43,44 Interestingly, substitution of the 
second aromatic ring of the [2.2]paracyclophane scaffold increases the lifetime of the col-
ored state over the unsubstituted CPC-H 78, whether the substituent is electron donating or 
electron withdrawing. In the case of the electron donating substituent, CPC-OMe 79, this is 
a direct result of an enhanced phane effect where the electron rich methoxy-substituted ring 
stabilizes the quinoid via through space π−π delocalization.41 For CPC-Ac 80, where the se-
cond ring of the paracyclophane scaffold is substituted with an electron withdrawing acyl 
moiety, two effects operate in concert. As with both CPC-H 78 and CPC-OMe 79, the phane 
effect stabilizes the quinoid via through space π−π delocalization, additionally the carbonyl 
oxygen of the o-quinoid form functions as a “nucleophile” towards the acetyl carbonyl fur-
ther stabilizing the open form of CPC-Ac 80.42 
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Figure 9. Photochromic [2.2]paracyclophane constrained benzopyrans. 
 
 Coehlo and coworkers have made significant strides in eliminating formation of the 
long-lived TT conformation of the quinoid.45,46 As noted previously, the TT isomer is long 
lived and results in persistence of residual coloration for several minutes after irradiation is 
ceased. In flash photolysis settings, formation of the TT isomer is indicated by a biexponen-
tial decay of the colored species, and thus monoexponential decay indicates that only the 
short-lived TC isomer is generated. Both a benzopyran 8145 and 2H-naphtho[1,2-b]pyran 
8346 derivative were prepared that are only capable of generating the TC isomer upon irradi-
ation, Figure 10. 
 
Figure 10. Photochromic benzopyran and naphthopyran capable of only generating the TC 
isomer. 
1.2.3. Miscellaneous Classes  
While significant strides have been made in regards to the development of the classes 
presented thus far, it would be remiss to exclude novel architectures whose identification as 
photoswitches is so recent that they are still being studied and developed. In this section 
three recently discovered classes will be highlighted. First, oxazolone-based photoswitches 
that were developed based on the GFP chromophores, second the fused coumarin-
heterocycles and finally a borylated dibenzoborepin. 
O
H
OO
Ph
Ph
Ph
Ph
O
MeO
Ph
Ph
CPC-H 78 CPC-OMe 79 CPC-Ac 80
O
Ph Ph
OSi(CH3)2(t-Bu)
OH Ph
Ph
OSi(CH3)2(t-Bu)
Δ
O
O Ph
Ph
Ph Ph
O
O Ph
Ph
Ph
Ph
Δ
UV UV
81 82 83 84
  25 
1.2.3.1. Oxazolone-Based Photoswitches 
Nature has often inspired chemists and the field of photochromism is no exception. For 
example, the retinal protonated Schiff base (PSB) chromophores from rhodopsins are very 
efficient E/Z isomerization switches.47 In fact several PSB type photoswitches have been 
prepared and studies on their properties have been reported. Sampedro and coworkers, have 
drawn inspiration from the chromophore of the green fluorescent protein (GFP) 85, Figure 
11.48,49 
 
Figure 11. The GFP chromophore and oxazolone-based photochromic derivatives. 
 
The GFP chromophore 85 is know to undergo Z/E isomerization, as a nonradiative re-
laxation pathway after irradiation, which reduces the luminescence quantum yield.50 Further, 
this photoisomerization process has also been reported for intermediates in the synthesis of 
GFP chromophore derivatives, in particular oxazolone analogs 86. However, these phenom-
ena have only been slightly investigated, with the primary focus of these studies on the ef-
fect of isomerization on fluorescence.  To gain a better understanding of the photochromism 
of these GFP-oxazolone derivatives 86, Sampedro and coworkers employed classical condi-
tions for the synthesis of azalactones, and prepared a diverse range of these compounds, Ta-
ble 3, and examined their behavior as photoswitches. 
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Table 3. Synthesis, spectroscopic and photochromic properties of some oxazolone-based 
GFP chromophore derivatives. 
 
R1 R2 % Yield λmax (nm) 
Ratio at PSS 
% Z % E 
Ph Ph 85 360 75 25 
Ph p-MeOPh 60 381/404 83 17 
Ph o-MeOPh 87 385/403 65 35 
Ph p-BrPh 72 366 75 25 
Me Ph 80 327 85 15 
Me p-Tol 75 336 85 15 
Me p-MeOPh 65 355 85 15 
Me o-MeOPh 82 363 64 36 
Me p-NO2Ph 90 350 83 17 
Me p-CNPh 80 334 75 25 
Me p-MeCO2Ph 60 331 80 20 
Me p-BrPh 72 333 85 15 
Me 2-naphthyl 61 342 83 17 
Me 3-thienyl 74 358 60 40 
Me o-BrPh 42 330 60 40 
Ph p-NO2Ph 71 376 80 20 
Ph p-CNPh 34 370 45 55 
 
The derivatives are obtained solely as the Z isomer (86) in greater than 60% yield, the 
notable exceptions being the incompatibility of 2-carboxybenzaldehyde, 2-
cyanobenzaldehyde and ketones, which fail to provide the desired product. Having a range 
of derivatives, the UV/Vis spectra of the Z isomers were obtained. It was found that chang-
ing R1 from a methyl to phenyl group results in a bathochromic shift in the λmax, as a result 
of the increase in conjugation. Further, a bathochromic shift is also observed when R1 is 
maintained as a methyl group and R2 changed from phenyl to a substituted phenyl, heteroar-
omatic, or naphthyl group. Finally, those derivatives where R1 is phenyl exhibit absorbance 
in the visible region and the photochromic transition can be effected using this low energy 
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irradiation. This is a highly desirable trait for applications in biological systems where high-
energy UV light is often detrimental to the system. 
Each of the derivatives was irradiated with >290 nm light to determine the effect of 
structure on the photoswitching behavior. While none of the materials achieved full switch-
ing several notable effects on the photostationary state (PSS) were observed. It was found 
that R1 plays a minimal role in the PSS ratio, while R2 has a pronounced role. When R1 is 
held constant as a methyl group and R2 changed from phenyl to an ortho substituted phenyl 
or thiophene the ratio of isomers at the PSS is highly enriched in the E isomer. If R1 is main-
tained as a phenyl group and the substituent on the phenyl ring of R2 is changed from para 
to ortho there is a similar increase in the E isomer content of the PSS. Finally, the only in-
stance in which the E isomer is dominant in the PSS was for R2 = p-CNPh. 
Remarkably the both isomers have incredibly thermal stability. When held in the dark at 
room temperature the PSS did not change, nor does heating to 50 oC in the dark effect rever-
sion from the PSS. Only after prolonged refluxing toluene could the E isomer be slowly 
converted back to the more thermodynamically stable Z isomer. In fact these compounds 
demonstrate such high stability in the PSS that the resulting mixture can be separated by 
standard flash chromatography.  
1.2.3.2. Fused Coumarin-Heterocycles 
The coumarin framework is an important class of heterocycle that has wide applications 
in the fields of functional materials and medicinal chemistry. Yang and coworkers have 
found that when coumarins are fused with other heterocyclic scaffolds, they resulting sys-
tems exhibiting unique and unprecedented properties. In 2011 they reported on the thermo-
chromism of fused coumarin-phenanthridines,51 this was followed-up by their development 
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of photochromic pyranocoumarins in 2012,52 and finally photochromic fused coumarin-
pyrroles in 201353. 
The coumarin and phenanthridine scaffolds constitute two subsets of the heterocycles 
have found wide application as dyes,54,55 drugs56,57 and DNA targeting agents.58 With inter-
est in the potential biological activity of a fused coumarin-phenanthridine framework, Yang, 
Li, and Chen developed a highly efficient synthesis of these materials (Figure 12).51 At room 
temperature the neutral form 92 produces a light yellow solution in methanol, on cooling to 
0 oC the solution rapidly changes to orange-red as the material converts to the aromatized 
zwitterion 93. This discovery represents the first instance of inverse organic thermochrom-
ism where the leaving group is an alkoxide. The switching cycle was repeated 10 times 
without discernable degradation of the system as monitored by UV-Vis spectroscopy indi-
cating excellent fatigue resistance. While the zwitterion 93 could not be isolated for struc-
tural characterization, its formation and structure was confirmed by variable temperature 
NMR. 
 
Figure 12. Synthesis and thermochromism of a fused coumarin-phenanthridine. 
 
In the following year, Yang, Lin, and Li reported the microwave synthesis of a quinoline 
substituted pyranocoumarin 95 (Figure 13).50 Upon UV irradiation (306 nm), the absorption 
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band of 95 at 407 nm steadily decreases with the concurrent appearance of an absorption 
band centered at 507 nm. The photochromic process results in the 6π electrocyclic ring 
opening of the pyran moiety, and a change in the color of the solution from yellow to red. 
Interestingly, quinoline substituted pyranocoumarin 95 exhibits only weak fluorescence (λEm 
= 450 nm), while the ring opened product is strongly fluorescent (λEm = 598 nm). Reversion 
of ring-opened product is induced by the addition of base (DABCO or imidazole). 
 
Figure 13. Synthesis and photochromism of a quinoline substituted pyranocoumarin. 
 
As can be seen in Figure 13, the ring opening of the quinoline substituted of pyranocou-
marin can lead to four diene configurations 96-99, as proposed based on 1H NMR spectra 
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after irradiation. In order to gain a greater understanding of the ring opening process com-
pound 100 was prepared as a model for the trans-trans 98 and cis-trans 99 ring opening 
products in which the Cl substituted coumarin and quinoline groups are conjugated through 
a trans olefin (Figure 14). 
 
Figure 14. Model system to evaluate photochromic products of parent quinoline substituted 
pyranocoumarin. 
 
On irradiation with UV light (306 nm), a chloroform solution of model compound 100 
changes in color from yellow to red, and undergoes a similar change in UV-Vis absorption 
to that observed for the parent quinoline substituted pyranocoumarin. These changes in spec-
tral absorption arise from a trans to cis isomerization, as confirmed by 1H NMR, which ena-
bles a donor-acceptor charge transfer from the coumarin to the quinoline in cis conformer 
101. Based on these results the overall photochromic process is believed to be a ring open-
ing followed by olefin isomerization to the trans-cis and cis-cis isomers 96 and 97, as the 
trans-trans and cis-trans isomers 98 and 99 would be expected to exhibit similar absorption 
to the parent quinoline substituted pyranocoumarin. 
The ring-opened isomers have high stability, and revert by thermal back reaction after 
prolonged storage in the dark (~ 2 weeks). DABCO was found to efficiently mediate the re-
version, presumably through a zwitterionic intermediate. For repeated reversible cycling of 
the system, the DABCO would have to be removed chemically and thus a mechanically sep-
arable alternative would eliminate repeated neutralization. To this end imidazoline-
functionalized magnetic nanoparticles (ImMNPs) were evaluated as mediators for the rever-
sion. Reversible switching between the two states using UV irradiation and ImMNPs was 
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repeated for 10 cycles without noticeable degradation of the photochromes as monitored by 
UV-Vis spectroscopy. The role of imidazoline as the mediator was confirmed by the failure 
of the ring-opened isomers to revert when subjected to unfunctionalized MNPs. 
 
Figure 15. Synthesis and photochromism of a fused coumarin-pyrrole. 
 
Based on the knowledge that certain pyrrole derivatives undergo oxidation when irradi-
ated with UV light57, Yang and Li designed and prepared a fused coumarin-pyrrole 105 
(Figure 15).51  Upon UV irradiation (352 nm), methylene chloride solutions of the fused 
coumarin-pyrrole 105 convert from colorless to red, with the expected changes in UV-Vis 
absorption, to give the tertiary alcohol 106. In addition to the change in absorbance, upon 
photo-oxidation the fused coumarin-pyrrole 105 has a nearly complete loss of fluorescence. 
While the fused coumarin-pyrrole 105 exhibits Φf = 0.65, the tertiary alcohol 106 is virtually 
non-emitting with Φf = 0.03. The photo-oxidation product 106 reverts under acidic reducing 
conditions (Figure 15), presumably via hydrogenation/reduction of the imine followed by 
acid catalyzed dehydration. The use of mechanically separable and reusable Pd-
functionalized magnetic nanoparticles (Pd-MNPs) greatly facilities a reversible process by 
eliminating the centrifugation and filtration required when employing Pd/C. Finally, the 
overall redox cycle is ‘nearly’ perfect since the oxidizing agent is O2, and the reductant H2. 
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Oxygen, an ultimate oxidant, is virtually unlimited and free, while hydrogen is the most at-
om economical reductant and generates no waste. 
1.2.3.3. Borylated Dibenzoborepin 
Introduction of boron to π conjugated systems is a useful strategy to generated novel ma-
terials with interesting electronic structures.58 The key design principle being that a tricoor-
dinated boron atom is isosteric with a tricoordinated cationic carbon atom. This substitution 
permits transformation of a strongly electron accepting system in to an uncharged isolable 
form. In 2013, Yamaguchi and coworkers sought to employ this principle to prepare novel 
ladder π systems, specifically borole-fused borole 107 shown in Figure 16.59 They envi-
sioned that the desired material could be prepared from bisboronic ester 109 via lithium hal-
ogen exchange followed by introduction of the aryl substituents with ArMgX. On attempting 
the synthesis employing tBuLi and mesityl magnesium bromide they isolated not the ex-
pected product but borylated dibenzoborepin 110 instead. 
 
Figure 16. Retrosynthetic plan and synthesis of the photochromic borylated dibenzoborepin. 
 
When irradiated with UV light (320 nm), it was found that a colorless solution of the 
borylated dibenzoborepin 110 in benzene rapidly turns navy blue. The absorbance bands at 
346 and 387 nm in the UV-Vis spectrum of 110 decrease during the photochromic transition 
with concomitant development of a broad absorption band centered at 634 nm. On cessation 
of irradiation, the cyclized photoproduct 111 thermally reverts at ambient temperature in the 
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dark. The structure of the photoproduct 111 was confirmed by X-ray crystallography. As 
seen in Scheme 10, the photochromic reaction is proposed to proceed through a 4π bora-
Nazarov cyclization. It is believed that this unique behavior is possible since the borylated 
dibenzoborepin is isosteric to the cyclopentadienal cation intermediate of the acid catalyzed 
Nazarov cyclization. Unlike the Nazarov cyclization and the well-known 6π Nazarov-
analogous cyclizations of nitrogen, sulfur and oxygen bearing substrates,60 which occur un-
der either thermal or photo mediated conditions, the bora-Nazarov only occurs via pho-
toirradiation. This is the first example of a light mediated bora-Nazarov cyclization, and 
opens the door to novel photochromic materials based on this reversible reaction. 
 
Scheme 10. Bora-Nazarov photochromism of borylated dibenzoborepin. 
 
1.3. Closing Remarks 
 As has been shown, in recent decades, significant effort has been devoted to the chemistry 
of organic photochromic compounds. These efforts have been spread between the design 
and development of novel systems and efforts towards improving and enhancing the proper-
ties of known and established classes. The primary driving force for these works, is the 
unique ability of these compounds to undergo reversible spectral and physical property 
changes which has led to their adoption in fields from energy production,61 chemical sens-
ing,62 and molecular actuators63 to biological systems.7,64–67 While a great many molecular 
switches are known, the advantage of photochromic systems, those activated by light, over 
those materials whose reversible transformations are mediated by stimuli such as pH, ionic 
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concentration, electrical or magnetic field, or humidity is the abundant and versatile nature 
of light as a stimulus which enables both temporal and spatial resolution. 
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2. Donor-Acceptor Stenhouse Adducts: Design and Discovery 
2.1. Design: Background and Historical Perspective 
In the field of adaptable and responsive materials, the ability of organic photochromic 
compounds to reversibly undergo changes in spectral absorption, volume, and solubility is 
of particular importance for applications in energy storage and chemical sensing and for 
controlling the conformation and activity of biomolecules.1–4 These switches are particularly 
valuable because their property changes are triggered by light, the most widely available, 
non-invasive, and environmentally benign external stimulus. Significantly, light also pro-
vides unique opportunities for spatial and temporal resolution.  
Among the classes of organic photochromic materials, azobenzenes, spiropyrans and di-
arylethenes have received the most attention because of their excellent performance and 
broad utility. Specifically, azobenzene has been extensively employed for its change in vol-
ume, resulting from a trans 1 to cis 2 isomerization, upon irradiation (Figure 1A).5,6 Similar-
ly, the change in spectral properties of spiropyrans (10) and diarylethenes (12) upon pho-
toswitching has been exploited in a number of applications,7,8 with spiropyran exhibiting the 
added benefit of a solubility switch, or a conversion from a hydrophobic (10) to a hydro-
philic form (11), upon irradiation.9,10 Despite their ubiquity and broad utility, these privi-
leged classes of photochromes all typically require the use of high-energy UV light to trig-
ger their photochemical reactions. This hinders their potential use in biomedical applications 
and material science because UV light can be damaging to healthy cells and results in deg-
radation for many macromolecular systems.3 Fatigue resistance is also a primary concern for 
UV-based photochromic switches. A common design principle to address this problem is to 
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make synthetic modifications to these known classes of photochromic compounds that ena-
ble the use of visible light (3-9).11–17 
 
Figure 1. A) Photoswitching of azobenzenes and representative visible light activated deriv-
atives, B) Photoswitching of spiropyrans, C) Photoswitching of diarylethenes. 
 
This is at best a stopgap solution. While effective, this strategy typically results in sys-
tems that are limited to specific applications, and necessitates laborious synthetic efforts. 
The unfortunate consequence being that these derivatives are not widely adopted or em-
ployed as their preparation is beyond the abilities of the non-expert.  It was our view, in-
spired by the works of Abe,15,18–24 Sampedro25,26, and Yang,27–29 that the challenge of devel-
oping new organic photochromic molecules required a paradigm shift. In addition to the 
widely employed and accepted practice of tuning known systems, critical analysis of the lit-
erature, specifically brief communications of unexpected chemical behavior, should be em-
ployed as a starting point for the rational design of novel photochromic compounds that ad-
dress the limitations of known classes. 
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After a careful and exhaustive search of the literature surrounding photochromic organic 
compounds we recognized that two major limitations had been poorly addressed to date. 
First, there has been a significant deficit in development of organic photochromic molecules 
that respond to visible light. Overwhelmingly, organic photochromic molecules, both newly 
developed and known systems, are activated and operate under the irradiation of Ultraviolet 
light. Second, the scientific community has essentially ignored the field of negative or in-
verse photochromism, where the stable isomer is colored and reversibly bleaches when irra-
diated. Indeed the few reports on negative photochromism identify the phenomenon as an 
accidental discovery. Further, after the initial report, there are rarely any further studies pre-
sented. It was with these considerations in mind that we began our efforts towards the design 
and development of a photochromic organic compound that operates as a negative photo-
chromic system activated by visible light. 
Our interest in the cascade rearrangements of activated furans30–35 and a pioneering re-
port by Honda36 inspired us to design a novel negative (colored to colorless) photochromic 
material.8,15 During the design stage, we established three criteria for an ideal new class of 
organic photochromic material that helped guide our discovery efforts: (1) intrinsic activa-
tion by visible light, (2) significant change in spectral absorption, solubility, and volume, 
and (3) facile synthetic access, modularity and tunability. A number of important contribu-
tions helped us conceive the molecular architecture we would target for study. 
In 1870, Stenhouse discovered that in the presence of 2 equiv of a primary or secondary 
aniline and 1 equiv of protic acid furfural undergoes ring opening to give stable, intensely 
colored salts whose structure, five-carbon cyanine dyes with an OH group at the second car-
bon atom, was established by Schiff in 1887 (Figure 2A).37,38 Initial imine/iminium for-
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mation between furfural and the aniline activates the furan nucleus to nucleophilic attack, 
which then leads to ring opening of furan and formation of the Stenhouse salt. Nearly a cen-
tury later, in 1982, Honda disclosed the visible light mediated negative photochromism of 
Stenhouse salts (Figure 2B).36 Although the mechanism and product of the photochromic 
reaction was not reported, the enolic OH group was determined to be critical for the photo-
bleaching−thermal recoloration process since the parent cyanine dyes with no OH group 
(obtained by the Zincke ring opening of pyridinium salts) do not display these properties.39–
41 In Honda’s report, the photobleaching-thermal recoloration process was strongly depend-
ent on the concentration of added acid, and in the presence of 100 equiv of HCl photo-
bleaching did not occur. This result is consistent with related studies on Stenhouse salts by 
Lewis and Mulquiney, even though they did not study the photochromic properties of these 
systems.42–44 In the Lewis study, treatment of the Stenhouse salts with base only gave the 
corresponding colorless cyclopentenone adducts (Figure 2C).42 Further, in 2000, Safar and 
co-workers reported a preliminary study on the rearrangement of 5-(furan-2-ylmethylene-)-
2,2-dimethyl-1,3-dioxane-4,6-dione 19 with cyclic secondary aliphatic amines (Figure 
2D).45 In contrast to Stenhouse’s work, this system exploited the electron-withdrawing na-
ture of the cyclic dicarbonyl to impart the same result as imine/iminium activation. Interest-
ingly, reaction of furan 19 with morpholine or piperidine in a 2:1 or 1:1 molar ratio resulted 
in a mixture of two compounds; the Stenhouse-based adduct 21 and the corresponding cy-
clopentenone 22. All attempts to separate this mixture were unsuccessful; however, treat-
ment of this mixture with excess HBr gave exclusively the cyclopentenone hydrobromide 
23, and presumably the equilibrium was driven to the product by precipitation of the salt. 
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Figure 2. A) Stenhouse’s ring opening of furfural by aniline and protic acid, B) photo-
chromism of Stenhouse salts examined by Honda, C) Lewis and Mulquiney’s base-mediated 
cyclization of Stenhouse salts, D) Safar’s secondary amine ring opening and rearrangement 
of activated furans. 
 
Based on these reports we hypothesized that the photochromic behavior observed by 
Honda was due to a reversible interconversion between the open Stenhouse salt and the 
closed 4,5-aminocyclopentenone. Combined, these studies also suggest that the ability to 
tune and control the process by which the open Stenhouse adduct and the closed cyclopente-
none adduct interconvert is dependent on the substituents of the push−pull system derived 
from the amine ring opening of furfural or its derivatives. With these considerations in mind, 
the donor-acceptor Stenhouse adducts (DASAs) with a general structure 21 were selected 
for initial studies (Figure 2D). 
2.2. Discovery: Synthesis 
At the outset, we sought to develop optimal conditions for the selective formation of the 
colored triene Stenhouse adduct 21 without concomitant generation of the cyclopentenone 
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equimolar ratio of furylidene−Meldrum’s acid 19 and pyrrolidine 20 in tetrahydrofuran pro-
vided the desired Stenhouse adduct 21 in 95% yield with filtration as the only purification 
necessary (entry 7). In direct contrast, the use of other solvents required heating to 50 °C and 
resulted in lower yields (entries 5 and 6) or inseparable mixtures of Stenhouse adduct 21 and 
cyclopentenone 22 (entries 1−4). While the addition of Lewis acids or bases such as dyspro-
sium triflate or DABCO increased yields, these conditions also produced mixtures of 21 and 
22 (entries 2 and 3). 
Table 1. Optimization of reaction conditions for the selective formation of Stenhouse-based 
adducts (DASAs)a 
 
Entry Solvent Temp. (°C) Time (min) Product Yield (%)b 
1 MeCN 50 60 21 + 22 60c 
2d MeCN 50 60 21 + 22 70c 
3e MeCN 50 60 21 + 22 80c 
4 MeOH 50 30 21 + 22 80c 
5 CH2Cl2 23 60 21 50 
6 PhMe 50 30 21 50 
7 THF 23 10 21 95 
aActivated furan 19 (1 equiv) and pyrrolidine 20 (1 equiv) were sequentially added to the 
solvent and stirred at the temperature indicated. bIsolated yields. cInseparable mixture of 21 
and 22. d10 mol % of dysprosium triflate added. e10 mol % of DABCO added. 
 
With our success in employing Meldrum’s acid as an activating group, we were curious 
if other 1,3-dicarbonyl moieties would be equally effective. Five motifs were selected for 
examination: 2,4-pentanedione 24, malonic acid diethyl ester 28, dimedone 31, and N,N`-
dimethylbarbituric acid 34 (Figure 3).  Diethyl amine 26 was employed as the nucleophile in 
testing the susceptibility of the activated furans, obtained by condensation of these dicar-
bonyls with furfural, towards ring opening.  Neither 2,4-pentanedione 24 nor malonic acid 
diethyl ester 28 sufficiently activated furfural, implicating the importance of the cyclic na-
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ture of Meldrum’s acid. Similarly, the dimedone activated furan 32 failed to produce the de-
sired Stenhouse adduct, indicating that 1,3-diketones, whether cyclic or acyclic are not ca-
pable of activating furfural for the desired ring opening under the described conditions (at-
tempts to overcome this limitation were not pursued). Gratifyingly, N,N`-dimethylbarbituric 
acid 34 was an effective activating group, providing the Stenhouse adduct 36 in excellent 
yield, 81%. 
 
Figure 3. Initial evaluation of the scope of 1,3-dicarbonyl activating groups. 
 
Inherent in the versatility and overall usefulness of these DASA photoswitches is the 
high yielding and simple nature of the synthetic procedures, which allows non-experts easy 
access to more complex or functional substrates that are attractive for tailored applications in 
materials science. Having efficient access to the triene derivatives, the photophysical proper-
ties were examined with diethyl amine derived adducts as model systems (Scheme 1). 
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Scheme 1. DASAs selected as model systems for examining photophysical and photo-
chromic properties. 
 
2.3. Discovery: Photophysical and Photochromic Properties 
We began by examining the unidirectional conversion of the colored triene 38 to its col-
orless zwitterionic cyclopentenone isomer 39 using NMR spectroscopy in a deuterated 
methanolic solution (Figure 4A). Exposure of 38 to a standard incandescent bulb or hand-
held fluorescent lamp results in a decrease over the course of 4 h in the NMR peaks corre-
sponding to 38 and a concomitant increase in the peaks for 39. Similarly, this process was 
also studied using UV−Vis spectroscopy for 36 in methanol (Figure 4B). Again, irradiation 
with visible light leads to a decrease of the absorption of 36 as it is converted to 37 over 50 
min. The difference in the rate of conversion between the triene and the zwitterionic cyclo-
pentenone isomers was governed by concentration (1H NMR required high concentration to 
obtain adequate data, dilute conditions were used for UV−vis experiment) and not the nature 
of the derivative or solvent employed. The isosbestic point was determined to occur at 280 
nm for both compounds. 
 
N
OH
O
O
O
O N
O
O
OO
O
H
visible light
Δ
N
OH
N
N
O
O O N
O
N
NO
O
O
H
visible light
Δ
38 3936 37
  47 
 
Figure 4. A) Conversion of 38 to 39 by 1H NMR in CD3OD over 4 h. B) Absorption spectra 
of 36 to 37 on irradiation with visible light in CH3OH. C) Expanded view of absorption 
spectra of 36 to 37 between 250 and 280 nm. 
 
Having controlled access to both structural forms, we next determined conditions that 
would facilitate rapid, quantitative, and fully reversible switching between the triene and 
cyclopentenone forms. Similar to spiropyrans and diarylethenes, reversible photoswitching 
of DASAs was found to be solvent dependent.46,47 We found aromatic solvents to be ideal, 
providing conversion of the triene to cyclopentenone upon irradiation with visible light with 
thermal reversion from the meta-stable cyclopentenone back to the triene when irradiation is 
stopped. 
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Figure 5. Relative rates of interconversion for derivatives 36 and 38. 
 
With reversible conditions identified, the relative rates of interconversion between the 
triene and cyclopentenone isomer were evaluated in toluene for the two photoswitches (36 
and 38, illustrated in Scheme 1) bearing different acceptor groups. As illustrated in Figure 5 
both derivatives undergo conversion from the open triene isomer (36 and 38) to the closed 
zwitterionic cyclopentenone isomer (37 and 39) at approximately the same rate. A more 
dramatic rate difference was observed in the thermal recoloration, upon cessation of irradia-
tion, where the 1,3-dimethyl barbituric acid derivative (36) reverted back approximately 
twice as fast. This process is solvent (Figure 6) and temperature dependent (Figure 7), but it 
is worth noting that in polar protic solvent thermal reversion was not observed.  
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Figure 6. Effect of solvent on photoswitching of 36, half-life of thermal recoloration (τ1/2) 
denoted in legend adjacent to solvent. Irradiations were performed with un-filtered high in-
tensity light. 
 
 
Figure 7: Effect of temperature on photoswitching of 36. Experiments performed in reagent 
grade toluene, irradiating with unfiltered high intensity light. 
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The reversible conversion between the colored triene and the colorless cyclopentenone 
adduct is most dramatically effected by solvent (Figure 8). This is similar to spiropyran47 
and diarylethene46 systems, which have also been shown to be highly solvent dependent. In 
protic solvents (methanol or water), the colored triene can be triggered by visible light and 
converted into the colorless zwitterionic cyclopentenone form; however, thermal reversion 
to the triene does not occur. In contrast, thermal reversion to the colored triene form is facile 
in halogenated solvents (dichloromethane, chloroform, or chlorobenzene), but photoisomeri-
zation to the cyclopentenone does not occur. For reversible photocyclization of the triene to 
cyclopentenone with thermal reversion of the cyclopentenone back to the triene, aromatic 
solvents (toluene, benzene, or xylenes) are ideal. 
 
Figure 8. Solvent effects on the solution state switching behavior of DASAs. 
 
We also found that the choice of acceptor group has an effect on the λmax and associated 
color of the triene. For example, in toluene the Meldrum’s acid derived triene 38 displays a 
λmax of 545 nm, changing the acceptor to the more electron-withdrawing 1,3-dimethyl barbi-
turic acid, 36, results in a bathochromic shift to 570 nm. In both cases these derivatives are 
excellent organic dyes with extinction coefficients determined to be ∼100,000 M−1 cm−1 for 
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the triene form. Further, we have found that these trienes display appreciable solvatochrom-
ism similar to other merocyanine-type materials (Figures 9 and 10).48,49 
 
Figure 9 Solvent dependent spectral absorption of 38. 
 
 
Figure 10. Solvent dependent spectral absorption of 36. 
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From related studies, the mechanism of switching is proposed to occur via a reversible 
Nazarov-type 4π electrocyclization.30–35 Importantly, conversion to the zwitterionic cyclo-
pentenone (37 and 39) results in bleaching of all derivatives studied, providing colorless, 
water-soluble materials. Intrigued by the solution-state behavior of our DASA materials, we 
reasoned that these compounds could engage in dynamic phase transfer. If true, this enables 
applications of these compounds as visible light activated phase-transfer tags.50–55 To probe 
the potential of this avenue, we layered toluene solutions of a variety od DASAs over water 
(Table 2). Upon irradiation of these biphasic systems with visible light, the DASAs were 
observed to cyclize with transfer of the DASA to the aqueous layer being quantified by 
UV−Vis and NMR spectroscopy. 
Table 2. Schematic representation of DASA dynamic phase transfer and results. 
 
Entry Acceptor Donor % Transferred to Aqueous 
% Recovered 
from Aqueous 
1 Meldrum’s acid Diethylamine 100 10 
2 Meldrum’s acid Dibutylamine >99 98 
3 Meldrum’s acid Dihexylamine 80 77(96) 
4 Meldrum’s acid Dioctylamine 0 NA 
5 Dimethyl Barbituric acid Diethylamine 100 5 
6 Dimethyl Barbituric acid Dibutylamine 85 81(95) 
7 Dimethyl Barbituric acid Dihexylamine 67 60(90) 
8 Dimethyl Barbituric acid Dioctylamine 0 NA 
 
We found that the amine donor plays a dramatic role in the efficacy of transfer to the 
aqueous phase. Employing short alkyl chain amine donors (entries 1, 2, 5 and 6) results in 
near quantitative transfer of the DASA to the aqueous phase. Conversely, a long alkyl chain 
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donor (entries 4 and 8) results in DASA cyclization; however, these derivatives fail to trans-
fer to the aqueous phase. Efforts to thermally revert the cyclopentenone to the triene and 
transfer the adduct from the aqueous layer back to the aromatic organic layer were unsuc-
cessful. However, separation of the resultant aqueous solution and extraction with DCM en-
abled recovery of the triene forms (entries 1-3, 6 and 7) in 10% to quantitative yield, again 
highlighting the critical role of the amine donor in this process. 
 
Figure 11. Fatigue testing of 36 in PhMe (0.16 mM), alternative irradiation at 570 nm (red) 
and dark (black). 
 
Fatigue resistance is a key characteristic for gauging the potential of photochromic mate-
rials, thus the performance of DASA photoswitches was tested (Figure 11).56 Rapid and 
complete switching of 36 was consistently observed when irradiating with visible light cen-
tered at the λmax of our DASA with negligible material degradation (<0.05% loss per cycle), 
as measured by the intensity of absorbance.2 As a comparison, when cycled with a broad-
band light source, a ~0.25% loss in efficiency was observed per cycle due to unfiltered UV 
light from the broadband source. Fatigue experiments were conducted in ambient conditions 
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without the need to exclude oxygen or water, demonstrating the robust nature of this pro-
cess. 
Further structural characterization of the two isomeric DASA states was provided by 
single-crystal X-ray diffraction, which revealed the triene form to be a conjugated, linear, 
hydrophobic material with an amine “donor” and a 1,3- dicarbonyl “acceptor” (see below in 
Figure 15). Our assignment of the cyclopentenone form as a zwitterion comes from the ob-
servation that these materials are water-soluble and further from bond length measurements 
in their crystal structures. We have found that one of the ester (or amide) functionalities in 
the 1,3-dicarbonyl moiety displays bond lengths more appropriate for a β-enolic ester (or 
amide) than a β-dicarbonyl (Figure 12). 
 
Figure 12. ORTEP renderings of A) derivative 39 and B) derivative 37, showing atomic dis-
tance measurements used to initially assign the cyclopentenone form as a zwitterion (Dis-
tances in Å, 50% probability ellipsoids, hydrogen atoms omitted for clarity. 
 
While we felt that both the hydrophilicity of the closed isomer and the data provided 
from our X-ray crystallographic studies gave nearly conclusive evidence that the closed 
isomer was indeed a zwitterion, we sought to unambiguously confirm protonation of the do-
nor amine, in the cyclized state. X-ray photoelectron spectroscopy (XPS), is perhaps the 
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most powerful technique for the characterization of a surface57 or crystal.58–62 In an XPS 
measurement, X-rays of known energy are irradiated onto a surface or crystal, resulting in 
the emission of core electrons from the elements present. In turn the kinetic energy of the 
ejected electrons is quantified in relation to the energy of the incident X-ray beam. Thereby 
the ejected electrons binding energy is determined, which is dependent on the identity and 
electronic nature of the element from which they were emitted. In this way chemical chang-
es in the material analyzed can be followed. For our purposes, we sought to track conversion 
of the neutral tertiary amine donor of the triene to the protonated ammonium of the proposed 
zwitterion. In high resolution X-ray photoelectron spectroscopy (HRXPS), these two states 
can be distinguished as neutral amines exhibit binding energy of ~400 eV, while ammonium 
species display binding energy of ~402 eV. 
 
Figure 13. Preparation of DASA functionalized surface for XPS studies. 
 
To accomplish this goal we designed and prepared a secondary amine functionalized 
polymer covalently bound to a silicon surface, which was reacted with activated furan 19 to 
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generate DASA functionalized surface 45, Figure 13. DASA functionalized surface 45 was 
then exposed to visible light to presumably form surface 46. We then analyzed surfaces 44 
and 46 by HRXPS. Importantly, the choice of monomers and the use of activated furan 19, 
ensure that any nitrogen signature in the XPS spectrum will arise solely from the amine do-
nor of the appended DASA. If our hypothesis, that the cyclized form is a zwitterion, was 
correct we should clearly see this difference in the HRXPS spectra of the two substrates, 
where surface 44 should only show a peak at ~400 eV, and surface 46 at ~402 eV.  
Indeed as can be seen in Figure 14A, surface 44 generates the expected single HRXPS 
peak centered at ~400 eV. In contrast surface 46 exhibits a broadened HRXPS signature 
centered at ~402 eV, Figure 14B. Deconvolution and peak fitting of this spectrum indicates 
that the nitrogen content of the surface is composed of 70% ammonium species. We are 
therefore confident based on solubility, single crystal X-ray diffraction, and HRXPS that the 
structure of the colorless cyclized isomer is a zwitterion. 
 
Figure 14. A) HRXPS spectra of surface 44, B) HRXPS spectra of surface 46. 
 
The large molecular contraction these materials exhibit upon switching is clearly evident 
in their crystal structures (Figure 15). Atomic distance measurements identify a 52% molec-
ular contraction of the DASA upon switching as measured from the nitrogen donor to the 
carbon at the 5 position of the acceptor (7.34/7.40 Å for the open derivative, 3.55/3.53 Å for 
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the closed). This distance is significantly greater than that observed for other privileged pho-
toswitches, including the spiropyran63,64 or azobenzene65,66 systems, (∼20% and 30% mo-
lecular contraction based on distance (Å) in published crystal structures, respectively). 
 
Figure 15: ORTEP renderings of 38 and 39 (top) and 36 and 37 (bottom) (Distances in Å, 
50% probability ellipsoids, hydrogen atoms omitted for clarity). 
 
2.4. Closing Remarks 
With the ever increasing desire for on demand changes in material properties controlled 
by environmentally benign triggers, there exists a need for novel molecular switches capable 
of engaging in these functions.  With the limited efforts towards the development of new 
organic negative photochromic compounds, fulfillment of this need has relied on tailoring 
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known systems to specific applications.  We have developed a novel class organic photo-
chromic compound, donor acceptor Stenhouse adducts, derived from renewable feedstocks, 
and prepared through a mild, rapid and operationally simple synthesis and purification. We 
have successfully identified conditions for the reversible and quantitative switching of these 
compounds in the solution phase. This new class of photoswitchable molecules is syntheti-
cally versatile and exhibits a unique combination of physical and chemical properties. These 
DASAs show reverse photochromism under visible light, which is complementary to previ-
ous classes of photoswitches, and display excellent fatigue resistance under ambient condi-
tions. 
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3. Synthetic Scope 
3.1. Background and Motivation 
Having succeeded in our efforts to prepare DASAs,1 we sought to determine the limits of 
diversity in terms of the scope of acceptors, donors and methods to effect cyclization. 
Among the factors motivating us to probe structural diversity, our primary interests were 
focused on the ability to tune the wavelength of activation and functional group tolerance. 
While our interest in alternate methods to effect cyclization were driven by a desire to pro-
vide access to the cyclopentenone isomer for those applications where thermochromism was 
desired.  
In recent decades, significant effort has been devoted to the chemistry of organic photo-
chromic systems. Their ability to undergo reversible spectral and physical property changes 
has led to applications ranging from energy production,2 chemical sensing,3 and molecular 
actuators4 to biological systems.5–9 The driving force for this focus is the abundant and ver-
satile nature of light as a stimulus which enables both temporal and spatial resolution. How-
ever, for a photochromic compound to be applied it is often necessary that it be chemically 
ligated to a macromolecular system. As such, it is critical to know which functional groups, 
which can be exploited for this chemical ligation, are tolerated in the synthetic methodology 
used to prepare the photochromic molecule. 
The ability to tune wavelength of activation without the need to modify the synthetic 
methodology would constitute a significant advance over the accepted practices widely em-
ployed for tuning azobenzenes,10–12 spiropyrans13 and diarylethenes.14,15 Specifically, with 
the discovery that the acceptor moiety has a direct effect on the wavelength of activation, we 
were interested in examining not only what properties of the acceptor lead to a change in 
  64 
triene absorbance, but also in attempting to prepare derivatives activated by near infrared 
(NIR) radiation (650-900 nm). In the realm of biomedical applications, photo-therapeutics 
are most effective when activated by NIR.16 The superior performance of NIR in biomedical 
applications is a result of the spectral absorbance of tissues and fluids; hemoglobin (which 
absorbs visible light) along with water and lipids (which absorb infrared light) have their 
lowest absorption coefficient in the NIR.17,18 
Finally, as a T-type photochromic system,19 the ability to use heat (ambient or elevated) 
to revert the metastable DASA cyclopentenone isomer to the more thermodynamically sta-
ble triene allows for potential thermochromic applications. As has been shown, photo-
chromic cyclization of DASA triene occurs at dilute concentrations, preventing isolation of 
the colorless isomer. Accordingly, we sought to develop chemical methods for the cycliza-
tion of the triene that also facilitated isolation of the cyclopentenone isomer. 
3.2. Donors 
3.2.1. Meldrum’s Acid Derived DASAs 
Having developed optimized conditions for the selective formation and isolation of the 
triene isomer, we proceeded to evaluate the generality of this process with a range of amine 
nucleophiles. We found that a broad array of secondary aliphatic amines are competent reac-
tion partners. As can be seen in Figure 1, employing Meldrum’s acid activated furan 1, the 
desired DASA trienes were obtained in good to excellent yield. We were gratified to find 
that cyclic secondary amines, including those that bear heteroatoms, and acyclic secondary 
amines were well tolerated. It is of not that while amino-esters 9 are compatible, the corre-
sponding amino acid, proline, returns only unreacted 1.  Diallylamine, which can be em-
ployed as a reaction partner in thiol-ene “click” reactions, was also effective for producing 
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triene 16.20 The broad applicability and widespread adoption of the copper catalyzed azide-
alkyne cycloaddition (CuAAC) “click” reaction, prompted us to prepare derivative 15.21,22 
With an interest in potential applications in polymer settings, derivatives 17 and 18 were 
prepared with amine donors that could serve as an acrylate monomer and ATRP initiator, 
respectively. Further, benzylic amines, both cyclic and acyclic were well tolerated, again 
providing the expected DASA trienes in excellent yield. Finally, secondary anilines were 
found to participate in the ring opening reaction, though with significantly diminished yield. 
In the course of this investigation we found that the reaction of 1 with primary aliphatic 
amines and primary anilines resulted in decomposition. 
 
Figure 1. Synthesis of Meldrum’s acid derived DASAs, isolated yields. 
3.2.2. 1,3-Dimethylbarbituric Acid Derived DASAs 
With these results in hand, we proceeded to evaluate this selection of amine donors to-
wards ring opening of 1,3-dimethylbarbituric acid activated furan 24, Figure 2. We were 
pleased to find that the desired Stenhouse adducts were formed in good yield and had nearly 
equal scope as the Meldrum’s acid derivatives with respect to the compatibility of the amine 
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nucleophile with few exceptions. In the case of morpholine (28) and phenylpiperazine (29) 
decomposition of 24 is observed, whereas for isoindoline (43), dibenzylamine (44), and N-
methylaniline (45) the starting material is recovered. Again here, as was seen for activated 
furan 1, the reaction of 24 with primary aliphatic amines and primary anilines resulted in 
decomposition. 
 
Figure 2. Synthesis of 1,3-dimethylbarbituric acid derived DASAs, isolated yields. aNR: no 
reaction. 
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the ATRP initiator (18 and 40) engage in the photochromic transformation to produce the 
corresponding zwitterionic cyclopentenone. 
3.3. Acceptors 
3.3.1. Exploration of Cyclic Active Methylene Acceptors 
In our initial studies we found that both Meldrum’s acid and 1,3-dimethylbarbituric acid 
were effective activating groups for the ring opening reaction, where acyclic β-diketones 
and β-diesters or cyclic β-diketones were not. Further, we observed several significant dif-
ferences in the photophysical properties of the photochromes obtained from these two ac-
ceptors. First, there is a bathochromic shift of 25 nm in the λmax of the triene isomer on 
changing the acceptor from Meldrum’s acid to 1,3-dimethylbarbituric acid. Second, there is 
a marked difference in their rates of thermal reversion, where the zwitterionic cyclopente-
none of the 1,3-dimethylbarbituric acid derived DASA recolors approximately twice as fast 
as its Meldrum’s acid derived counterpart.  
To probe the limits of diversity in the structure and nature of the acceptor, and ultimately 
determine its effect on the photochromism of any DASA adducts obtained, we evaluated a 
wider selection of cyclic and heterocyclic β-dicarbonyl active methylene compounds.23–25 
As outlined in Scheme 1, these potential acceptors were condensed with furfural and the re-
sulting Knoevenagel adducts were then treated with diethylamine.26,27  
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Scheme 1. Expanded evaluation of the scope of active methylene activating groups. 
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ing the furan providing the desired DASA triene 56 in 85% yield. This adduct has a λmax of 
605 nm, and exhibits the expected photochromic behavior. It is of note that while this deriv-
ative behaves as expected, the triene decomposes when stored under ambient conditions. 
Interestingly, the use of barbituric acid 57 as an activating group provides only the corre-
sponding zwitterionic cyclopentenone 59. All efforts to access the corresponding triene iso-
mer, either thermally or chemically, were unsuccessful. Similar to 1,3-Diethylthiobarbituric 
acid 54, the use of 1,3-indandione 60 provided DASA adduct 62 with a λmax of 600 nm. 
However, this derivative was not observed to engage in photochromism under the currently 
optimized conditions. Finally, the use of 1,1-dicyanomethylene-3-indanone 63 and 1,3-
bis(dicyanomethylene)-indan 66, did not produce the desired triene, instead giving the ex-
panded ring dihydroindenopyridine carbonitrile derivatives 65 and 68, respectively.28 We 
have found that these derivatives (65 and 68) oxidize in air to the corresponding pyridine 
adduct. This oxidation can also be affected synthetically with either the mild oxidizing agent 
chloranil for 65, or the much stronger KMnO4 for 68. While we had expected that the use of 
activating groups 63 and 66 would provide a further bathochromic shift in the absorbance of 
the triene, however, the isolation of 65 and 68 demonstrate that this strategy was not effec-
tive. Thus the continued exploration of activating groups to determine the properties that 
control the absorbance of the triene remains as a challenge in the further development of 
DASA photoswitches, particularly if they are to be successfully and widely adopted in bio-
logical or biomedical applications. 
3.3.2. Diversity in 1,3-Disubsituted Barbituric Acids 
Considering the limited success of these efforts we chose to refocus and probe the poten-
tial diversity of substituents on the barbituric acid group. This would provide evidence that 
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the N-group could serve as a functional handle for the incorporation of these molecules into 
materials. We thus prepared several 1,3-disubstituted barbituric acids with various alkyl and 
aryl substituents. After condensation with furfural, reaction with diethylamine resulted in 
ring opening to give the anticipated colored trienes in high yield (Scheme 2). 
 
Scheme 2. Synthesis of 1,3-disubstituted barbituric acid derived DASAs. 
 
 All of the DASA derivatives shown in Scheme 2 display the expected λmax of ~570 
nm that was observed for those derived from 1,3-dimethylbarbituric acid, demonstrating that 
the nature of substituents on the nitrogen atoms of the barbituric acid group do not affect the 
absorbance of the triene. On examining the photochromic behavior of these derivatives, we 
were gratified to find that all engage in fully reversible T-type photochromism, under the 
conditions previously established. Further, we were particularly pleased to obtain derivative 
82, which bears an ATRP initiator allowing for this DASA (and the activated furan it was 
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derived from) to serve as complement to secondary amine donor used to prepared DASA 
adducts 18 and 40. 
3.4. Cyclization by Chemical Catalysis 
3.4.1. Background 
In accord with Safar’s work, we found that furan substrates bearing a substituent at the 
3-postion, did not afford Stenhouse adducts, providing only the cyclopentenone products 
(Scheme 3). 
 
Scheme 3. Effect of substitution of on the furan nucleus. 
 
We hypothesized that this result is due to A1,3 strain in the 2E,4E conformation of the 
substituted Stenhouse intermediate (Figure 3). Isomerization to the 2E,4Z conformation re-
lieves this strain and place the molecule in the appropriate conformation for the electrocy-
clization to occur.  Based on this we reasoned that a catalyst capable of alkene isomerization 
would facilitate isomerization and subsequent electrocyclization to provide the desired cy-
clopentenone isomers. 
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Figure 3.  Alkene isomerization due to A1,3 strain.  
3.4.2. Development and Scope 
A number of catalysts known to induce alkene isomerization were evaluated (Table 1). 
Although, DMAP, DABCO and PPh3 all mediated the cyclization, PPh3 was identified as 
the ideal catalyst due to its reduced toxicity in comparison to DMAP.  As with the Stenhouse 
adducts, these products are easily isolated by filtration and washing with cold diethyl ether.  
While initial experiments were conducted using a stoichiometric quantity of catalyst, further 
testing revealed that loading could be reduced as low as 5 mol %. Importantly, this mild 
procedure allows for isolation of these materials without the use of concentrated HBr, as 
previously developed by Safar.29 
Table 1. Optimization of cyclopentenone formation by chemical catalysis. 
 
Catalyst mol % Solvent % Yield 
DMAP 100 Acetonitrile 90 
DABCO 100 Acetonitrile 70 
PPh3 100 CH2Cl2 80 
PPh3 100 Acetonitrile 90 
PPh3 25 Acetonitrile 97 
PPh3 5 Acetonitrile 93 
 
The triphenylphosphine catalyzed cyclization conditions were then applied to a selection 
of the Meldrum’s acid derived Stenhouse adducts. To our delight, we found that nearly all 
adducts were converted to the desired cyclopentenones in good yield (Figure 4).  Notable 
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exceptions were the adduct derived from diallylamine (98), which decomposed under the 
reaction conditions, and substrates that either contained an electron-withdrawing group on 
the amine component (95) or possessed two benzylic carbon on the amine (101 and 102) 
where the starting triene was recovered. 
 
Figure 4. Triphenylphosphine catalyzed cyclization of Meldrum’s acid derived DASAs, iso-
lated yields. aNR: no reaction. 
 
Encouraged by these results, we evaluated if visible light alone could be employed, as an 
environmentally benign method, to convert the deeply colored Stenhouse adducts to the col-
orless cyclopentenones.  As discussed in Chapter 2, protic solvents stabilize the cyclopente-
none isomer. Thus we irradiated methanolic solutions of the same selection of Meldrum’s 
acid derived DASA trienes with a commercially available GE crystal clear 200 bulb. Appli-
cation of these conditions gratifyingly provided the cyclopentenones in good to excellent 
yield, including the diallylamine adduct 98.  Again, those substrates with an electron-
withdrawing group 94 or two benzylic carbons in the amine component (101 and 102) failed 
to convert to the cyclopentenone (Figure 5). 
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Figure 5. Photo-cyclization of Meldrum’s acid derived DASAs, isolated yields. aNR: no re-
action. 
 
We then proceeded to evaluate the efficacy of the PPh3 protocol to a selection of the 1,3-
dimethylbarbituric acid derived DASAs (Figure 6). We found that the corresponding zwit-
terions were formed in good to excellent yield. Here as with the Meldrum’s acid based DA-
SAs, the adduct derived from diallylamine (110) decomposed and the substrate bearing an 
electron-withdrawing group on the amine component (107) returned only unconverted start-
ing material. 
 
Figure 6. Triphenylphosphine catalyzed cyclization of 1,3-dimethylbarbituric acid derived 
DASAs, isolated yields. aNR: no reaction. 
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Finally, we subjected the same selection of 1,3-dimethylbarbituric acid derived DASAs 
to the photo-cyclization conditions (Figure 7). A similar trend was again observed, here the 
1,3-dimethylbarbituric acid/diallylamine cyclopentenone 110 was obtained in 77% yield, 
while the adduct bearing an electron-withdrawing group 107 returned only starting material. 
 
Figure 7. Photo-cyclization of 1,3-dimethylbarbituric acid derived DASAs, isolated yields. 
aNR: no reaction. 
 
3.5. Advances in Synthetic Methodology 
Having explored the scope of the donors and acceptors, we sought to probe the synthetic 
methodology used to prepare both the DASA trienes and zwitterionic cyclopentenones, with 
a primary interest in developing one-pot procedures. Domino reactions have become a flour-
ishing field in organic synthesis, as they hold the promise of greener and more efficient 
methods for the synthesis of chemical building blocks.30–32 Further, the ability to conduct 
organic reaction in aqueous media is highly attractive. There several potential advantages of 
replacing traditional organic solvents with water. Among the myriad of reason the three 
most pressing are: (1) Cost. No organic solvent can compete on a fiscal level. (2) Safety. 
The overwhelming majority of organic solvents commonly employed in laboratories come 
with significant risks including: flammability, explosion or the formation of explosives on 
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prolonged storage, and toxicity. (3) Environmental considerations: the chemical industry is a 
major contributor to pollution leading to regulatory and social pressures focusing on organic 
solvents.33–37 
Initially, we evaluated the practicality of developing a one-pot synthesis of the DASA 
cyclopentenones beginning from the activated furan. We were gratified to find that the cas-
cade can be achieved in a one-pot fashion on a multigram scale without affecting yield using 
either the photo-cyclization protocol (Scheme 4, Method A) or the PPh3 procedure (Scheme 
4, method B). 
 
Scheme 4. One-pot cascade reaction for the synthesis of DASA cyclopentenones. 
 
With this success we then proceeded to develop a one-pot preparation of DASA trienes. 
We considered that the first step in preparing DASA adducts is the “on-water” Knoevenagel 
condensation of the acceptor with furfural.26,27 Further, based on the phase transfer behavior 
of DASA photoswitches (Chapter 2, Section 2.3.) we reasoned that when employing amine 
donors with eight carbons or more it should be possible to prepare the triene in aqueous me-
dia. We were pleased to find that the two-step synthesis of the organic photochromic mole-
cules can be achieved in a one-pot fashion “on water” without affecting yield.38 As shown in 
Scheme 5, Knoevenagel condensation between furfural and either Meldrum’s acid or 1,3-
dimethylbarbituric acid is complete within 2 h. Direct addition of the amine nucleophile re-
sults in formation of the Stenhouse adduct, which then can be isolated by extraction with 
dichloromethane. The facile nature of this process further highlights the practicality and us-
er-friendly protocol to access these novel organic photochromic materials. 
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Scheme 5. One-pot “on water” synthesis of DASA trienes. 
 
3.6. Closing Remarks 
In summary, we have developed general conditions for the ring opening of furfural de-
rivatives activated with cyclic β-dicarbonyl compounds by a wide variety of secondary 
amines to provide 1-dicarbonylmethylene-2-hydroxy-5-(dialkylamino)pentadienes. This 
strategy provides unprecedented synthetic modularity and tunability in the preparation of 
visible light activated photoswitches. We have further demonstrated that this process can be 
performed in a one-pot fashion in water from commercially available starting materials. We 
have further identified which of the trienes obtained undergo reversible photochromism to 
give stable, colorless 4-aminocyclopentenone zwitterions. Specifically we have found tri-
enes where the amine donor bears an electron withdrawing group (such as proline methyl 
ester) or two benzylic carbons off the nitrogen atom of the donor, fail to engage in photo-
chromism. We have further demonstrated mild, efficient and practical conditions for their 
subsequent cyclization to 4-amino-cyclopentenones using either catalytic PPh3 or visible 
light, which facilitated isolation of the cyclized form of the adduct. This chemical cycliza-
tion protocol provided nearly identical results to the photo-cyclization protocol, with the ex-
ception that diallylamine derived DASAs trienes do not decompose providing the corre-
sponding cyclopentenones in good yield. Finally, either of these cyclization protocols can be 
executed in a one-pot fashion, beginning from the activated furan, to furnish the desired cy-
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clopentenones without affecting yield. Combined these results demonstrate the diversity and 
practicality of DASA syntheses, providing a versatile platform with unique properties that 
are synthetically accessible to a wide range of researchers. 
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4. Applications 
4.1. Introduction 
Any new development in chemical technology necessitates application to ensure it is not 
relegated as merely a curiosity. This is particularly important in the field of photochromism 
as without demonstrating the applicability of a new photochromic architecture, a potentially 
powerful tool can easily be overlooked. As a recent addition to the selection of organic pho-
tochromic materials, the potential applications of DASAs are still being explored and devel-
oped. However, the dramatic solubility inversion they undergo upon irradiation has been 
exploited for organo-catalyst recycling and micellar disassembly for cargo delivery. 
A fundamental challenge in the field of homogeneous catalysis is the difficulties inher-
ent in recovery of the molecular catalyst. This problem is exacerbated by the fact that in-
creasingly sophisticated organo-catalysts result in high costs and therefore losses. To over-
come this problem, several methods have been developed to solve the problem of cata-
lyst/product separation including to immobilize them on polymer resins,1–3 metal-oxides,4–6 
or textiles.7 An alternate approach relies on manipulation of the solubility properties of the 
catalyst by employing so-called phase-tags.8 Based on the solubility inversion that DASAs 
undergo upon photoswitching we sought to develop their use as a visible light activated 
phase-tag for the recycling of a homogeneous organo-catalyst (described in section 4.2.). 
Traditional treatments used to combat illnesses typically access their targets via blood 
circulation. However, these medicines are usually plagued by challenges such as low aque-
ous solubility, poor selectivity, and high toxicity. To combat these challenges researchers 
have investigated drug delivery systems for decades. Specifically, drug delivery systems that 
respond to light have received great attention as they offer both spatial and temporal resolu-
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tion for drug release, offering the ability to limit side effects and generate considerable ther-
apeutic levels of the drug that may otherwise be unattainable.9 With these advantages in 
mind, we sought to develop a polymeric micellar system that disassembles via a one-photon 
process to deliver a hydrophobic cargo with both spatial and temporal resolution (described 
in section 4.3.). 
4.2. Catalyst Recycling 
4.2.1. Background 
Organic catalysts have become increasingly important in the field of synthetic chemistry 
for their ability to catalyze a range of valuable transformations.10,11 As the field has matured, 
modern developments in organocatalysis look toward increasingly complex chiral catalysts 
that come at high synthetic or monetary cost.12 To date, this increasing complexity has not 
been met with a robust effort to engineer solutions for recycling these valuable moieties and 
making organocatalysis more sustainable.13 Broadly, all techniques that separate a catalyst 
from a reagent mixture involve either liquid-solid or liquid/liquid phase separation. The 
most common method for reusing homogeneous organic catalysts has been to support them 
on polymer resins,1–3 metal-oxides,4–6 or even textiles and separate the catalyst post-reaction 
by filtration.7 Although promising, supported homogeneous catalysts have not proven to be 
a general solution for catalyst recycling due to the adverse effects supported systems can 
have on catalyst activity and selectivity.14  
Another common approach to catalyst recycling, referred to as phase tagging, relies on 
differential catalyst solubility and is an important tool for recycling organic catalysts. Gen-
erally, the phase tag has some intrinsic property that enables easy phase separation from the 
organic product. For catalyst recycling, fluorous15–17 and ionic liquid18–21 tags have proven 
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effective in a variety of systems. However, drawbacks associated with these methods, such 
as cost, solvent leaching, and environmental persistence of the phase tag have shifted atten-
tion toward the development of separation techniques where the phase tag properties can be 
controlled by a benign and inexpensive external stimuli. As such, redox- and light-controlled 
phase tags have been developed and applied to the recycling of the Grubbs-Hoveyda cata-
lyst.22–24  
Recently, we reported a new class of modular photoswitches termed donor-acceptor 
Stenhouse adducts (DASAs).25,26 These systems are easily accessible from furfural, a com-
modity chemical derived from nonedible biomass, and their modular synthesis enables adop-
tion into a number of functional materials. Upon irradiation, DASAs switch from a conju-
gated, colored, and hydrophobic form to a ring-closed, colorless, and zwitterionic structure. 
Most importantly, their switching is stimulated by low-energy visible light, which is non-
invasive to many reagents in typical chemical reactions. In collaboration with Frank 
Leibfarth of the Hawker group, we envisioned the differential solubility imparted by the 
photoswitching of DASAs and their activation by an external, abundant, and non-
transformative stimulus would provide an ideal platform for application in the recycling of 
organic catalysts (Figure 1).22  
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Figure 1. Application of DASA photoswitch as a phase tag for catalyst recycling using visi-
ble light and heat. 
 
The ubiquity and broad utility of privileged thiourea organocatalysts make them an ideal 
target for recycling.12,27 Further, many of the more complex thiourea derivatives are non-
trivial to synthesize and are typically used at high catalyst loadings; thus, catalyst recycling 
would provide a distinct advantage. To begin our studies, we chose to pursue thiourea cata-
lyzed lactide polymerization.28,29 This industrially important transformation would not only 
benefit from catalyst recycling, but a light-mediated separation of catalyst from the polymer 
product is advantageous to reduce deleterious transesterification reactions and polymer deg-
radation that occur from residual catalyst left in the final material.30,31  
The modular nature of the DASA photoswitch, broad utility of the thiourea organic cata-
lyst, and benign nature of the stimulus for recycling make this an attractive concept for fur-
ther application. An easily accessed DASA-appended thiourea catalyst is shown to effective-
ly polymerize lactide with control over polymer molecular weight and dispersity. The pho-
toswitch-organocatalyst construct can subsequently be separated from the reactant mixture 
by irradiation with visible light, recovered and reused. This process can be repeated numer-
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ous times with negligible affect on catalyst activity or performance. Lastly, mechanistic 
studies demonstrating the advantages and limitations of the reported system and providing 
valuable insights into future recyclable catalyst design principles are presented.  
4.2.2. Catalyst Synthesis 
The exceptional properties of DASA photoswitches, including their activation by visible 
light and their solubility, color, and shape change upon irradiation, make them excellent 
candidates to interface with catalytic moieties. The ease and modularity of DASA synthesis 
enabled preparation of thiourea catalyst 4 in a convergent manner, as outlined in Figure 2. 
We chose to use the barbituric acid-derived DASA photoswitch for its superior performance 
in control experiments compared to its Meldrum’s acid based counterpart. First, an alkyne-
functionalized thiourea was prepared from 4-aminocyclohexanol through Boc-protection of 
the amine, alkylation with propargyl bromide, and subsequent Boc-deprotection. The free 
amine was reacted with 3,5-di(trifluoromethyl)phenyl isothiocyanate in dichloromethane to 
generate an alkyne-functionalized variant of the well-known electron deficient thiourea cata-
lyst 1 (Figure 2, top). An azide-bearing DASA was prepared from activated furan 2 and an 
azide-containing secondary amine to provide the azide terminated DASA 3 (Figure 2, cen-
ter). Finally, the catalyst and photoswitch were coupled though the copper catalyzed azide-
alkyne cycloaddition to yield the DASA-catalyst conjugate 4 as a dark purple solid (Figure 
2, bottom). 
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Figure 2. Synthesis of thiourea-photoswitch adduct 4.  
4.2.3. Catalyst Photochromism and Phase-Transfer 
The utility of DASA photoswitches for catalyst recycling is dependent on its ability to 
undergo reversible phase-change upon irradiation with visible light. To confirm this behav-
ior for the thiourea-photoswitch adduct, 4 was dissolved in toluene at a concentration of 0.05 
M and the dark purple solution was layered over water. We chose water as the polar solvent 
for the phase transfer studies because it is widely employed in liquid/liquid extractions. The 
bi-phasic mixture was irradiated with visible light (550-750 nm) for ten minutes, after which 
the purple color had disappeared from the organic layer and 4 resided in the aqueous layer in 
its zwitterionic form. To quantify the phase transfer, the same experiment was performed 
and aliquots from the organic phase were taken at intervals throughout the photoswitching. 
The results in Figure 3 demonstrate the characteristic decrease in absorbance at ~570 nm 
that accompanies photoswitching from the linear, conjugated form 4 to the cyclic, zwitteri-
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onic form, resulting in 98% photoswitching efficiency in ten minutes. The transfer of the 
catalyst-photoswitch construct to the aqueous phase was confirmed by employing deuterated 
solvents in the experiment, where the diagnostic 1H-NMR peaks of the zwitterionic moiety 
are evident in the D2O phase after photoswitching and no observable peaks are left in the 
toluene-D8 layer. 
 
Figure 3. The photoswitching of catalyst 4 under visible light irradiation displays character-
istic decrease in absorbance at 568 nm (left), which can be visualized in a biphasic system 
(right). 
 
Reclaiming the DASA-catalyst conjugate from the aqueous phase is imperative for a 
functioning catalyst recycling system. After phase transfer into the water layer, heating the 
biphasic mixture results in ca. 20% recovery of the catalyst into the toluene layer. Screening 
solvents for catalyst recovery, led to the discovery that chlorinated solvents, such as meth-
ylene chloride and chloroform, allow far superior catalyst recovery. Therefore, dissolving 4 
in toluene, layering the solution over water, and irradiating with visible light provides com-
plete transfer of the catalyst to the aqueous layer. Separating the aqueous phase, layering it 
over methylene chloride, and heating the mixture to ~40 ºC for two minutes results in near 
quantitative isolation of the catalyst.  This process of catalyst recycling compares favorably 
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to a previously reported light-controlled catalyst recycling protocol based on a spiropyran 
phototag.22  
4.2.4. Catalyst Performance and Recycling 
To demonstrate the utility of recycling a thiourea catalyst, we chose to employ 4 for the 
ring opening polymerization of lactide. The parent thiourea catalyst is well established to 
provide controlled polymerization of lactide, resulting in polymers with predictable molecu-
lar weight and low polydispersity (PDI).28,29 Assuming the photoswitch would not interfere 
with polymerization, we hypothesized that polymerization of lactide by adduct 4 would pro-
vide well-controlled polymerization to afford polylactide (PLA). Subsequently, visible light 
irradiation of the polymerization solution in the presence of water would prompt pho-
toswitching and concurrent transfer of 4 to the aqueous phase. Phase transfer of 4 would 
provide multiple benefits. First, this would fully remove the transesterification catalyst from 
the PLA product; thus, preventing undesired scrambling of PLA by residual catalyst during 
polymer processing or device fabrication which is a known problem.31 Further, the reversi-
bility of DASA photoswitching would allow the catalyst to be recovered from the aqueous 
phase of the mixture for reuse.  
The catalyst-photoswitch adduct 4 was effective for polymerizing lactide. Polymeriza-
tions were initiated by pyrene butanol targeting a degree of polymerization (DP) of 100, em-
ploying 10 mol% of 4 and 20 mol% of pentamethyldiethylenetriamine (PMDETA) as the 
amine co-catalyst.32 After 48 hours, polymerizations provided PLA with a molecular weight 
of 11.2 kg/mol at 70% conversion (as determined by 1H-NMR) and a PDI of 1.12. Control 
experiments excluding 4, excluding PMDETA, and excluding both resulted in no polymer 
formation. The polymerization catalyzed by 4 displayed the characteristics of a living sys-
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tem, similar to previous thiourea catalysts, with good agreement between theoretical and 
calculated molecular weight and a linear relationship between molecular weight and conver-
sion being observed (Figure 4A). Further, comparing the refractive index (RI) and absorb-
ance spectra obtained from the size-exclusion chromatogram of the crude polymerization 
mixture confirms the successful polymerization of lactide by 4. As shown in Figure 4B, the 
RI peak of the polymer centered at a retention time of ~15.2 minutes overlaps with the char-
acteristic absorbance for the initiator pyrene butanol. This demonstrates the chain-end fideli-
ty of the polymerization and confirms (along with control experiments and characterization 
of the purified polymer) that 4 is not incorporated into the polymer. The peak at a longer re-
tention time of ~18.5 min has the characteristic absorbance profile of the catalyst-
photoswitch adduct 4, with a strong absorbance centered at ~570 nm, confirming that 4 both 
catalyzes the polymerization and survives the reaction.  
 Upon conclusion of the polymerization, the DASA photoswitch assumes its role in re-
cycling the thiourea catalyst. The reaction mixture is taken up in benzene, layered over wa-
ter, and exposed to visible light for 1 hour. Irradiation triggers photoswitching of the DASA 
and thus a drastic change in its solubility properties. The catalyst-photoswitch adduct trans-
fers to the aqueous phase, separating it from the polymer product that remains in the organic 
layer and enabling its recovery. The PLA, free of catalyst, can be precipitated into methanol 
yielding pure product. The aqueous phase, containing the thiourea, can be extracted with 
dichloromethane to recover 4 in its linear, hydrophobic form for reuse in subsequent 
polymerizations. After passing recovered 4 through a short silica plug to remove base-line 
impurities, the catalyst-photoswitch adduct is recovered in 70% yield. 
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Figure 4. A) Polymerization of lactide catalyzed by 4 demonstrates good agreement be-
tween molecular weight and conversion. B) Crude GPC spectrum including both RI and 
UV-vis detectors show end-group fidelity and stability of the photoswitch to the reaction 
conditions. 
 
To our gratification, the catalyst was analytically unchanged by the polymeriza-
tion/recovery process and retained its activity. Employing the recycled catalyst for the 
polymerization of lactide under identical polymerization conditions to those used previously 
provided PLA with a molecular weight of 8.10 kg/mol and PDI of 1.24 at 60% conversion 
(Table 1). Repeating the visible light-mediated recovery procedure provided separation and 
re-isolation of the catalyst-photoswitch adduct in 65% yield. The catalyst was employed a 
third time to yield PLA with a molecular weight of 9.14 kg/mol and PDI of 1.31. These iter-
ative reaction, separation, and reuse cycles demonstrate the robust nature of the DASA-
organocatalyst construct and demonstrate its utility in both substrate purification and catalyst 
recovery. Accomplishing this unique function using a non-invasive and benign stimulus 
such as visible light makes this method attractive to a wide range of catalytic systems that 
could be applicable in polymer or small molecule synthesis. 
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Table 1. Recycling of 4 over three catalytic cycles. aMolecular weight determined by 1H-
NMR. 
 
Entry Time Conversion Molecular Weighta PDI 
Catalyst 4 48 h 70% 11.2 kg/mol 1.12 
1st Reuse 48 h 60% 8.10 kg/mol 1.24 
2nd Reuse 48 h 63% 9.14 kg/mol 1.31 
4.2.5. Mechanistic Studies 
Mechanistic studies of the polymerization employing the catalyst–photoswitch construct 
are critical to aid in the future design of visible light recyclable catalysts. Initially, the rate of 
polymerization was determined for reactions employing the parent thiourea catalyst as well 
as the catalyst–photoswitch construct 4. The rates were determined by running polymeriza-
tions in CDCl3 (1.2 M) targeting a DP of 100 with 10 mol% thiourea and 20 mol% 
PMDETA, recording 1H-NMR spectra every 30 minutes. The reactions were monitored to 
conversions under 60% where viscosity and undesired side-reactions are unlikely to have an 
effect. We assume that the alcohol concentration, as initially determined by the concentra-
tion of the pyrene butanol initiator, remains constant throughout the polymerization. These 
experiments produced three-dimensional NMR data (Figure 5A), which show the doublet of 
the lactide methyl group at 1.65 ppm decreasing over time and the commensurate growth of 
the polymer methyl group signal at 1.62 ppm. Integration of the individual spectra over time 
and fitting the data to a first-order kinetic model provides the plots shown in Figure 5B. 
O
O
O
O
10 mol% 4
pyrene butanol
20 mol% PMDETA
CHCl3, rt, 48 h
O
O
O
O
O H
n
  92 
 
Figure 5. A) Three dimensional 1H-NMR data of lactide polymerization. B) Kinetic data for 
polymerization catalyzed by parent thiourea 5 (green circles), 5 + one equivalent of diethyl 
DASA photoswitch (black triangles), 5 + two equivalents of diethyl DASA photoswitch (red 
squares), and catalyst-photoswitch construct 4 (blue diamonds). 
  
As shown in Figure 5B, the polymerization catalyzed by 4 (blue diamonds) is considera-
bly slower that the same polymerization catalyzed by the parent thiourea catalyst (green cir-
cles). Mechanistically, hydrogen bonding between the thiourea and lactide is proposed to 
activate the lactide ester for transesterification in this polymerization. We hypothesized that 
the slower rate of the catalyst–photoswitch construct 4 may be due to competitive binding of 
the thiourea between lactide and the electron-rich carbonyls of the barbituric acid. To test 
this hypothesis, we measured the rate of polymerization employing the parent thiourea cata-
lyst while including both one (black triangles) and two (red squares) equivalents of an inter-
molecular inhibitor in the form of the diethylamine-derived DASA photoswitch. The reac-
tions exhibit first-order kinetics and clearly illustrate the inhibitory affect of the DASA, as 
each equivalent of photoswitch decreased the reaction rate by approximately three-fold.   To 
gain further insight on the relative strength of thiourea binding to cyclic esters verses our 
DASA photoswitch, NMR titration experiments were undertaken, tracking the chemical 
shift of the thiourea N–H protons in the presence increasing amounts of binding partner. The 
magnitude of downfield shift of the N–H protons corresponds to the relative strength of the 
hydrogen-bonded complex being formed.33,34 A plot of chemical shift verses equivalents of 
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carbonyl is shown in Figure 6. To ensure 1:1 binding of thiourea to cyclic ester, caprolac-
tone was employed in place of lactide. As evidenced by the significantly larger chemical 
shift change when titrated with the DASA photoswitch, the thiourea binds the barbituric acid 
carbonyls much stronger than the carbonyl of the cyclic ester. 
	  
Figure 6. A) Example of 1H-NMR data obtained for the titration of the thiourea catalyst 
with a cyclic carbonyl. B) A plot depicting the change in the 1H-NMR chemical shift of one 
N–H proton of the thiourea upon titration with caprolactone (blue circles) or the diethyl 
DASA photoswitch (green squares). Titrations were carried out in C6D6 with the concentra-
tion of thiourea between 0.05 and 0.01 M. 
 
To the best of our knowledge, this is the first example of employing visible light as a 
stimulus to recycle a homogeneous catalyst35 and represents a rare example of catalyst recy-
cling in a polymer application. The challenge for this and any complex catalytic system is 
that each function, catalysis and recycling in this instance, works independently and one 
does not compromise the other.  The mechanistic studies undertaken herein demonstrate that 
while the presence of the DASA photoswitch decreases the rate of polymerization, the pres-
ence of the thiourea does not seem to affect the photoswitching and phase transfer of the 
DASA moiety. From the data presented, we surmise that the intramolecular binding of the 
barbituric acid to the thiourea competes with the activation of lactide, causing the rate de-
crease. Despite this decrease in rate, the DASA-catalyst conjugate was effective for the con-
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trolled polymerization of lactide, providing PLA with predictable molecular weights and 
narrow PDIs even after repeated use and recycling.   
4.3. Micellar Cargo Delivery 
4.3.1. Background 
Polymeric micelle drug delivery systems offer tremendous potential for the effective and 
safe treatment of human diseases due to their ability to minimize harmful side effects, in-
crease drug bioavailability, and carry drugs with prolonged circulation time.36–39 To gain 
greater control over the delivery process, on-demand triggered release of therapeutic agents 
has garnered enormous interest, specifically light-activated systems.40–42 As a non-invasive 
and readily available resource, light offers precise control over the nanocarrier system by 
releasing the encapsulated payload at a specific time and specific location. The ability to ex-
ert precise control over the delivery of a therapeutic cargo is highly desired as this level of 
control may serve as a method to significantly reduce or ultimately eliminate potential side 
effects of indiscriminate chemotherapeutics (e.g., paclitaxel or docetaxel).36–39,43 These 
“smart” drug delivery systems have been made possible by the development of photorespon-
sive compounds, such as o-nitrobenzyl ester,42,44 azobenzene40 and spiropyran.45 However, 
an inherent challenge arises from their reliance on ultraviolet (UV) light, which not only has 
the potential to harm healthy cells but also suffers from poor tissue penetration, thereby lim-
iting their applicability.  
To address this issue, researchers have shifted their attention to systems that are activat-
ed by light sources of longer wavelengths (600–1200 nm), which have minimal effect on 
cells and penetrate deeper through human tissue.46,47 While emerging technologies like two-
photon excitation,42,48,49 and upconverted UV light50,51 have enabled the use of near infrared 
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(NIR) spectral window of tissues, similar approaches have proven challenging to adapt to 
polymeric micelles. The most significant challenge is inefficient micelle disruption, which 
necessitates prolonged irradiation and the use of high laser power (3–5 W), both of which 
can lead to heat-induced cell toxicity. These limitations are rooted in the properties of the 
photoresponsive compounds used to control the micelle disruption and highlight the need for 
the development of new photochromic material for light-triggered drug delivery system. We 
therefore envisioned the development of a polymeric micelle system that could be controlled 
by a one-photon visible light process, thereby enhancing the drug delivery efficiency, sim-
plifying the synthetic strategy, and improving the therapeutic efficacy. 
A powerful aspect of the modular design of DASAs is the ability to rapidly modify their 
structure, critical for the adoption of these photoswitches into complex systems that require 
on-demand property changes.26 Accordingly, we sought to develop a functional polymer 
system to exploit the visible-light-mediated solubility switch of DASAs.25 The development 
of a general, stimuli-responsive micellar system with external control over assembly has 
been a long-standing goal in polymer chemistry with potential applications in biological set-
tings.52–54 The characteristics of DASA photoswitches are therefore perfectly suited to pro-
vide such a function, as visible light mediates structural and property changes from the hy-
drophobic, linear derivative to the fully hydrophilic, cyclic derivative. 
4.3.2. Initial Efforts 
The facile and modular synthesis of DASA photoswitches enabled the generation of a 
DASA-functionalized amphiphilic polymer. In collaboration with Saemi Polema, a DASA 
bearing a terminal azide and 1,3-di-n-octyl barbituric acid, was coupled to alkyne terminated 
monomethyl poly(ethylene glycol) (PEG) (Mw = 3000 g/mol, PDI = 1.1) to form the desired 
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end-functionalized polymer, 6a (Figure 7A). The amphiphilic nature of 6a induced micelle 
formation in aqueous environments (Figure 7B), as determined by Nile Red encapsulation 
experiments and dynamic light scattering, confirming that Nile Red is successfully encapsu-
lated and solubilized in water and that the critical micelle concentration for this system is 49 
µM (Figure 7C). Upon visible light irradiation, the absorption peak of 6a at 550 nm de-
creased steadily, indicating the photoswitching of the DASA to its cyclic, hydrophilic state. 
Concurrently, the fluorescence emission of encapsulated Nile Red showed a sharp decrease 
in intensity and red shift, indicating that the hydrophobic dye was released into the aqueous 
phase (Figure 7D).48,55–57 These results are consistent with a disruption in the micellar struc-
ture and a release of hydrophobic cargo caused by the light-induced photoswitching of 6a to 
the fully hydrophilic derivative 6b. This simple but powerful application of DASAs illus-
trates the significant potential of these photochromic compounds. 
 
Figure 7. A) Photoswitching of micelle-forming polymer amphiphile. B) Schematic of mi-
celle formation and hydrophobic cargo encapsulation by functional amphiphile 6a and mi-
celle disruption and cargo release on visible light irradiation. C) Fluorescence intensity (Em 
at 588 nm) vs log concentration (mg/mL) of 6a. D) Fluorescence emission spectra of Nile 
Red in 0.50 mg/mL 6a in water at various times of visible light irradiation. 
 
Based on these results and our interest in exploring the potential of this new class of 
photochromic material, we sought to explore their use in selective drug release to mammali-
an cells. To the best of our knowledge, this work would be the first example of controlled 
  97 
drug release to living cells by property change of a photochromic component to control the 
structural disassembly of a micelle. Moreover, this offers a new approach to drug delivery 
that does not rely on a metal or a two-photon process. 
4.3.3. Second Generation: Micelle Formation and Cargo Release 
Donor-acceptor Stenhouse adducts are photochromic compounds that respond to visible 
light. These materials are easily prepared by a two-step process: an “on-water” Knoevenagel 
condensation of a barbituric acid derivative with furfural to produce an activated furan, 
which is then treated with a secondary amine (which can bear tailored functionalities) to 
provide the highly colored DASA in good yield. This simple and modular synthesis of DA-
SAs facilitates their incorporation into visible light-responsive systems. As an example, we 
explored visible light-induced drug release based on functional amphiphiles. Specifically, a 
DASA was functionalized with an azide and reacted with alkyne-functionalized monome-
thyl poly(ethylene glycol) (PEG) under “click” reaction conditions to prepare amphiphilic 
DASA-PEG conjugate (DPC) 7 (Scheme 1A, left). Triggered by visible light, the hydropho-
bic triene form of the DASA moiety photoisomerizes into its hydrophilic zwitterionic form. 
This significant change in polarity and solubility of the DASA moiety leads to 8, which is 
doubly hydrophilic (Scheme 1A, right).  
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Scheme 1. A) Amphiphilic DPC 7 with hydrophobic and hydrophilic segments loses its am-
phiphilic character once irradiated with visible light. B) left: DPC 7 self-assembles into mi-
celles in an aqueous media encapsulating hydrophobic cargo, portrayed by the highly col-
ored micelle solution; right: Disruption of micelles and release of cargo molecules, colorless 
solution indicates complete photoisomerization of 7 to 8. 
 
Visible light irradiation on aqueous samples of DPC 7 induces isomerization of the 
DASA to its hydrophilic form, which leads to disassembly of the micelles. This process can 
be monitored by the naked eye as the strongly colored solution of DPC 7 indicates the hy-
drophobic DASA form and its subsequent photoisomerization to the zwitterion 8 is implied 
by the colorless solution. Based on this functional DPC 7, a visible light-responsive micellar 
system that can release hydrophobic cargo to an aqueous environment becomes viable 
(Scheme 1B). In an aqueous medium, self-assembly of DPC 7 into micelles is expected 
where hydrophilic PEG (blue) comprises the corona and hydrophobic DASAs (purple) con-
stitute the core.  
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Figure 8. A) DLS measurements of aqueous solution of DPC 7 (0.5 mg/mL) before (left) 
and after (right) irradiation. B) UV-Vis spectra of DPC 7 (0.5 mg/mL) in water after varying 
times of visible light irradiation. C) Fluorescence emission spectra of initially encapsulated 
Nile Red in aqueous solution of DPC 7 (0.5 mg/mL) after varying times of visible light irra-
diation. 
 
Dynamic light scattering (DLS) measurements of 7 were employed to verify the light-
induced micellar disruption. Prior to light irradiation, solutions of DPC 7 above the CMC 
(0.5 mg/mL) successfully formed micelles, whose average size was ~22 nm in diameter 
(Figure 8A, left). Upon irradiation with visible light, the micelles rapidly disassembled due 
to destabilization of micellar core caused by isomerization of the DASA moieties into hy-
drophilic zwitterions. After irradiation no particle greater than 3 nm could be detected by 
DLS (Figure 8A, right).   
To verify that the disruption of micelle is being induced by the photoisomerization of the 
DASA segments, UV-Vis spectroscopy was employed (Figure 8B).  A micellar solution was 
prepared and the change in absorbance of the DASA moiety (λmax = 553 nm) was monitored 
at different time intervals of visible light irradiation. After 1 hour of irradiation, the absorb-
ance decreased by ~80%. This observation confirms that the primary reason for micelle dis-
ruption is indeed the visible light-triggered photoisomerization of the DASA segments from 
7 to 8. As the triene form of the DASA is isomerized to a hydrophilic zwitterion by visible 
light, the amphiphilic character of the DPC is lost, and thus the micellar structure disinte-
grates. 
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In order to demonstrate the disassembly of the micelles with visible light, fluorescence 
spectroscopy was used to monitor the release of cargo with respect to irradiation time. Nile 
Red, a solvatochromic and hydrophobic dye that fluoresces at 660 nm with weak emission 
intensity in water and at < 600 nm with enhanced emission intensity in hydrophobic envi-
ronments, was chosen as an ideal cargo.55,58 Accordingly, a micelle-encapsulated solution of 
Nile Red was prepared, and the micellar disruption by visible light was observed by moni-
toring the fluorescence emission of Nile Red (Figure 8C). At 0 min of irradiation, the mi-
celles remained intact and provided a hydrophobic environment for Nile Red, as indicated 
by the emission λmax at 590 nm. As irradiation was continued, the intensity of fluorescence 
steadily decreased with a concurrent bathochromic shift of the emission λmax. This confirms 
that Nile Red is slowly released into the aqueous solution from the micelle core as the 
DASA segments of DPC 7 isomerize to their hydrophilic form of DPC 8 in response to visi-
ble light.  
Working with Seung Soo Oh, we visualized the selective unloading of the hydrophobic 
dye into cells by micelle disassembly in response to irradiation with visible light (Figure 9). 
The CMC was pre-determined using Nile Red as a fluorescent probe. Initially, we incubated 
0.5 mg/mL of DPC 7 containing 10 µM Nile Red with MCF-7 human breast cancer epitheli-
al cells for 1 hour in the presence or absence of visible light. Nile Red easily penetrates cell 
membranes and subsequently stains intracellular lipids, emitting strong fluorescence at 530 
nm.56 To monitor the delivery of Nile Red into the cells, we performed live-cell imaging via 
a fluorescence microscopy immediately after cell washing. In the absence of irradiation, the 
Nile Red remained in the micelles, and its delivery into the cells was suppressed, as evi-
denced by the negligible levels of fluorescence (Figure 9A, left). In contrast, irradiation by 
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visible light induced the disruption of micelles and allowed successful cargo delivery into 
the cells, as evidenced by the strong fluorescence of Nile Red observed from the interior of 
the cells (Figure 9A, right). 
 
Figure 9. Visible light mediated cargo delivery of Nile Red into MCF-7 cells. A) Schematic 
of experimental process (top), corresponding fluorescence microscopy images of MCF-7 
before irradiation (bottom left), after irradiation (bottom right). B) Linear relationship of cell 
fluorescence to Nile Red concentration (inset), and visible light mediated release of Nile red 
and relevant controls. 
 
To further verify that cargo delivery is triggered by visible light, we measured the 
amount of delivered cargo through the fluorescence of cell-internalized Nile Red. As shown 
in the inset of Figure 9B, cell fluorescence after incubation with free Nile Red and subse-
quent washing was proportional to the concentration of Nile Red (0.1 µM to 10 µM). From 
this linear relationship, we found that compared to the absence of visible light (grey), visible 
light irradiation (green) induced an approximately 3-fold increase in intensity, confirming 
light-mediated cargo delivery to the cells. Moreover, the intensity of cells incubated with 
free Nile Red (blue) was comparable to that of the cells incubated with Nile Red encapsulat-
ing DPC 7 after visible light irradiation (green). This result suggests that DPC 8 does not 
interfere with intracellular diffusion of the unloaded cargo, achieving highly efficient deliv-
ery. Note that the visible light-induced cargo delivery requires the self-assembly of am-
phiphiles and their subsequent disassembly triggered by visible light. Below the CMC of the 
  102 
amphiphiles, we observed no evidence of light-induced cargo delivery, implying that the 
cargo freely diffuses into the cells in the absence of micelle formation. 
4.3.4. Micellar Delivery of a Chemotheraputic 
Finally, in collaboration with Saemi Polema and Seung Soo Oh the capability of light-
mediated cell death was explored by unloading hydrophobic chemotherapy drugs (Figure 
10). As a model drug, we chose paclitaxel, which is widely used as a mitotic inhibitor that 
interferes with cell division for the treatment of tumors including breast cancers.59,60 We 
prepared 0.5 mg/mL solutions of DPC 7 containing 1 µM of paclitaxel and incubated MCF-
7 cells with this solution for an hour in both the presence and absence of visible light irradia-
tion. Following thorough washing, the cells were further incubated at 37 °C for 4 days, and 
cell viability was measured every 24 hours by live/dead cell viability assay. It is noteworthy 
that DPC 7 is not inherently toxic to the cells, and thus only the drug was responsible for the 
decrease in cell viability. Regardless of light irradiation, cells previously incubated with 
DPC 7 did not show any notable decrease of cell viability over 4 days (Figure 10, black and 
red). In addition, the viability of the cells directly exposed to DPC 7 for 24 hours without 
washing did not change significantly, which supports that DPC 7 is biocompatible. Com-
pared to cells incubated with paclitaxel-loaded DPCs and not irradiated with visible light 
(Figure 10, orange), similarly incubated cells exposed to visible light irradiation (Figure 10, 
green) displayed a significantly greater decrease in cell viability over 4 days. Within 48 
hours, the viability of cells irradiated with visible light decreased by 47%, approximately 3 
times more than did non-irradiated cells, resulting from light-enhanced drug delivery. While 
preparing micelles with a higher loading of paclitaxel provided larger decrease in cell viabil-
ity by light irradiation, the degree of enhanced cytotoxicity became smaller, which is pre-
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sumably related to the effective concentration of paclitaxel to inhibit the cell growth. Once 
again, the viability of the cells treated with paclitaxel alone (Figure 10, blue) was compara-
ble to that of the cells incubated with paclitaxel-loaded DPC 7 micelles and irradiated with 
visible light (green), indicating the efficient drug release mediated by visible light. 
 
Figure 10. Visible light-mediated cytotoxicity of cancer cells by paclitaxel loaded DPC 7 
micelles, and relevant controls. 
 
4.4. Closing Remarks 
We have demonstrated the considerable potential of employing DASA photoswitches for 
the visible light-initiated recycling of homogeneous organic catalysts. Catalyst development 
was enabled by modular and simple methods to generate functional thiourea and DASA 
coupling partners. The catalyst-photoswitch construct effectively polymerized lactide with 
control over molecular weight and a low PDI. The visible-light mediated phase transfer and 
subsequent recovery of the thiourea catalyst allowed recycling of the organocatalyst. The 
photoswitch-catalyst construct was shown to be effective over numerous polymerization cy-
cles with negligible effect on efficiency. Detailed mechanistic studies provided valuable in-
sight into future catalyst design for visible light-mediated recycling. The prevalence of or-
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ganocatalysis in modern synthetic chemistry coupled with the mild and benign nature of the 
recycling stimulus and procedure make this an attractive concept for further development. 
We have also developed a one-photon visible light-responsive micellar system for effi-
cient, on-demand drug delivery. The efficiency and effectiveness of this system was demon-
strated in an in-vitro setting, delivering the chemotherapeutic paclitaxel only on exposure to 
visible light.  Particularly, this is facilitated by the use of a novel class of photochromic ma-
terial, donor-acceptor Stenhouse adducts, which overcome challenges associated with UV 
light and multi-photon processes. This system offers promising new directions in photother-
apy and controlled release applications. 
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5. Future Directions 
5.1. Introduction 
In the course of any scientific endeavor it is only natural that certain efforts will be ini-
tially explored but ultimately abandoned. The intention in this chapter is to present some of 
these efforts as a guidance to future researchers who choose to apply their efforts in this 
field. Specifically, I will first outline our efforts towards the development of an “intramolec-
ular” DASA, where the donor amine is covalently appended to the activated furan. Second, 
our attempt to bathochromicaly shift the absorbance λmax of DASA trienes by extending 
conjugation of the activated furan precursor will be presented. Next we will outline our ef-
forts towards the synthesis of γ-alkylidene butenolides form Meldrum’s acid derived DASA 
trienes. Following this will be our work on developing DASA dimers, where two of the pho-
tochromic moieties are linked through either the donor or the acceptor group. Finally, we 
will present our investigations on the formation and properties of (dihydro)indenopyridine-
carbonitriles, derived from heterocyclic aldehydes activated by either 1,1-
dicyanomethylene-3-indanone or 1,3-bis(dicyanomethylene)-indane. Combined, all of these 
exploratory efforts were aimed at expanding the utility of our new class of photochromic 
material. 
5.2. Structural Variations and Synthetic Manipulations 
5.2.1. Intramolecular Variant 
Aza-spirocycles are important synthetic building blocks in alkaloid chemistry because 
such ring skeletons are present in many naturally occurring substances of biological proper-
ties.1 In 2010 Read de Alaniz and co-workers developed the aza-Piancatelli rearrangement, a 
powerful method for the highly diastereoselective formation of 4-aminocyclopentenones.2 In 
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the following year this discovery was expanded by their report of an intramolecular aza-
Piancatelli rearrangement, which provides aza-spirocycles in unprecedented yields and dia-
stereoselectivity.3 In the coming years these efforts were further expanded to methods for 
forming spirocyclic ethers,4 and fused oxabicycles,5 as well as fully substituted all-carbon 
stereocenters.6 Our general interest in the domino and cascade reactions of activated furans 
combined with our success in developing DASA photoswitches prompted us to consider if 
an intramolecular variant of these materials could be prepared, and what effect if any this 
structural variation would have on the photophysical properties of the resulting com-
pounds.2–5,7–10,6,11 
 Using procedures previously established by our group, we began from ethyl 3-
(furan-2-yl)propanoate 1, Figure 1. Saponification of the ester followed by coupling with 
benzyl amine 3, cleanly provided amide 4, which was reduced to give secondary amine 5. 
Boc protection of the amine functionality enabled Vilsmeier-Haack formylation to afford 
furfuraldehyde derivative 7 (81% yield from 1). 
 
Figure 1. Preparation of furaldehyde precursor 7. 
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With precursor 7 in hand, we proceeded to attempt formation of the activated furan, Fig-
ure 2. Repeated attempts to condense Meldrum’s acid 8 with 7, were met with varying de-
grees of success. At best we could isolate, activated furan 9 in only 10% yield, always with 
concomitant formation of DASA adduct 10 in up to 20% yield. The structure of DASA tri-
ene 10 was confirmed by 1H NMR, and has a similar spectral absorption to other Meldrum’s 
acid derived DASA trienes. We propose that after the initial condensation, the highly acidic 
nature of Meldrum’s acid, serves as a catalyst to remove the Boc protecting group from 9, 
which then undergoes ring opening to provide 10.  
 
Figure 2. Initial attempts towards formation of activated furan 9. 
 
Intrigued, but undaunted, by this result, we continued our efforts, finding that under pro-
longed exposure to the reaction conditions we could isolate the DASA adduct 10 in up to 
50% yield (Figure 3, top). With DASA adduct 10 in hand we next sought to evaluate its abil-
ity to undergo cyclization by either photochromic reaction or the PPh3 mediated conditions 
described in Chapter 3 (Figure 3, bottom). To our dismay, both of the developed conditions 
failed to provide the desired zwitterion 11, and 10 was recovered unchanged.  
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Figure 3. Improved synthesis of DASA adduct 10 (top), and attempted cyclization to zwit-
terion 11 (bottom). 
5.2.2. Extending Conjugation 
In Chapter 3 we outlined our investigations to bathochromically shift the absorbance 
λmax of DASA trienes to the NIR region by employing different acceptor moieties. In addi-
tion to these efforts we also considered if this goal could be achieved by extending conjuga-
tion in the activated furan precursor.12,13 To this end we prepared activated furans 13 and 15, 
from 3-(2-furyl)acrolein 12 (Figure 4). 
 
Figure 4. Preparation of activated furans 13 and 15 with extended conjugation. 
 
On reaction with secondary amines, both activated furans curiously only provided the 
DASA trienes 17 and 19 in poor yield, Figure 5. Repeated efforts to form or isolate DASA 
tetraenes 16 or 18, continued to provide similar results. 
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Figure 5. Ring opening reaction of activated furans 13 and 15. 
While disheartening, this result prompted us to consider what may be occurring to inhib-
it formation of the tetraene. After careful consideration, we hypothesize that the tetraenes are 
initially formed, however, convert to the triene after their formation. As shown in Figure 6, 
it is believed that nucleophilic attack by amine 20 leads to the ring opened tetraene 23. We 
propose that following alkene isomerization, iminium mesomer 24 undergoes intramolecular 
[2+2] cycloaddition to form cyclobutene intermediate 25. Cyclobutene 25 is believed to de-
compose via [2+2] cycloreversion, releasing acetylene 26 and ultimately producing DASA 
triene 27. 
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Figure 6. Proposed mechanism for formation of DASA trienes from activated furans with 
extended conjugation. 
5.2.3. γ-Alkylidene Butenolides 
Over one hundred years ago, in 1908, Scottish chemist Andrew Norman Meldrum syn-
thesized a substance that years later would bear his name.14 Today, Meldrum’s acid 8 is one 
of the most useful reagents in the synthesis of heterocycles. In his first independent publica-
tion, he studied the reaction between malonic acid 28 and acetone 29 and, following the 
suggestion of Prof. Japp, employed a mixture of acetic anhydride and sulfuric acid as con-
densing agent.15 From elemental analysis data, in conjunction with previous results and the 
acidic properties of the final compound, he formulated the structure of the product to be β-
lactone of β-hydroxyisopropylmalonic acid 31 (Scheme 1). 
 
Scheme 1. Synthesis of Meldrum’s acid. 
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4.83 in water) continues to be the focus of attention for research.16,17 However, it was not 
until 1948, when more experimental data on the chemistry of this product were collected, 
that its correct structure was determined to be 2,2-dimethyl-4,6-diketo-1,3-dioxane 8.14 The 
first review on the chemistry of Meldrum’s acid by McNab describes mostly the synthesis of 
derivatives via functionalization of the methylene group, and only a few reactions are men-
tioned where the 1,3-dioxane moeity is the reaction site.18 A more detailed literature survey 
shows an enormous interest in Meldrum’s acid chemistry in the 1980s that continues to this 
century.19 Thus, recent reviews focused on more specialized subjects such as the role of 
Meldrum’s acid in multicomponent reactions,20 flash vacuum pyrolysis (FVP) techniques,21 
and more recently in synthesis of natural products.22,23 
One of the most valuable manipulations of Meldrum’s acid derivatives is their thermoly-
sis or pyrolysis to form highly reactive ketene intermediates, Scheme 2. Specifically, 5,5-
dialkyl (32) or 5-methylene (35) Meldrum’s acids decompose at high temperatures (> 200 
°C) liberating acetone 28 and carbon dioxide 34, to generate dialkyl ketenes (33) or meth-
ylene ketenes (36), respectively (Scheme 2A). In recent years this transformation has also 
been applied materials chemistry. The Hawker group have pioneered this field demonstrat-
ing the versatility of ketenes in polymer chemistry in a number of advanced applications, 
including patterning of substrates,24,25 crosslinking of polyolefins,26 and the preparation of 
robust, solvent–stable nanostructured materials.27 Further, Leibfarth and co-workers have 
demonstrated, both computationally and experimentally, that the thermolysis temperature 
can be significantly lowered through inter- or intramolecular hydrogen bonding of a 
Bronsted acid (specifically a hydroxyl group) to one of the carbonyls of the Meldrum’s acid 
moiety (Scheme 2B).28  
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Scheme 2. Formation of ketenes from Meldrum’s acid derivatives. 
 
Single crystal X-ray diffraction studies of our Meldrum’s acid derived DASA trienes, 
revealed that the enolic hydroxyl proton engages in hydrogen bonding to a carbonyl oxygen 
in the Meldrum’s acid acceptor group, Scheme 3. Based on this observation and the works 
of Leibfarth28 and McNabb,18,21 we reasoned that thermolysis of Meldrum’s acid derived 
DASA trienes may provide access to methylene ketene intermediates, and further what 
products would arise from this process. 
 
Scheme 3. ORTEP rendering of DASA triene 17 highlighting intramolecular hydrogen 
bonding (50% probability ellipsoids, distance in Å, hydrogen atoms omitted for clarity).  
 
We began our study by examining the thermal decomposition of DASA triene 17 by 
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the effluent gas targeting CO2 and acetone, m/z 44 and 58 respectively, confirmed decompo-
sition of the Meldrum’s acid group in the solid state at this temperature, implying ketene 
formation. 
 
Figure 7. TGA/MS of DASA triene 17. 
 
Based on this result we proceeded to subject compound 17 to solution state thermolysis. 
Considering the high temperature needed to generate the ketene intermediate we chose to 
forgo conventional heating and opted to examine thermolysis under microwave irradiation. 
Based on the work of Vanderwal, we selected o-dicholorbenzene as the solvent for the reac-
tion, as it is both non-nucleophilic and is known to tolerate high temperatures.29,30 Following 
optimization of the temperature and time of the reaction, we were pleased to find that we 
could isolate γ-alkylidene butenolide 39 in up to 33% yield, Figure 8A. We propose that 
thermolysis of 17, leads to formation of methylene ketene 40, which then undergoes intra-
molecular cyclization and proton transfer to afford butenolide 39, Figure 8B. 
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Figure 8. A) Optimized synthesis of butenolide 39, B) Proposed mechanism of formation. 
 
With the ubiquity of the butenolide motif in many natural products and biologically rele-
vant compounds, this methodology allows for rapid access to these materials in as little as 3 
steps. This constitutes a significant advance in the synthesis of these compounds, which has 
historically been plagued by the use of highly toxic reagents, lengthy procedures and low 
yields.31–34 Further, Vanderwal has shown that 5-aminopentadienals can be treated with tri-
alkyl tin species, resulting in the exchange of the amine component for the trialkyl tin.35 We 
believe that our conjugated butenolides can undergo the same exchange reaction; enabling 
the use of these materials in Stille cross coupling reactions for the synthesis of complex pol-
yenes and natural products.  
5.3. DASA Dimers 
The ability to reversibly alter the geometry of macromolecules has been exploited for the 
elaboration of guest-encapsulation structures,36,37 and opto-mechanical materials,38–42 which 
enable direct conversion of photon energy into mechanical work. To prepare efficient struc-
tures and materials however, it is desirable to design macromolecules apt to dramatically 
change shape and dimensions upon exposure to light.43 The groups of Aida,44 and in particu-
lar McGrath,45–48 and later on also Mullen and co-workers,49 introduced azobenzene photo-
chromes into the core of rather spherical dendrimers, resulting in (quasi)isotropic nano-
objects that display significant changes in hydrodynamic volume upon photoirradiation, with 
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contractions as high as ΔVh= 37%, as evaluated by gel permeation chromatography (GPC). 
In 2011, Hecht and co-workers reported the synthesis of rigid-rod polymers consisting of 
azobenzene photochromes in the main chain and the dramatic change of their shape induced 
upon irradiation.50 The embedded photo-switches act as hinges, which upon light-induced 
isomerization lead to reversible shrinking and stretching of the polymer backbone. Based on 
these works and the dramatic change in molecular length that DASAs undergo upon irradia-
tion,9 we began a program to prepare DASA oligomers and polymers, wherein the backbone 
of the macromolecule was composed of DASA trienes. 
At the outset we sought to evaluate the feasibility of generating DASA dimers. We be-
gan by examining linking two DASA units through the acceptor. To this end we prepared 
Meldrum’s acid dimer 42, where a cyclohexane group links the two acceptors, Figure 9. 
Knoevenagel condensation of 42 with furfural 43 provided activated furan dimer 44. Treat-
ment of 44 with diethylamine 45 cleanly provided the anticipated DASA 46. When we irra-
diated a toluene solution of dimer 46, we observed an incomplete decrease in the absorbance 
attributed to the DASA triene by UV-Vis spectroscopy. Further, when irradiation was 
ceased, we observed only incomplete recovery of the triene absorbance. Based on these re-
sults, we believe that the highly rigid spirocyclic dimer may not have the conformational 
freedom necessary for both photochromic units to isomerize. Thus this strategy was not pur-
sued further. 
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Figure 9. Synthesis of acceptor linked DASA dimer 46. 
 
Following this effort we chose to pursue linking two DASAs through a single bifunc-
tional amine donor. For our initial attempt at this strategy, we selected piperazine 48. To our 
gratification reacting Meldrum’s acid activated furan 47 with piperazine 48, provided donor 
linked DASA dimer 49 in 67% yield, Figure 10. Further, this protocol was equally proficient 
when applied to 1,3-dimethyl barbituric acid activated furan 50, generating the correspond-
ing dimer 51 in 73% yield. 
 
 
Figure 10. Synthesis of first generation donor linked DASA dimers. 
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ble photochromism. To that end we substituted N,N`-dibutyl hexanediamine 52 for pipera-
zine 48, reasoning that the hexyl linker would provide greater conformational freedom while 
the butyl substituents would enhance solubility. We were gratified to find that not only were 
DASA dimers 53 and 54 obtained in excellent yield, but that both derivatives were observed 
to undergo complete and fully reversible photochromism under the developed conditions, 
Figure 11. 
 
Figure 11. A) Synthesis and B) Photochromism of 2nd generation donor linked DASA di-
mers. 
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57 was treated with 2 equivalents of butylamine 58 to provide bis-urea 59 in 96% yield, 
which was reacted with 2 equivalents of malonyl chloride 60 to afford the desired barbituric 
acid dimer 61 in 91% yield. 
 
Figure 12. Synthesis of barbituric acid dimer 61. 
 
With dimer 61 in hand, we were able to prepare acceptor linked bis-activated furan 62 in 
67% yield (unoptimized), and were pleased to find that reaction of 62 with 2 equivalents of 
diethylamine 43 provided acceptor linked DASA dimer 63 in 52% yield, Figure 13A. Fur-
ther, encouraged by these results we proceeded to prepare acceptor linked DASA dimer 65 
substituting diethylamine 43 with 6-azido-N-ethylhexan-1-amine 64, which we had previ-
ously employed for preparation of our micelle forming polymer amphiphiles and recyclable 
thiourea catalyst, Figure 13B. We were gratified to find that both derivatives 63 and 65, en-
gage in complete and fully reversible photochromism. 
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Figure 13. Synthesis of 2nd generation acceptor linked DASA dimers. 
 
We believe that these results lay the foundation for the preparation of DASA oligomers 
and polymers. As has been demonstrated, in future efforts a key design principle will be en-
suring that the resulting oligomers and polymers have the conformational flexibility needed 
to ensure complete and reversible photoisomerization of all incorporated DASA units. Fur-
ther, it has been demonstrated that rigid conjugated polymers typically exhibit poor solubili-
ty in traditional organic solvents.50–54 It is therefore clear that this feature cannot be over-
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posed to the use of butylamine 58, it would be beneficial to employ branched, acyclic alkyl-
amines such as 2-ethylhexylamine. Second, we advise that any donor amine employed in-
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clude branched acyclic alkyl chains, as well. With these considerations in mind we believe 
that DASA-backbone oligomers and polymers can be realized in the near future. 
5.4. Indenopyridine Carbonitriles 
5.4.1. Synthesis 
As discussed in Chapter 3, when we attempted to employ 1,1-dicyanomethylene-3-
indanone 66 or 1,3-bis(dicyanomethylene)-indan 69, we failed to obtain the desired DASA 
trienes instead we isolated expanded ring dihydroindenopyridine carbonitrile derivatives 68 
and 71, respectively, Figure 14.55 We then prepared thiophene analog 74 to determine if this 
phenomenon was limited to furans or if it was applicable to other 5-membered heterocycles 
as well. It should be noted that while we were successful in preparing a thiophene analog 
with 1,1-dicyanomethylene-3-indanone 66, both the Knoevenagel adduct and corresponding 
dihydroindenopyridine were unstable and decomposed rapidly in air. 
 
Figure 14. Synthesis of dihydroindenopyridine carbonitrile derivatives. 
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As discussed previously (Chapter 3, Section 3.3.1.), these dihydroindenopyridine car-
bonitriles oxidize on standing in air to the corresponding pyridines. We have subsequently 
found that the pyridines can also be accessed via chemical oxidation.  As shown in Figure 
15, the mild oxidizing agent chloranil afforded pyridine 75 in 47% yield, however, it was 
ineffective at oxidizing derivatives 71 and 74. We were pleased to find that 71 and 74 could 
be oxidized synthetically, albeit with the use of the much stronger KMnO4 affording pyri-
dines 76 and 77 in 52% and 39% yield respectively. 
 
Figure 15. Oxidation of dihydroindenopyridine carbonitriles to indenopyridine carbonitriles. 
 
We believe that with some optimization, these synthetic manipulations can provide fac-
ile access to either dihydroindenopyridine carbonitriles or indenopyridine carbonitriles. Fur-
ther, the generality of this process will allow for the rapid introduction of structural diversi-
ty, both in the heterocyclic moiety appended to the (dihydro)pyridine moiety and the amine 
group employed. 
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5.4.2. Electrochemical Properties 
Intrigued by these materials we sought to determine their electrochemical properties, as a 
first step to determining what if any application they may have. As such, we contacted Dan-
isha M. Rivera-Nazario and Luis Echegoyen of University of Texas at El Paso who gra-
ciously conducted the experiments discussed below. The electrochemical properties of the 
samples were studied by cyclic voltammetry (CV) and square wave voltammetry (SWV) 
using 0.1 M TBAPF6 in anhydrous DCM at a scan rate of 100 mV/s. The sample concentra-
tions were 0.5 mM for all samples.  
5.4.2.1. Dihydroindenopyridines 
All compounds exhibited similar behavior with the exception of 68 (Figure 16). On the 
anodic scan two irreversible waves were observed for 68 and one irreversible wave for both 
71 and 74. These waves could be attributed to the oxidation of the dihydropyridine (DHP) 
moiety. 
 
Figure 16. Cyclic voltammograms in 0.1 M TBAPF6/DCM of 0.5 mM a) 68, b) 71 and c) 
74. 
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It has been reported that the oxidation of DHP follows a two-electron pathway leading to 
the formation of neutral pyridine.56,57 Scheme 4 shows the proposed mechanism involving 
the loss of two electrons and two hydrogen atoms, however, the mechanism has been pro-
posed only for 1,4-dihydropyridine not for 1,2-dihydropyridine containing compounds.58 
 
Scheme 4. Proposed mechanism for the oxidation of 1,2-dihydropyridines following the 
proposed mechanism reported by Srividya et al. Note: This is the proposed mechanism for 
all three compounds, 71 was used as example. 
  
Interestingly, the cathodic scan exhibits one irreversible and one reversible wave for 68, 
but two reversible waves upon incorporation of the dicyano moiety on both 71 and 74. The 
first reduction waves at -1.47, -1.37 and -1.34 V for 68, 71 and 74, respectively, are tenta-
tively assigned to a possible DHP radical anion. Structurally, the compounds are similar to 
fluorene compounds and can be considered modified fluorenes. We thus assigned the second 
reversible reduction waves to the reduction of the fluorene-like portion of the molecule 
(highlighted in Figure 17) since similar reduction potentials have been reported for this sys-
tem.59  
 
Figure 17. Fluorene-like portion of the compounds under study. 
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5.4.2.2. Pyridines 
In the pyridine series, all compounds exhibit similar electrochemical behavior (Figure 
18). No oxidation processes were observed due to the absence of oxidizable groups such as 
the DHP.  
 
Figure 18. Cyclic voltammograms in 0.1 M TBAPF6/DCM of 0.5 mM a) 75, b) 76 and c) 
77. 
 
Interestingly, the cathodic processes of 75 are very different than those for 68. The first 
reduction wave at -1.72 V is reversible and cathodically shifted 250 mV when compared to 
that for 68. Therefore, we assigned the first reduction waves to the reduction of the fluorene-
like portion of the molecules (Figure 17) which are in the potential range for similar sys-
tems.59 It is known that pyridines can be reduced in proton-rich media to hydrogenated pyri-
dines, but as the experiments were conducted under neutral conditions we tentatively as-
signed the second reduction waves to a radical anion localized in the pyridine moiety.60 
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Table 1. Electrochemical potentials (E/V) from cyclic voltammetry experiments vs Fc/Fc+ 
and electrochemical HOMO/LUMO levels. 
 
Compound E2
ox 
(V) 
E1ox 
(V) 
E1red 
(V) 
E2red 
(V) 
Eonsetox 
(V) 
HOMO 
(eV)b 
Eonsetred 
(V) 
LUMO 
(eV)c 
68 +0.619a +0.222 -1.47a -2.05 -0.039 -4.34 -1.23 -3.15 
75 - - -1.72 -2.24 - - -1.51 -2.87 
71 - +0.537a -1.37 -1.86 +0.292 -4.67 -1.16 -3.22 
76 - - -1.78 -2.35a - - -1.61 -2.77 
74 - +0.576a -1.34 -1.83 +0.331 -4.71 -1.13 -3.25 
77 - - -1.70 -2.23a - - -1.51 -2.87 
a Peak potentials. 
b Calculated from EHOMO = -q(Eonsetox + 4.38) eV. 
c Calculated from ELUMO = -q(Eonsetred + 4.38) eV.  
 
Table 2. Electrochemical potentials (E/V) from square wave voltammetry experiments vs 
Fc/Fc+. 
 
Compound E2
ox 
(V) 
E1ox 
(V) 
E1red 
(V) 
E2red 
(V) 
68 +0.590 +0.194 -1.42 -2.02 
75 - - -1.71 -2.16 
71 - +0.551 -1.33 -1.83 
76 - - -1.73 -2.23 
74 - +0.565 -1.32 -1.82 
77 - - -1.71 -2.17 
 
While we currently have not determined a potential application for these materials we 
believe that they should continue to be studied, as it is clear the structural variations have a 
direct impact on their electrochemical properties.  
5.5. Closing Remarks 
In summary, we have demonstrated that there are still a number of potentially promising 
avenues of exploration for DASA photo switches. Specifically, we believe that our efforts 
towards the preparation of γ-alkylidene butenolides from Meldrum’s acid derived DASA 
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trienes has significant potential to impact natural product synthesis. Further, our work on 
DASA dimers lays the foundation for the development of oligomeric and polymeric materi-
als that can undergo dramatic changes in size and volume. Finally, our investigations on the 
formation and properties of (dihydro)indenopyridine-carbonitriles, derived from heterocy-
clic aldehydes activated by either 1,1-dicyanomethylene-3-indanone or 1,3-
bis(dicyanomethylene)-indane, provides rapid access to these unique materials. We hope 
that the work presented here will serve as an inspiration to further the applications of donor-
acceptor Stenhouse adducts. 
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6. Experimental Procedures and Analytical Data 
6.1. Chapter 2 
General Methods:  
All commercially obtained solvents and reagents were used without further purification. An-
alytical thin-layer chromatography (TLC) was carried out on Merck silica gel 60 F254 glass 
plates and flash column chromatography was performed on Merck silica gel 60 (70 – 230 
mesh) or on a Biotage SP1 Flash Purification System using FLASH 40+M cartridges and 
FLASH 40+ sample cartridges. Dry column vacuum chromatography was performed on 
Merck silica gel 60 (15 – 40 mesh).  1H and 13C solution-state NMR were recorded on a Var-
ian VNMRS 600 (600 MHz for 1H and 150 MHz for 13C) spectrometer or Varian Inova-500 
(500 MHz for 1H, and 125 MHz for 13C). Chemical shifts are reported relative to residual 
solvent peaks (δ 7.26 for CDCl3 in 1H NMR and δ 77.2 for CDCl3 in 13C NMR). IR spectra 
were recorded on a Perkin Elmer Spectrum 2 FT/IR or a Perkin Elmer Spectrum 100 em-
ploying a Universal ATR Sampling Accessory and are reported in terms of frequency of ab-
sorption (cm-1). X-Ray analysis was obtained from the UC Santa Barbara X-Ray Facilities. 
Mass spectral data were collected on a Micromass QTOF2 Quadrupole/Time-of Flight Tan-
dem mass spectrometer (ESI-MS). UV-vis spectral and kinetic data were collected on a 
Shimadzu UV-3600 UV-Vis-NIR Spectrophotometer with a quartz spectrasil UV-vis cuvette 
(1 x 1 x 4 cm) using direct detection at a slit width of 2 nm.  Fluorescence measurements 
were obtained using a Cary Eclipse spectrophotometer (Varian, Inc.) with a quartz fluores-
cence cuvette (1 x 1 x 0.2 cm) with the following settings: excitation wavelength of 550 nm, 
excitation slit width = 5 nm, emission slit width = 10 nm, range = 560 nm to 700 nm and 
scan speed = 30 nm/min. 
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Synthetic Methods 
5-(furan-2-ylmethylene)-2,2-dimethyl-1,3-dioxane-4,6-dione (19): 
2,2-dimethyl-1,3-dioxane-4,6-dione (1.51 g, 10.5 mmol) and 2-furaldehyde (961 mg, 10 
mmol) were added sequentially to 30 mL H2O. The heterogeneous mixture was heated to 75 
oC and stirred at that temperature for 2 h. During the course of the reaction a yellow precipi-
tate formed. At the completion of the reaction  (as monitored by TLC, 3:1 hexane:ethyl ace-
tate) the mixture was cooled to room temperature. The precipitated solid was collected by 
vacuum filtration and washed twice with 30 mL cold H2O. The collected solid was dissolved 
in dichloromethane, washed sequentially with 30 mL saturated aqueous NaHSO3, 30 mL 
H2O, 30 mL saturated aqueous NaHCO3, and 30 mL brine. The organic layer was dried over 
MgSO4, filtered and the solvent removed by rotary evaporation to give 2.19 g (99%) of 5-
(furan-2-ylmethylene)-2,2-dimethyl-1,3-dioxane-4,6-dione (a known compound) as a bright 
yellow powder. All spectroscopic data match reported values.1 
 
5-(furan-2-ylmethylene)-1,3-dimethylpyrimidine-2,4,6(1H,3H,5H)-trione (35): 
1,3-dimethylpyrimidine-2,4,6(1H,3H,5H)-trione (1.56 g, 10 mmol) and 2-furaldehyde (961 
mg, 10 mmol) were added sequentially to 40 mL H2O. The heterogeneous mixture was 
stirred at room temperature for 2 h. During the course of the reaction a yellow precipitate 
formed. At the completion of the reaction  (as monitored by TLC, 3:1 hexane:ethyl acetate) 
the precipitated solid was collected by vacuum filtration and washed twice with 30 mL cold 
H2O. The collected solid was dissolved in dichloromethane (75 mL), washed sequentially 
with 30 mL saturated aqueous NaHSO3, 30 mL H2O, 30 mL saturated aqueous NaHCO3, 
and 30 mL brine. The organic layer was dried over MgSO4, filtered and the solvent removed 
by rotary evaporation to give 2.26 g (96%) of 5-(furan-2-ylmethylene)-1,3-
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dimethylpyrimidine-2,4,6(1H,3H,5H)-trione (a known compound) as a bright yellow pow-
der. All spectroscopic data match reported values.2 
 
5-((2Z,4E)-5-(diethylamino)-2-hydroxypenta-2,4-dien-1-ylidene)-2,2-dimethyl-1,3-
dioxane-4,6-dione (38): 5-(furan-2-ylmethylene)-2,2-dimethyl-1,3-dioxane-4,6-dione (1 
gram, 4.5 mmol, 1 eq) was dissolved in 10 ml tetrahydrofuran.  To this solution was added 
diethylamine (466 µL, 329 mg, 4.5 mmol, 1 eq). The mixture was stirred at 23 oC for 10 min 
followed by cooling at 0 oC for 20 min. The reaction mixture was then filtered to collect the 
precipitated solid, the solid was washed with cold diethyl ether, and dried in vacuo to afford 
Stenhouse adduct 38 (1.13g, 85%) as a red solid. 1H NMR (600 MHz, cd2cl2) δ 11.37 – 
11.34 (m, 1H), 7.33 (d, J = 12.2 Hz, 1H), 6.96 (s, 1H), 6.80 (dd, J = 12.5, 1.3 Hz, 1H), 6.08 
(t, J = 12.4 Hz, 1H), 3.54 – 3.45 (m, 4H), 1.68 (s, 6H), 1.31 (dt, J = 18.1, 7.3 Hz, 6H). 13C 
NMR (151 MHz, cd2cl2) δ 167.0, 164.6, 157.6, 151.4, 144.5, 137.8, 103.0, 102.2, 89.8, 52.0, 
44.2, 26.4, 14.1, 12.1. IR (KBR) 3071, 2996, 2938, 1681, 1634, 1603, 1573, 1510, 1463, 
1414, 1369, 1340, 1264, 1235, 1196, 1172, 1139, 1128, 1096, 1083, 1059, 1015 cm-1. 
HRMS (ESI+) m/z 318.1313 (318.1317 calc’d for C15H21NO5Na+ [M + Na]+). Crystal struc-
ture data for 5-((2Z,4E)-5-(diethylamino)-2-hydroxypenta-2,4-dien-1-ylidene)-2,2-
dimethyl-1,3-dioxane-4,6-dione can be obtained free of charge from the Cambridge Crys-
tallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif  CCDC# 865315 
 
5-((2Z,4E)-5-(diethylamino)-2-hydroxypenta-2,4-dien-1-ylidene)-1,3-dimethyl-
pyrimidine-2,4,6-(1H,3H,5H)-trione (36): 5-(furan-2-ylmethylene)-1,3-
dimethylpyrimidine-2,4,6(1H,3H,5H)-trione (234 mg, 1 mmol) was suspended in 10 ml tet-
rahydrofuran. To this suspension was added diethylamine (104 µL, 1 mmol). The mixture 
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was stirred at 23 oC for 10 min followed by cooling at 0 oC for 20 min. The reaction mixture 
was then filtered to collect the precipitated solid, the solid was washed with cold diethyl 
ether, and dried in vacuo to afford Stenhouse adduct 36 (283 mg, 92%) as a purple solid. 1H 
NMR (Methylene Chloride-d2) δ: 12.50 (s, 1H), 7.30 (d, J = 12.2 Hz, 1H), 7.06 (s, 1H), 6.82 
(dd, J = 12.3, 1.5 Hz, 1H), 6.10 (t, J = 12.3 Hz, 1H), 3.50 (dq, J = 25.4, 7.2 Hz, 4H), 3.29 (s, 
3H), 3.27 (s, 3H), 1.31 (dt, J = 13.0, 7.2 Hz, 6H). 13C NMR (151 MHz, cd2cl2) δ 165.7, 
163.6, 157.8, 151.8, 146.7, 138.2, 103.3, 98.1, 52.6, 44.8, 28.6, 28.5, 14.8, 12.7. IR (KBr) 
3365, 2944, 2486, 1685, 1618, 1592, 1566, 1509, 1460, 1418, 1373, 1328, 1309, 1286, 
1270. HRMS (ESI+) m/z 330.1433 (330.1430 calc’d for C15H21N3O4Na+ [M +Na]+). 
 
5-(2-(diethylammonio)-5-oxocyclopent-3-en-1-yl)-2,2-dimethyl-4-oxo-4H-1,3-dioxin-6-
olate (39): Stenhouse adduct 38 (148 mg, 0.5 mmol) was suspended in 10 mL methanol. 
The reaction mixture was irradiated with a GE Crystal Clear 200 bulb (200 watt, 3780 lu-
mens) placed approximately 10 inches from the reaction vessel at ambient temperature with 
stirring for 12 h.  The reaction mixture was cooled to 0 oC for 20 min, then filtered to collect 
the precipitated solid; the solid was washed with cold diethyl ether, and dried in vacuo to 
afford 39 (140 mg, 95%) as a white solid. 1H NMR (600 MHz, d2o) δ 7.68 (dd, J = 6.1, 1.9 
Hz, 1H), 6.55 (dt, J = 6.1, 1.4 Hz, 1H), 4.72 – 4.69 (m, 1H), 3.49 (d, J = 3.6 Hz, 1H), 3.24 
(b, J = 72.0 Hz, 4H), 1.54 (s, 6H), 1.22 (t, J = 7.3 Hz, 6H). 13C NMR (151 MHz, d2o) δ 
208.2, 155.1, 138.0, 103.7, 72.6, 66.6, 44.1, 24.5, 9.3. IR (KBr) 3409, 3071, 2992, 2956, 
2916, 2589, 2439, 1714, 1673, 1572, 1513, 1487, 1475, 1460, 1416, 1376, 1339, 1287, 
1261, 1233, 1215, 1198, 1182, 1161, 1148, 1121, 1047, 1030 cm-1. HRMS (ESI) m/z 
318.1313 (318.1317 calc’d for C15H21NO5Na+ [M + Na]+). Crystal structure data for 5-(2-
(diethylammonio)-5-oxocyclopent-3-en-1-yl)-2,2-dimethyl-4-oxo-4H-1,3-dioxin-6-olate 
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can be obtained free of charge from the Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif  CCDC# 977459  
 
5-(2-(diethylammonio)-5-oxocyclopent-3-en-1-yl)-1,3-dimethyl-2,6-dioxo-1,2,3,6-
tetrahydropyrimidin-4-olate (37): Stenhouse adduct 36 (154 mg, 0.5 mmol) was suspend-
ed in 10 mL methanol. The reaction mixture was irradiated with a GE Crystal Clear 200 
bulb (200 watt, 3780 lumens) placed approximately 10 inches from the reaction vessel at 
ambient temperature with stirring for 12 h.  The reaction mixture was cooled to 0 oC for 20 
min, then filtered to collect the precipitated solid; the solid was washed with cold diethyl 
ether, and dried in vacuo to afford 37 (142 mg, 92%) as a white solid. 1H NMR (600 MHz, 
Deuterium Oxide) δ 7.84 (dd, J = 6.1, 1.9 Hz, 1H), 6.71 (ddd, J = 6.1, 1.9, 0.8 Hz, 1H), 4.83 
(d, J = 1.8 Hz, 1H), 3.88 (d, J = 3.6 Hz, 1H), 3.39 (dq, J = 14.6, 7.4 Hz, 2H), 3.36 – 3.21 (m, 
6H), 3.18 (s, 2H), 1.30 (t, J = 7.3 Hz, 6H). 13C NMR (151 MHz, d2o) δ 208.5, 164.6, 163.7, 
154.0, 138.0, 85.6, 66.5, 66.5, 46.4, 44.4, 44.4, 28.0, 27.2, 9.2. IR (KBr) 3052, 2986, 2972, 
2919, 2742, 2660, 2502, 1727, 1674, 1667, 1614, 1599, 1578, 1517, 1477, 1435, 1397. 
HRMS (ESI+) m/z 330.1433 (330.1430 calc’d for C15H21N3O4Na+ [M +Na]+). 
 
 
 
 
 
 
 
 
  140 
Representative NMR Spectra:  
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Uv-vis Spectral Data: 
 
Figure S1: Normalized of UV/vis absorption spectrum of 38 in toluene, λmax = 545 nm.  
 
Figure S2: UV/vis concentration vs. absorbance curve for 38, ε= 1x105 M-1 cm-1. 
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Figure S3: Normalized of UV/vis absorption spectrum of 36 in toluene, λmax = 570 nm. 
  
Figure S4: UV/vis concentration vs. absorbance curve for 36, ε= 1x105 M-1 cm-1. 
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Figure S5: Determination of Isosbestic Point for 38 in methanol, which occurs at 280 nm. 
 
Figure S6: Absorption spectra of the photoisomerization 38 to 39 on irradiation with unfil-
tered, high intensity visible light in methanol, λmax = 515 nm. Isosbestic point occurs at 280 
nm.  
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Figure S7: Comparison of light source intensities. 
Figure S8: Effect of light source intensity on photoswitching rates of 36 in toluene.  
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6.2. Chapter 3 
General Methods Unless stated otherwise, reactions were conducted in flame dried glass-
ware under an atmosphere of air using reagent grade solvents. All commercially obtained 
reagents were used as received. Reaction temperatures were controlled using automated 
temperature modulator, and unless stated otherwise, reactions were performed at room tem-
perature (rt, approximately 23 ºC). Thin-layer chromatography (TLC) was conducted with E. 
Merck silica gel 60 F254 pre-coated plates (0.25 mm) and visualized by exposure to UV 
light (254 nm) or stained with anisaldehyde or potassium permanganate. Flash column 
chromatography was performed using normal phase silica gel (60 Å, 230-240 mesh, Merck 
KGA). 1H NMR spectra were recorded at 500 or 600 MHz and are reported relative to deu-
terated solvent signals. Data for 1H NMR spectra are reported as follows: chemical shift (δ 
ppm), multiplicity, coupling constant (Hz) and integration. 13C NMR spectra were recorded 
at 125 or 150 MHz. Data for 13C NMR spectra are reported as follows: shift (δ ppm). High-
resolution mass spectra (HRMS) were obtained using a TOF mass spectrometer, whereas 
infrared (IR) spectra were obtained using a Fourier transform infrared spectrometer. 
General Procedure A: preparation of Stenhouse adducts: The activated furan (1.0 
equiv.) is added to tetrahydrofuran (0.4 M). To this solution at 23 ºC is added 1.0 equiv. of 
secondary amine. The reaction mixture is stirred at 23 oC for 10 minutes followed by cool-
ing at 0 oC for 20 minutes. The reaction mixture is then filtered to collect the precipitated 
solid; the solid is washed with cold diethyl ether, and dried in vacuo to afford the title com-
pounds. 
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5-((2Z,4E)-2-hydroxy-5-(pyrrolidin-1-yl)penta-2,4-dien-1-ylidene)-2,2-dimethyl-1,3-
dioxane-4,6-dione (4): Following General Procedure A, the title compound was obtained as 
a red solid (1.25g, 95%). 1H NMR (600 MHz, CD2Cl2) δ 11.36 (s, 1H), 7.53 (d, J = 12.0 Hz, 
1H), 6.95 (s, 1H), 6.77 (d, J = 12.6 Hz, 1H), 5.97 (t, J = 12.3 Hz, 1H), 3.71 (t, J = 6.5 Hz, 
2H), 3.54 (t, J = 6.6 Hz, 2H), 2.14 – 2.08 (m, 2H), 2.05 – 1.98 (m, 2H), 1.68 (s, 6H). 13C 
NMR (150 MHz,  CD2Cl2) δ 167.0, 164.6, 155.0, 150.7, 144.7, 137.7, 103.6, 103.0, 89.8, 
54.1, 48.7, 26.4, 24.9, 24.9. IR (KBr) 2986, 2874, 1689, 1643, 1640, 1574, 1521, 1453, 
1391, 1371, 1344, 1308, 1263, 1228, 1200, 1152, 1104, 1004 cm-1. HRMS (ESI+) m/z 
316.1154 (316.1161 calculated for C15H19NO5Na+ [M + Na]+). 
 
5-((2Z,4E)-2-hydroxy-5-(piperidin-1-yl)penta-2,4-dien-1-ylidene)-2,2-dimethyl-1,3-
dioxane-4,6-dione (5): Following General Procedure A, the title compound was obtained as 
a red solid (1.10g, 80%). 1H NMR (600 MHz,  CD2Cl2) δ 11.38 (s, 1H), 7.32 (d, J = 12.2 Hz, 
1H), 6.93 (s, 1H), 6.85 – 6.79 (m, 1H), 6.14 (t, J = 12.3 Hz, 1H), 3.58 (d, J = 23.3 Hz, 4H), 
1.75 (s, 6H), 1.68 (s, 6H). 13C NMR (150 MHz,  CD2Cl2) δ 167.0, 164.7, 157.5, 151.6, 
144.5, 137.0, 102.9, 101.7, 57.0, 47.9, 26.7, 26.4, 25.4, 23.5. IR (KBr) 3855, 3841, 3678, 
3446, 3075, 2987, 2941, 1720, 1681, 1639, 1599, 1571, 1524, 1469, 1452, 1412, 1372, 
1263, 1244, 1201, 1149, 1024 cm-1. HRMS (ESI+) m/z 330.1318 (330.1317 calculated for 
C16H21NO5Na+ [M + Na]+). 
 
5-((2Z,4E)-2-hydroxy-5-morpholinopenta-2,4-dien-1-ylidene)-2,2-dimethyl-1,3-
dioxane-4,6-dione (6): Following General Procedure A, the title compound was obtained as 
a red solid (1.19g, 85%). 1H NMR (600 MHz,  CD2Cl2) δ 11.27 (s, 1H), 7.22 (d, J = 12.4 Hz, 
1H), 7.10 (s, 1H), 6.76 (d, J = 12.2 Hz, 1H), 6.09 (t, J = 12.3 Hz, 1H), 3.80 – 3.78 (m, 4H), 
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3.58 (s, 4H), 1.69 (s, 6H). 13C NMR (150 MHz,  CD2Cl2) δ 161.7, 156.1, 156.1, 149.8, 
140.5, 140.5, 140.5, 134.3, 100.9, 69.3, 67.0, 49.6, 46.1, 44.7, 28.0, 26.8, 26.5. IR (KBr) 
2988, 2934, 2857, 1688, 1633, 1604, 1569, 1520, 1442, 1392, 1371, 1354, 1301, 1278, 
1258, 1244, 1204, 1162, 1139, 1114, 1067, 1025, 1009 cm-1. HRMS (ESI+) m/z 332.1105 
(332.1110 calculated for C15H19NO6Na+ [M + Na]+). Crystal structure data for 5-((2Z,4E)-2-
hydroxy-5-morpholinopenta-2,4-dien-1-ylidene)-2,2-dimethyl-1,3-dioxane-4,6-dione (6) 
can be obtained free of charge from the Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif  CCDC 844844 
 
5-((2Z,4E)-2-hydroxy-5-(4-phenylpiperazin-1-yl)penta-2,4-dien-1-ylidene)-2,2-
dimethyl-1,3-dioxane-4,6-dione (7): Following General Procedure A, the title compound 
was obtained as a red solid (273 mg, 71%). 1H NMR (600 MHz,  CD2Cl2) δ 11.22 (s, 1H), 
7.24 – 7.14 (m, 4H), 7.00 (s, 1H), 6.89 – 6.83 (m, 4H), 6.73 – 6.66 (m, 1H), 6.06 (t, J = 12.3 
Hz, 1H), 3.65 (s, 4H), 3.24 (t, J = 5.2 Hz, 4H), 1.61 (s, 6H). 13C NMR (150 MHz,  CD2Cl2) δ 
164.4, 156.0, 150.2, 150.0, 140.1, 134.2, 129.3, 129.0, 121.0, 119.6, 116.8, 116.0, 103.3, 
101.1, 93.9, 69.0, 49.4, 49.2, 46.3, 44.8, 28.0, 26.8, 26.5.  IR (KBr) 3055, 2995, 2930, 2829, 
1689, 1634, 1601, 1568, 1523, 1503, 1443, 1389, 1374, 1362, 1283, 1258, 1249, 1230, 
1208, 1163, 1095, 1051, 1015 cm-1. HRMS (ESI+) m/z 407.1581 (407.1583 calculated for 
C21H24N2O5Na+ [M + Na]+). 
 
5-((2Z,4E)-2-hydroxy-5-((R)-2-methylpyrrolidin-1-yl)penta-2,4-dien-1-ylidene)-2,2-
dimethyl-1,3-dioxane-4,6-dione (8): Following General Procedure A, the title compound 
was obtained as a red solid (1.21g, 87%). 1H NMR (600 MHz,  CD2Cl2) δ 11.28 (s, 1H), 
7.42 (d, J = 12.0 Hz, 1H), 6.85 (s, 1H), 6.72 (d, J = 12.6 Hz, 1H), 5.90 (t, J = 12.3 Hz, 1H), 
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3.83 (d, J = 6.5 Hz, 1H), 3.56 – 3.47 (m, 2H), 2.17 – 1.87 (m, 4H), 1.59 (s, 6H), 1.28 (d, J = 
6.5 Hz, 3H). 13C NMR (150 MHz,  CD2Cl2) δ 167.0, 164.7, 153.9, 150.9, 144.6, 137.3, 
103.9, 102.9, 89.6, 60.4, 49.2, 32.7, 26.4, 26.4, 22.8, 20.1. IR (KBr) 3065, 2996, 2877, 1676, 
1599, 1509, 1466, 1441, 1369, 1345, 1311, 1259, 1232, 1191, 1135, 1004 cm-1. HRMS 
(ESI+) m/z 330.1320 (330.1317 calculated for C16H21NO5Na+ [M + Na]+). 
 
(S)-methyl-1-((1E,3Z)-5-(2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-ylidene)-4-hydroxypenta-
1,3-dien-1-yl) pyrrolidine-2-carboxylate (9): Following General Procedure A, the title 
compound was obtained as a green solid (1.33g, 84%). 1H NMR (600 MHz,  CD2Cl2) δ 
11.14 (s, 1H), 7.29 (d, J = 12.5 Hz, 1H), 7.05 (s, 1H), 6.63 (d, J = 12.3 Hz, 1H), 5.89 (t, J = 
12.3 Hz, 1H), 4.37 – 4.32 (m, 1H), 3.70 (s, 3H), 2.24 – 2.17 (m, 2H), 2.07 – 1.98 (m, 2H), 
1.74 (d, J = 3.6 Hz, 2H), 1.61 (d, J = 2.0 Hz, 6H). 13C NMR (150 MHz,  CD2Cl2) δ 166.8, 
164.2, 161.6, 153.6, 149.0, 141.8, 134.5, 110.0, 103.4, 103.1, 65.0, 62.9, 51.8, 48.8, 46.5, 
29.7, 29.5, 26.5, 26.5, 23.9, 23.7, 23.5. IR (KBr) 3068, 2990, 2953, 2880, 1742, 1688, 1627, 
1485, 1450, 1407, 1391, 1362, 1340, 1274, 1244, 1234, 1200, 1141, 1118, 1043, 1006 cm-1. 
HRMS (ESI+) m/z 374.1212 (374.1216 calculated for C17H21NO7Na+ [M + Na]+).  Crystal 
structure data for (S)-methyl 1-((1E,3Z)-5-(2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-ylidene)-
4-hydroxypenta-1,3-dien-1-yl)pyrrolidine-2-carboxylate (9) can be obtained free of 
charge from the Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif  CCDC 844843 
 
5-((2Z,4E)-5-(dipropylamino)-2-hydroxypenta-2,4-dien-1-ylidene)-2,2-dimethyl-1,3-
dioxane-4,6-dione (11): Following General Procedure A, the title compound was obtained 
as a red solid (252 mg, 78%). 1H NMR (500 MHz,  CD2Cl2) δ: 11.35 (s, 1H), 7.31 (d, J = 
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12.2 Hz, 1H), 6.96 (s, 1H), 6.78 (d, J = 12.4 Hz, 1H), 6.06 (t, J = 12.3 Hz, 1H), 3.38 (q, J = 
7.4 Hz, 4H), 1.72 (dq, J = 9.6, 7.5 Hz, 4H), 1.67 (s, 6H), 0.96 (dt, J = 25.4, 7.4 Hz, 6H). 13C 
NMR (125 MHz,  CD2Cl2) δ 167.6, 165.3, 159.0, 152.0, 145.2, 138.5, 103.6, 102.9, 59.9, 
51.8, 27.0, 22.8, 21.1, 11.6, 11.2. IR (KBr) 3150, 2993, 2917, 2696, 1644, 1589, 1548, 1501, 
1447, 1403, 1359, 1315, 1278, 1232, 1196, 1145, 1122 cm-1. HRMS (ESI+) m/z 346.1620 
(346.1630 calculated for C17H25NO5Na+ [M + Na]+). 
 
5-((2Z,4E)-5-(dibutylamino)-2-hydroxypenta-2,4-dien-1-ylidene)-2,2-dimethyl-1,3-
dioxane-4,6-dione (12): Following General Procedure A, the title compound was obtained 
as a red solid (288 mg, 82%). 1H NMR (500 MHz,  CD2Cl2) δ: 11.34 (s, 1H), 7.31 (d, J = 
12.3 Hz, 1H), 6.95 (s, 1H), 6.78 (dd, J = 12.5, 1.5 Hz, 1H), 6.06 (t, J = 12.3 Hz, 1H), 3.41 (q, 
J = 7.0 Hz, 4H), 1.67 (s, 10H), 1.37 (dh, J = 29.9, 7.4 Hz, 4H), 0.97 (q, J = 7.5 Hz, 6H). 13C 
NMR (125 MHz,  CD2Cl2) δ 167.6, 165.2, 159.0, 152.0, 145.2, 138.2, 103.6, 103.0, 58.1, 
50.1, 31.4, 29.7, 27.0, 20.7, 20.2, 14.0, 140. IR (KBr) 3157, 2991, 2923, 1691, 1645, 1592, 
1544, 1498, 1446, 1404, 1357, 1311, 1274, 1228, 1191, 1136, 1116 cm-1. HRMS (ESI+) m/z 
374.1947 (374.1943 calculated for C19H29NO5Na+ [M + Na]+). 
 
5-((2Z,4E)-5-(dihexylamino)-2-hydroxypenta-2,4-dien-1-ylidene)-2,2-dimethyl-1,3-
dioxane-4,6-dione (13): Following General Procedure A, the title compound was obtained 
as a red solid (371 mg, 91%). 1H NMR (500 MHz,  CD2Cl2) δ: 11.34 (s, 1H), 7.31 (d, J = 
12.2 Hz, 1H), 6.94 (s, 1H), 6.78 (dd, J = 12.5, 1.5 Hz, 1H), 6.06 (t, J = 12.3 Hz, 1H), 3.41 (q, 
J = 6.7 Hz, 5H), 1.67 (s, 10H), 1.38 – 1.25 (m, 16H), 0.90 (ddt, J = 10.8, 7.6, 4.4 Hz, 6H). 
13C NMR (125 MHz,  CD2Cl2) δ 167.6, 165.3, 159.0, 152.0, 145.2, 138.2, 103.6, 103.0, 
58.3, 50.3, 31.9, 31.9, 31.9, 29.4, 27.6, 27.1, 27.0, 26.6, 23.1, 23.1, 23.0, 14.3. IR (KBr) 
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3163, 2996, 2921, 1694, 1639, 1585, 1537, 1487, 1435, 1395, 1344, 1297, 1260, 1223, 
1183, 1125, 1109 cm-1. HRMS (ESI+) m/z 430.2573 (430.2569 calculated for 
C23H37NO5Na+ [M + Na]+). 
 
5-((2Z,4E)-5-(dioctylamino)-2-hydroxypenta-2,4-dien-1-ylidene)-2,2-dimethyl-1,3-
dioxane-4,6-dione (14): Following General Procedure A, the title compound was obtained 
as a red solid (1.75g, 83%). 1H NMR (600 MHz,  CD2Cl2) δ 11.36 (s, 1H), 7.30 (d, J = 12.2 
Hz, 1H), 6.96 (s, 1H), 6.78 (d, J = 12.4 Hz, 1H), 6.07 (t, J = 12.3 Hz, 1H), 3.41 (q, J = 7.2 
Hz, 4H), 1.68 (s, 6H), 1.41 – 1.18 (m, 24H), 0.90 (t, J = 6.8 Hz, 6H). 13C NMR (150 MHz,  
CD2Cl2) δ 167.0, 164.6, 158.3, 151.3, 144.6, 137.7, 103.0, 102.3, 89.8, 57.7, 49.7, 31.7, 
31.7, 29.1, 29.1, 29.0, 28.8, 27.3, 27.0, 26.9, 26.4, 26.4, 22.6, 13.8. IR (KBr) 2924, 2855, 
1719, 1676, 1575, 1503, 1462, 1416, 1391, 1346, 1287, 1262, 1231, 1199, 1142, 1117, 
1047, 1029 cm-1. HRMS (ESI+) m/z 486.3181 (486.3195 calculated for C27H45NO5Na+ [M + 
Na]+). 
 
5-((2Z,4E)-5-(diallylamino)-2-hydroxypenta-2,4-dien-1-ylidene)-2,2-dimethyl-1,3-
dioxane-4,6-dione (16): Following General Procedure A, the title compound was obtained 
as a purple solid (968 mg, 68%). 1H NMR (600 MHz,  CD2Cl2) δ 11.17 (s, 1H), 7.23 (d, J = 
12.4 Hz, 1H), 7.00 (s, 1H), 6.65 (d, J = 12.3 Hz, 1H), 5.96 (t, J = 12.3 Hz, 1H), 5.75 (dt, J = 
13.8, 7.6 Hz, 2H), 5.32 – 5.15 (m, 4H), 3.94 (dd, J = 16.9, 5.0 Hz, 4H), 1.60 (s, 6H). 13C 
NMR (150 MHz,  CD2Cl2) δ 166.9, 164.4, 157.1, 150.1, 145.1, 140.5, 131.2, 129.4, 120.5, 
119.1, 119.0, 103.3, 102.0, 91.9, 59.1, 51.3, 26.5. IR (KBr) 3071, 3003, 2943, 1698, 1646, 
1612, 1561, 1499, 1446, 1368, 1299, 1283, 1242, 1207, 1164 cm-1. HRMS (ESI+) m/z 
342.1324 (342.1317 calculated for C17H21NO5Na+ [M +Na]+). 
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5-((2Z,4E)-5-(benzyl(methyl)amino)-2-hydroxypenta-2,4-dien-1-ylidene)-2,2-dimethyl-
1,3-dioxane-4,6-dione (19): Following General Procedure A, the title compound was ob-
tained as a purple solid (1.31g, 85%). 1H NMR (600 MHz,  CD2Cl2) δ 11.32 (d, J = 1.6 Hz, 
1H), 7.53 (d, J = 12.2 Hz, 1H), 7.42 (qd, J = 7.8, 7.2, 3.7 Hz, 3H), 7.31 – 7.18 (m, 2H), 7.08 
(s, 1H), 6.82 (dd, J = 12.5, 1.6 Hz, 1H), 6.14 (dt, J = 93.0, 12.3 Hz, 1H), 4.61 (d, J = 18.0 
Hz, 2H), 3.13 (d, J = 122.7 Hz, 3H), 1.68 (d, J = 5.1 Hz, 6H). 13C NMR (150 MHz,  CD2Cl2) 
δ 166.9, 164.5, 158.8, 158.0, 150.7, 150.4, 145.1, 139.9, 139.5, 134.0, 129.2, 129.1, 128.8, 
128.7, 128.5, 128.4, 127.8, 127.4, 103.2, 102.1, 102.0, 62.9, 53.8, 53.6, 53.4, 53.3, 53.1, 
36.3, 26.5. IR (KBr) 3082, 3028, 2990, 2940, 1695, 1610, 1565, 1502, 1447, 1401, 1386, 
1356, 1276, 1260, 1239, 1200, 1150, 1065, 1032, 1003 cm-1. HRMS (ESI+) m/z 366.1320 
(366.1317 calculated for C19H21NO5Na+ [M +Na]+). 
 
5-((2Z,4E)-5-(3,4-dihydroisoquinolin-2(1H)-yl)-2-hydroxypenta-2,4-dien-1-ylidene)-2,2-
dimethyl-1,3-dioxane-4,6-dione (20): Following General Procedure A, the title compound 
was obtained as a red solid (1.32 g, 82%). 1H NMR (600 MHz,  CD2Cl2) δ 11.24 (s, 1H), 
7.36 (d, J = 12.4 Hz, 1H), 7.25 – 6.90 (m, 7H), 6.71 (d, J = 12.3 Hz, 1H), 6.06 (d, J = 12.5 
Hz, 1H), 4.64 (s, 2), 3.75 – 3.64 (m, 2H), 2.96 (d, J = 18.9 Hz, 2H), 1.60 (s, 6H). 13C NMR 
(150 MHz,  CD2Cl2) δ 166.9, 164.4, 156.7, 156.6, 150.1, 150.0, 140.1, 128.7, 128.6, 127.3, 
127.1, 127.1, 127.0, 126.5, 126.4, 125.6, 101.5, 101.4, 52.4, 48.3, 29.3, 26.5. IR (KBr) 3469, 
3062, 2992, 2937, 1690, 1632, 1609, 1561, 1500, 1458, 1440, 1364, 1283, 1267, 1234, 
1203, 1153, 1051 cm-1. HRMS (ESI+) m/z 378.1314 (378.1317 calculated for 
C20H21NO5Na+ [M +Na]+). 
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5-((2Z,4E)-2-hydroxy-5-(isoindolin-2-yl)penta-2,4-dien-1-ylidene)-2,2-dimethyl-1,3-
dioxane-4,6-dione (21): Following General Procedure A, the title compound was obtained 
as a red solid (870 mg, 91%). 1H NMR (600 MHz,  CD2Cl2) δ 11.21 (s, 1H), 7.48 (d, J = 
12.2 Hz, 1H), 7.27 (d, J = 26.5 Hz, 4H), 7.05 (s, 1H), 6.69 (d, J = 12.2 Hz, 1H), 5.96 (t, J = 
12.3 Hz, 1H), 4.97 (s, 2H), 4.78 (s, 2H), 1.61 (s, 6H). 13C NMR (150 MHz,  CD2Cl2) δ 
153.6, 149.0, 141.1, 128.4, 128.2, 122.8, 122.5, 103.3, 103.0, 58.3, 54.5, 26.5. IR (KBr) 
3063, 2985, 2958, 1688, 1637, 1611, 1565, 1505, 1468, 1451, 1368, 1349, 1284, 1268, 
1235, 1223, 1198, 1180, 1151, 1114, 1025, 1006 cm-1. HRMS (ESI+) m/z 364.1163 
(364.1161 calculated for C19H19NO5Na+ [M +Na]+). Crystal structure data for 5-((2Z,4E)-2-
hydroxy-5-(isoindolin-2-yl)penta-2,4-dien-1-ylidene)-2,2-dimethyl-1,3-dioxane-4,6-
dione (21) can be obtained free of charge from the Cambridge Crystallographic Data Centre 
via www.ccdc.cam.ac.uk/data_request/cif  CCDC 846378 
 
5-((2Z,4E)-5-(dibenzylamino)-2-hydroxypenta-2,4-dien-1-ylidene)-2,2-dimethyl-1,3-
dioxane-4,6-dione (22): Following General Procedure A, the title compound was obtained 
as a green solid (1.42g, 75%). 1H NMR (600 MHz,  CD2Cl2) δ 11.25 (s, 1H), 7.59 (d, J = 
12.4 Hz, 1H), 7.40 (tt, J = 14.8, 6.6 Hz, 6H), 7.22 (dd, J = 12.8, 7.3 Hz, 4H), 7.13 (s, 1H), 
6.83 (d, J = 12.2 Hz, 1H), 6.23 (t, J = 12.3 Hz, 1H), 4.56 (d, J = 5.5 Hz, 4H), 1.68 (s, 6H). 
13C NMR (150 MHz,  CD2Cl2) δ 166.9, 164.4, 157.7, 150.2, 145.2, 140.8, 134.1, 133.8, 
129.2, 129.1, 128.8, 128.8, 128.4, 128.3, 128.1, 127.5, 127.3, 103.4, 102.0, 92.2, 60.0, 54.5, 
51.7, 26.6, 26.5. IR (KBr) 3469, 3058, 3027, 2992, 2932, 1696, 1626, 1553, 1489, 1476, 
1449, 1391, 1365, 1346, 1291, 1261, 1231, 1197, 1139, 1111, 1030, 1016, 1003 cm-1. 
HRMS (ESI+) m/z 442.1637 (442.1630 calculated for C25H25NO5Na+ [M + Na]+). Crystal 
structure data for 5-((2Z,4E)-5-(dibenzylamino)-2-hydroxypenta-2,4-dien-1-ylidene)-2,2-
  156 
dimethyl-1,3-dioxane-4,6-dione (22) can be obtained free of charge from the Cambridge 
Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif  CCDC 844842 
 
5-((2Z,4E)-2-hydroxy-5-(methyl(phenyl)amino)penta-2,4-dien-1-ylidene)-2,2-dimethyl-
1,3-dioxane-4,6-dione (23): Following general procedure A, the title compound was ob-
tained as a purple solid (74 mg, 22%). 1H NMR (600 MHz,  CD2Cl2) δ 7.67 (d, J = 5.5 Hz, 
1H), 7.24 (t, J = 7.8 Hz, 2H), 6.84 (d, J = 8.1 Hz, 2H), 6.78 (t, J = 7.3 Hz, 1H), 6.43 (d, J = 
4.6 Hz, 1H), 5.52 (s, 1H), 4.00 (s, 1H), 3.50 – 3.43 (d, J = 3.4 Hz, 1H), 2.79 (s, 3H), 1.70 (s, 
6H). 13C NMR (125 MHz,  CD2Cl2) δ 163.8, 149.9, 134.7, 130.4, 130.0, 118.9, 114.1, 106.2, 
63.6, 48.4, 45.0, 32.8, 28.4, 27.2, 27.2. IR (ATR) 3060, 2999, 2921, 1780, 1742, 1710, 1596, 
1503, 1470, 1382, 1324, 1269, 1197, 1147, 1104, 1015, 990, 927, 871, 791, 749, 694 cm-1. 
HRMS (ESI+) m/z 352.1147 (352.1161 calculated for C18H19NO5Na+ [M + Na]+). 
 
2-((2Z,4E)-5-(diethylamino)-2-hydroxypenta-2,4-dien-1-ylidene)-1H-indene-1,3(2H)-
dione (62): Following General Procedure A the title compound was obtained as a dark blue 
solid (259 mg, 87%). 1H NMR (600 MHz,  CD2Cl2) δ 11.51 (s, 1H), 7.60 (dt, J = 19.4, 2.6 
Hz, 2H), 7.57 – 7.52 (m, 2H), 7.24 (d, J = 12.2 Hz, 1H), 6.71 (d, J = 12.3 Hz, 1H), 6.64 (s, 
1H), 6.04 (t, J = 12.3 Hz, 1H), 3.46 (dq, J = 28.1, 7.2 Hz, 4H), 1.27 (dt, J = 7.9, 4.5 Hz, 6H). 
13C NMR (125 MHz,  CD2Cl2) δ 193.2, 190.8, 156.4, 147.8, 147.3, 141.2, 140.9, 133.5, 
133.2, 132.0, 121.3, 121.1, 114.5, 102.6, 52.3, 44.5, 14.8, 12.6. IR (ATR): 3007, 2971, 2924, 
2869, 1674, 1613, 1583, 1483, 1439, 1373, 1353, 1331, 1262, 1163, 1146, 1110, 974, 905, 
765 cm-1. HRMS (ESI+) m/z 320.1262 (320.1263 calculated for C18H19NO3Na+ [M + Na]+). 
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5-((2Z,4E)-2-hydroxy-5-(pyrrolidin-1-yl)penta-2,4-dien-1-ylidene)-1,3-
dimethylpyrimidine-2,4,6(1H,3H,5H)-trione (26): Following General Procedure A, the 
title compound was obtained as a purple solid (275 mg, 90%).  1H NMR (600 MHz, CDCl3) 
δ 12.53 (s, 1H), 7.43 (d, J = 12.2 Hz, 1H), 7.14 (s, 1H), 6.72 (d, J = 12.4 Hz, 1H), 5.98 (t, J 
= 12.3 Hz, 1H), 3.70 (t, J = 6.8 Hz, 3H), 3.52 (t, J = 7.0 Hz, 3H), 3.35 (d, J = 6.2 Hz, 7H), 
3.21 (s, 2H), 2.13 (p, J = 6.8 Hz, 4H), 2.04 (p, J = 6.6 Hz, 4H). 13C NMR (150 MHz, CDCl3) 
δ 163.3, 153.6, 150.0, 146.7, 139.4, 104.0, 70.0, 53.8, 48.4, 28.4, 28.3, 25.0, 22.7. IR (KBr) 
2961, 2915, 2763, 1693, 1617, 1580, 1559, 1491, 1454, 1419, 1370, 1343, 1266, 1226, 
1177, 1105, 1043, 967, 941, 924, 829, 754 cm-1. HRMS (ESI+) m/z 328.1263 (328.1273 cal-
culated for C15H19N3O4Na+ [M + Na]+). 
 
5-((2Z,4E)-2-hydroxy-5-(piperidin-1-yl)penta-2,4-dien-1-ylidene)-1,3-
dimethylpyrimidine-2,4,6(1H,3H,5H)-trione (27): Following General Procedure A, the 
title compound was obtained as a purple solid (297mg, 93%).   1H NMR (500 MHz, CD2Cl2) 
δ: 12.52 (s, 1H), 7.32 (d, J = 12.1 Hz, 1H), 7.01 (s, 1H), 6.85 (d, J = 12.5 Hz, 1H), 6.16 (t, J 
= 12.3 Hz, 1H), 3.71 – 3.65 (m, 2H), 3.61 – 3.58 (m, 2H), 3.55 (bs, 2H), 3.29 (s, 3H), 3.26 
(s, 3H), 3.17 (bs, 2H), 1.84 – 1.79 (m, 2H). 13C NMR (125 MHz, CD2Cl2) δ 165.0, 163.0, 
157.3, 151.6, 146.1, 136.7, 102.4, 67.7, 57.0, 27.9, 25.5, 23.6. IR (KBr) 2964, 2915, 2832, 
1694, 1616, 1578, 1557, 1488, 1452, 1419, 1369, 1345, 1260, 1217, 1164, 1105, 1043, 967, 
941, 924, 829, 754 cm-1. HRMS (ESI+) m/z 342.1426 (342.1430 calculated for 
C16H21N3O4Na+ [M + Na]+). 
 
5-((2Z,4E)-2-hydroxy-5-((R)-2-methylpyrrolidin-1-yl)penta-2,4-dien-1-ylidene)-1,3-
dimethylpyrimidine-2,4,6(1H,3H,5H)-trione (30): Following General Procedure A, the 
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title compound was obtained as a purple solid (278 mg, 87%).   1H NMR (600 MHz,  CDCl3) 
δ 12.53 (s, 1H), 7.38 (d, J = 12.2 Hz, 1H), 7.15 (s, 1H), 6.75 (d, J = 12.6 Hz, 1H), 5.99 (t, J 
= 12.3 Hz, 1H), 3.89 (q, J = 6.5 Hz, 1H), 3.58 (q, J = 6.7 Hz, 2H), 3.35 (d, J = 5.8 Hz, 7H), 
2.32 – 1.95 (m, 5H), 1.71 (dq, J = 12.9, 6.6 Hz, 1H), 1.37 (d, J = 6.5 Hz, 3H). 13C NMR 
(150 MHz,  CDCl3) δ 165.1, 152.3, 152.0, 150.2, 146.7, 139.2, 104.2, 59.9, 49.0, 32.9, 28.4, 
28.3, 22.9, 20.5. IR (KBr) 2965, 2913, 2821, 1694, 1616, 1576, 1557, 1487, 1452, 1421, 
1369, 1346, 1260, 1219, 1166, 1109, 1050, 976, 968, 924, 829, 754 cm-1. HRMS (ESI+) m/z 
342.1430 (342.1430 calculated for C16H21N3O4Na+ [M + Na]+). 
 
(S)-methyl-1-((1E,3Z)-5-(1,3-dimethyl-2,4,6-trioxotetrahydropyrimidin-5(2H)-ylidene)-
4-hydroxypenta-1,3-dien-1-yl) pyrrolidine-2-carboxylate (31): Following General Proce-
dure A, the title compound was obtained as a purple solid (189 mg, 52%). 1H NMR (500 
MHz,  CD2Cl2) δ: 12.35 (s, 1H), 7.37 (d, J = 12.1 Hz, 1H), 7.18 (s, 1H), 6.72 (d, J = 12.5 Hz, 
1H), 5.96 (t, J = 12.3 Hz, 1H), 4.43 (dd, J = 7.7, 4.3 Hz, 1H), 3.76 (s, 3H), 3.71 – 3.58 (m, 
2H), 3.28 (s, 3H), 3.25 (s, 3H), 2.32 – 2.18 (m, 2H), 2.07 (tdd, J = 12.8, 8.0, 5.9 Hz, 2H). 13C 
NMR (125 MHz,  CD2Cl2) δ 171.3, 165.8, 163.3, 153.9, 152.2, 149.4, 147.5, 141.9, 135.0, 
104.3, 65.6, 53.5, 49.4, 30.1, 28.7, 28.6, 24.1. IR (KBr) 2966, 2912, 2813, 1694, 1615, 1573, 
1557, 1486, 1452, 1425, 1369, 1347, 1260, 1222, 1180, 1126, 1071, 1004, 968, 924, 829, 
754 cm-1.  HRMS (ESI+) m/z 386.1321 (386.1328 calculated for C17H21N3O6Na+ [M + 
Na]+). 
 
5-((2Z,4E)-5-(dipropylamino)-2-hydroxypenta-2,4-dien-1-ylidene)-1,3-
dimethylpyrimidine-2,4,6(1H,3H,5H)-trione (33): Following General Procedure A, the 
title compound was obtained as a purple solid (278 mg, 83%).   1H NMR (500 MHz, 
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CD2Cl2) δ: 12.50 (s, 1H), 7.31 (d, J = 12.2 Hz, 1H), 7.05 (s, 1H), 6.83 (d, J = 12.5 Hz, 1H), 
6.09 (t, J = 12.3 Hz, 1H), 3.39 (dt, J = 11.8, 7.8 Hz, 4H), 3.29 (s, 3H), 3.26 (s, 3H), 1.72 (dh, 
J = 16.8, 9.6, 8.1 Hz, 4H), 0.97 (dt, J = 28.8, 7.4 Hz, 6H). 13C NMR (125 MHz, CD2Cl2) δ 
165.6, 163.6, 158.8, 151.9, 146.8, 138.1, 103.4, 59.8, 51.8, 28.6, 28.5, 22.8, 21.1, 11.7, 11.5, 
11.2. IR (KBr) 2972, 2920, 2813, 1695, 1614, 1569, 1558, 1485, 1451, 1424, 1386, 1346, 
1260, 1221, 1176, 1122, 1078, 1009, 977, 936, 836, 757 cm-1. HRMS (ESI+) m/z 358.1740 
(358.1743 calculated for C17H25N3O4Na+ [M + Na]+). 
 
5-((2Z,4E)-5-(dibutylamino)-2-hydroxypenta-2,4-dien-1-ylidene)-1,3-
dimethylpyrimidine-2,4,6(1H,3H,5H)-trione (34): Following General Procedure A, the 
title compound was obtained as a purple solid (276 mg, 76%).   1H NMR (500 MHz, CD2Cl2) 
δ: 12.49 (s, 1H), 7.29 (d, J = 12.2 Hz, 1H), 7.04 (s, 1H), 6.81 (d, J = 12.4 Hz, 1H), 6.08 (t, J 
= 12.3 Hz, 1H), 3.42 (dt, J = 12.2, 7.7 Hz, 4H), 3.29 (s, 3H), 3.26 (s, 3H), 1.71 – 1.62 (m, 
4H), 1.37 (dh, J = 30.1, 7.4 Hz, 4H), 0.97 (dt, J = 11.4, 7.4 Hz, 6H). 13C NMR (125 MHz, 
CD2Cl2) δ 165.1, 163.0, 158.0, 151.2, 146.2, 137.4, 102.9, 57.4, 49.5, 30.9, 29.1, 28.0, 27.9, 
20.2, 19.6, 13.4, 13.3. IR (KBr) 2971, 2919, 2813, 1695, 1613, 1586, 1558, 1484, 1451, 
1423, 1370, 1339, 1257, 1221, 1176, 1122, 1063, 1007, 977, 936, 836, 759 cm-1.  HRMS 
(ESI+) m/z 386.2049 (386.2056 calculated for C19H29N3O4Na+ [M + Na]+). 
 
5-((2Z,4E)-5-(dihexylamino)-2-hydroxypenta-2,4-dien-1-ylidene)-1,3-
dimethylpyrimidine-2,4,6(1H,3H,5H)-trione (35): Following General Procedure A, the 
title compound was obtained as a purple solid (394 mg, 94%).   1H NMR (500 MHz, CD2Cl2) 
δ: 12.49 (s, 1H), 7.30 (d, J = 12.2 Hz, 1H), 7.03 (s, 1H), 6.82 (d, J = 12.1 Hz, 1H), 6.08 (t, J 
= 12.3 Hz, 1H), 3.41 (dt, J = 10.8, 7.8 Hz, 4H), 3.29 (s, 3H), 3.26 (s, 3H), 1.69 – 1.65 (m, 
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4H), 1.34 – 1.30 (m, 12H), 0.91 – 0.89 (m, 6H). 13C NMR (125 MHz, CD2Cl2) δ 165.0, 
163.0, 158.0, 151.3, 146.2, 137.3, 103.0, 57.7, 49.7, 31.3, 31.3, 28.8, 28.0, 27.9, 27.0, 26.5, 
26.4, 26.0, 22.5, 22.4, 13.7. IR (KBr) 2971, 2919, 2818, 1699, 1613, 1568, 1553, 1484, 
1457, 1423, 1369, 1343, 1264, 1220, 1173, 1123, 1075, 1009, 979, 944, 848, 766 cm-1.  
HRMS (ESI+) m/z 442.2681 (442.2682 calculated for C23H37N3O4Na+ [M + Na]+). 
 
5-((2Z,4E)-5-(dioctylamino)-2-hydroxypenta-2,4-dien-1-ylidene)-1,3-
dimethylpyrimidine-2,4,6(1H,3H,5H)-trione (36): Following General Procedure A, the 
title compound was obtained as a purple solid (414 mg, 87%).   1H NMR (500 MHz, CD2Cl2) 
δ: 12.49 (s, 1H), 7.29 (d, J = 12.2 Hz, 1H), 7.03 (s, 1H), 6.82 (d, J = 12.5 Hz, 1H), 6.08 (t, J 
= 12.3 Hz, 1H), 3.41 (dt, J = 11.0, 7.7 Hz, 4H), 3.29 (s, 3H), 3.26 (s, 3H), 1.70 – 1.65 (m, 
4H), 1.32 – 1.27 (m, 20H), 0.90 – 0.87 (m, 6H). 13C NMR (125 MHz, CD2Cl2) δ 165.0, 
163.0, 158.0, 151.3, 146.2, 137.3, 102.9, 57.7, 49.7, 31.7, 31.7, 31.7, 29.1, 29.1, 29.1, 29.1, 
28.9, 28.0, 27.9, 27.1, 26.9, 26.4, 22.6, 13.8. IR (KBr) 2969, 2917, 2806, 1693, 1616, 1576, 
1557, 1487, 1453, 1425, 1360, 1342, 1267, 1226, 1180, 1124, 1073, 1006, 978, 941, 851, 
761 cm-1.  HRMS (ESI+) m/z 498.3296 (498.3308 calculated for C27H45N3O4Na+ [M + 
Na]+). 
 
5-((2Z,4E)-5-(diallylamino)-2-hydroxypenta-2,4-dien-1-ylidene)-1,3-
dimethylpyrimidine-2,4,6(1H,3H,5H)-trione (38): Following General Procedure A, the 
title compound was obtained as a purple solid (315 mg, 95%).   1H NMR (500 MHz, CD2Cl2) 
δ: 12.40 (s, 1H), 7.31 (d, J = 12.4 Hz, 1H), 7.15 (s, 1H), 6.78 – 6.75 (m, 2H), 6.06 (t, J = 
12.3 Hz, 1H), 5.40 – 5.33 (m, 2H), 5.31 – 5.24 (m, 2H), 4.07 – 3.96 (m, 4H), 3.36 (m, 2H), 
3.29 (s, 3H), 3.27 (s, 3H). 13C NMR (125 MHz, CD2Cl2) δ 165.8, 163.5, 157.4, 152.2, 150.6, 
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147.2, 140.7, 131.9, 130.1, 121.1, 119.6, 103.2, 59.7, 50.8, 30.3, 28.7, 28.6. IR (KBr) 2967, 
2911, 2809, 1694, 1610, 1552, 1459, 1428, 1361, 1348, 1263, 1222, 1174, 1116, 1060, 991, 
965, 931, 836, 758 cm-1.  HRMS (ESI+) m/z 354.1426 (354.1430 calculated for 
C17H21N3O4Na+ [M + Na]+). 
 
5-((2Z,4E)-5-(benzyl(methyl)amino)-2-hydroxypenta-2,4-dien-1-ylidene)-1,3-
dimethylpyrimidine-2,4,6(1H,3H,5H)-trione (41): Following General Procedure A, the 
title compound was obtained as a purple solid (327 mg, 92%).   1H NMR (500 MHz, CD2Cl2) 
δ: 12.44 (s, 1H), 7.46 (d, J = 12.3 Hz, 1H), 7.40 (dd, J = 13.8, 7.2 Hz, 3H), 7.24 (d, J = 7.4 
Hz, 2H), 7.18 (s, 1H), 6.82 (d, J = 12.3 Hz, 1H), 6.06 (t, J = 12.3 Hz, 1H), 4.58 (s, 2H), 3.30 
(s, 3H), 3.27 (s, 3H), 3.03 (s, 3H). 13C NMR (150 MHz, CD2Cl2) δ 165.8, 163.5, 157.8, 
152.3, 150.4, 147.3, 140.7, 134.7, 129.7, 129.4, 128.3, 128.0, 102.9, 63.4, 36.9, 28.7, 28.6. 
IR (KBr) 2961, 2918, 2816, 1692, 1614, 1573, 1559, 1486, 1456, 1421, 1369, 1341, 1261, 
1221, 1179, 1118, 1062, 994, 968, 932, 841, 752 cm-1.  HRMS (ESI+) m/z 378.1428 
(378.1430 calculated for C19H21N3O4Na+ [M + Na]+). 
 
5-((2Z,4E)-5-(3,4-dihydroisoquinolin-2(1H)-yl)-2-hydroxypenta-2,4-dien-1-ylidene)-1,3-
dimethylpyrimidine-2,4,6(1H,3H,5H)-trione (42): Following General Procedure A, the 
title compound was obtained as a purple solid (301 mg, 82%).   1H NMR (500 MHz, CD2Cl2) 
δ: 12.48 (s, 1H), 7.45 (d, J = 12.9 Hz, 1H), 7.30 – 7.10 (m, 6H), 6.84 (d, J = 12.3 Hz, 1H), 
6.17 (d, J = 11.9 Hz, 1H), 4.73 (s, 2H), 3.81 (s, 2H), 3.30 (s, 3H), 3.26 (s, 3H), 3.09 – 2.99 
(m, 2H). 13C NMR (125 MHz, CD2Cl2) δ 165.7, 163.6, 157.0, 152.3, 150.6, 140.3, 129.5, 
129.3, 128.5, 127.7, 127.1, 102.7, 68.3, 52.6, 45.4, 42.4, 29.9, 28.7, 28.6, 26.1, 25.9. IR 
(KBr) 2965, 2913, 2814, 1697, 1619, 1573, 1556, 1481, 1456, 1426, 1362, 1345, 1269, 
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1228, 1175, 1120, 1065, 998, 972, 933, 838, 759 cm-1.  HRMS (ESI) m/z 390.1425 
(390.1430 calculated for C20H21N3O4Na+ [M + Na]+). 
 
1,3-dibutyl-5-((2Z,4E)-5-(diethylamino)-2-hydroxypenta-2,4-dien-1-
ylidene)pyrimidine-2,4,6(1H,3H,5H)-trione (70): Following General Procedure A, the title 
compound was obtained as a purple solid (341 mg, 87%). 1H NMR (600 MHz,  CD2Cl2) δ 
12.56 (s, 1H), 7.28 (d, J = 12.3 Hz, 1H), 7.06 (s, 1H), 6.80 (d, J = 11.5 Hz, 1H), 6.07 (t, J = 
12.3 Hz, 1H), 3.87 (dt, J = 14.9, 7.5 Hz, 4H), 3.49 (dq, J = 24.8, 7.2 Hz, 4H), 1.55 (m, 4H), 
1.40 – 1.23 (m, 10H), 0.93 (q, J = 7.3 Hz, 6H). 13C NMR (126 MHz,  CD2Cl2) δ 165.5, 
163.3, 157.4, 151.9, 151.3, 146.8, 138.7, 103.0, 98.7, 52.5, 44.7, 41.8, 41.7, 30.9, 30.9, 20.8, 
20.8, 14.8, 14.2, 14.2, 12.7. IR (ATR): 2958, 2932, 2873, 1691, 1622, 1596, 1556, 1497, 
1405, 1373, 1339, 1261, 1205, 1143, 1076, 990, 907, 779 cm-1. HRMS (ESI+) m/z 414.2379 
(414.2369 calculated for C21H33N3O4Na+ [M + Na]+) 
 
5-((2Z,4E)-5-(diethylamino)-2-hydroxypenta-2,4-dien-1-ylidene)-1,3-dioctylpyrimidine-
2,4,6(1H,3H,5H)-trione (72): Following General Procedure A, the title compound was ob-
tained as a purple solid (453 mg, 90%).  1H NMR (600 MHz, CD2Cl2) δ 12.56 (s, 1H), 7.28 
(d, J = 12.2 Hz, 1H), 7.06 (s, 1H), 6.79 (d, J = 12.4 Hz, 1H), 6.07 (t, J = 12.3 Hz, 1H), 3.92 
– 3.81 (m, 4H), 3.49 (dq, J = 24.7, 7.2 Hz, 4H), 1.57 (dt, J = 18.5, 7.4 Hz, 4H), 1.28 (m, 
26H), 0.87 (td, J = 7.0, 2.1 Hz, 6H). 13C NMR (125 MHz, CD2Cl2) δ 165.5, 163.3, 157.4, 
151.8, 151.3, 146.8, 138.7, 103.0, 98.8, 52.5, 42.1, 32.4, 30.0, 29.9, 28.8, 27.6, 23.2, 14.4. 
IR (ATR) 2956, 2923, 2854, 1691, 1620, 1595, 1556, 1492, 1454, 1403, 1370, 1337, 1260, 
1198, 1074, 989, 907, 779 cm-1. HRMS (ESI+) m/z 526.3612 (526.3621 calculated for 
C29H49N3O4Na+ [M + Na]+). 
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(E/Z)-5-((2Z,4E)-5-(diethylamino)-2-hydroxypenta-2,4-dien-1-ylidene)-1-methyl-3-
octylpyrimidine-2,4,6(1H,3H,5H)-trione (74): Following General Procedure A, the title 
compound was obtained as a dark purple solid (90 mg, 65 %). 1H NMR (500 MHz,  CD2Cl2) 
δ 12.53 (dd, J = 28.6, 1.3 Hz, 1H), 7.29 (dd, J = 12.2, 1.2 Hz, 1H), 7.06 (s, 1H), 6.81 (ddd, J 
= 12.3, 2.8, 1.5 Hz, 1H), 6.08 (t, J = 12.3 Hz, 1H), 3.93 – 3.81 (m, 2H), 3.49 (dq, J = 21.1, 
7.2 Hz, 4H), 3.27 (d, J = 14.2 Hz, 3H), 1.63 – 1.52 (m, 2H), 1.30 (m, 16H), 0.88 (td, J = 7.0, 
2.0 Hz, 3H). 13C NMR (125 MHz,  CD2Cl2) δ 165.7, 165.4, 163.6, 163.2, 157.6, 152.1, 
151.6, 146.7, 146.7, 138.4, 103.2, 98.4, 52.5, 44.7, 42.1, 42.0, 32.4, 30.0, 29.9, 29.9, 29.8, 
28.8, 28.7, 28.5, 28.4, 27.6, 27.5, 23.2, 14.8, 14.4, 12.7. IR (ATR) 2925, 2854, 1692, 1621, 
1596, 1557, 1495, 1461, 1425, 1406, 1371, 1352, 1261, 1229, 1203, 1150, 1074, 989, 909, 
838, 777, 729, 685. HRMS (ESI+) m/z 428.2524 (428.2525 calculated for C22H35N3O4Na+ 
[M + Na]+). 
 
5-((2Z,4E)-5-(diethylamino)-2-hydroxypenta-2,4-dien-1-ylidene)-1,3-
diphenylpyrimidine-2,4,6(1H,3H,5H)-trione (76): Following General Procedure A, the 
title compound was obtained as a purple solid (371 mg, 86%). 1H NMR (600 MHz,  CD2Cl2) 
δ 12.19 (s, 1H), 7.52 – 7.24 (m, 11H), 7.02 (s, 1H), 6.92 (dd, J = 12.6, 1.5 Hz, 1H), 6.16 (t, J 
= 12.4 Hz, 1H), 3.50 (dq, J = 36.5, 7.3 Hz, 4H), 1.30 (dt, J = 10.2, 7.2 Hz, 6H). 13C NMR 
(150 MHz,  CD2Cl2) δ 165.1, 163.2, 158.7, 153.2, 151.2, 146.3, 136.7, 136.3, 135.6, 129.0, 
129.0, 128.9, 128.8, 128.5, 128.2, 128.0, 103.9, 96.5, 52.2, 44.5, 14.1, 12.2. IR(ATR) 3398, 
2976, 2927, 1691, 1623, 1583, 1491, 1453, 1430, 1367, 1348, 1254, 1223, 1181, 1115, 
1071, 986, 958, 883, 751, 692 cm-1. HRMS (ESI+) m/z 454.1735 (454.1743 calculated for 
C25H25N3O4Na+ [M + Na]+). 
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5-((2Z,4E)-5-(diethylamino)-2-hydroxypenta-2,4-dien-1-ylidene)-1,3-bis(4-
methoxyphenyl)pyrimidine-2,4,6(1H,3H,5H)-trione (78): Following General Procedure 
A, the title compound was obtained as a purple solid (398 mg, 81%). 1H NMR (600 MHz,  
CD2Cl2) δ 12.21 (s, 1H), 7.35 (d, J = 12.1 Hz, 1H), 7.17 (dd, J = 19.5, 8.8 Hz, 4H), 7.03 (s, 
1H), 6.97 (t, J = 9.1 Hz, 4H), 6.90 (dd, J = 12.7, 1.5 Hz, 1H), 6.14 (t, J = 12.3 Hz, 1H), 3.83 
(d, J = 3.4 Hz, 6H), 3.51 (dq, J = 28.3, 7.2 Hz, 4H), 1.34 – 1.27 (m, 6H). 13C NMR (125 
MHz,  CD2Cl2) δ 165.3, 163.3, 159.3, 159.1, 158.2, 152.7, 151.6, 146.3, 136.4, 129.9, 129.2, 
128.8, 114.1, 103.6, 96.9, 55.4, 52.2, 44.4, 14.1, 12.2. IR(ATR) 3444, 2984, 2928, 2837, 
1697, 1587, 1508, 1462, 1432, 1368, 1349, 1244, 1181, 1143, 1117, 1073, 1026, 987, 961, 
828, 769, 748 cm-1. HRMS (ESI+) m/z 514.1949 (514.1954 calculated for C27H29N3O6Na+ 
[M + Na]+). 
 
1,3-bis(4-chlorophenyl)-5-((2Z,4E)-5-(diethylamino)-2-hydroxypenta-2,4-dien-1-
ylidene)pyrimidine-2,4,6(1H,3H,5H)-trione (80): Following General Procedure A, the title 
compound was obtained as a purple solid (445 mg, 89%). 1H NMR (600 MHz,  CD2Cl2) δ 
12.08 (s, 1H), 7.44 (dd, J = 11.2, 8.5 Hz, 4H), 7.40 (d, J = 12.1 Hz, 1H), 7.24 (dd, J = 18.5, 
8.6 Hz, 4H), 6.97 (s, 1H), 6.93 (dd, J = 12.8, 1.4 Hz, 1H), 6.20 (t, J = 12.4 Hz, 1H), 3.54 
(dq, J = 25.9, 7.3 Hz, 4H), 1.32 (dt, J = 18.1, 7.2 Hz, 6H). 13C NMR (125 MHz,  CD2Cl2) δ 
163.4, 159.6, 154.4, 151.5, 146.9, 135.5, 134.3, 131.1, 131.0, 129.6, 129.6, 104.9, 96.6, 
54.4, 53.0, 45.3, 14.7, 12.8. IR(ATR) 3468, 3007, 2986, 2928, 1701, 1625, 1589, 1489, 
1461, 1430, 1366, 1347, 1275, 1258, 1224, 1181, 1142, 1116, 1073, 1014, 959, 824, 810, 
765, 750 cm-1. HRMS (ESI+) m/z 522.0953 (522.0963 calculated for C25H23N3O4Cl2Na+ [M 
+ Na]+). 
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General Procedure B: Photo-isomerization of Stenhouse adducts to cyclopentenones: 
Stenhouse adduct is suspended in methanol (0.04 M). The reaction mixture is irradiated with 
a GE Crystal Clear 200 bulb (200 watt, 3780 lumens) placed approximately 10 inches from 
the reaction vessel at ambient temperature with stirring for 12 hours.  The reaction mixture 
is then cooled to 0 oC for 20 minutes, then filtered to collect the precipitated solid; the solid 
is washed with cold diethyl ether, and dried in vacuo to afford the title compounds. 
 
2,2-dimethyl-4-oxo-5-(2-oxo-5-(pyrrolidin-1-ium-1-yl)cyclopent-3-en-1-yl)-4H-1,3-
dioxin-6-olate (89): Following General Procedure B, the title compound was obtained as a 
white solid (87.8 mg, 82%). 1H NMR (600 MHz, D2O) δ 7.87 (d, J = 6.1 Hz, 1H), 6.67 (d, J 
= 6.0 Hz, 1H), 4.57 (s, 1H), 3.66-3.41 (b, 4H), 3.56 (d, J = 3.1 Hz, 1H), 2.12 (b, 4H), 1.68 
(s, 6H). 13C NMR (150 MHz, D2O) δ 208.4, 155.1, 137.6, 103.7, 72.3, 69.1, 52.6, 46.6, 24.5, 
22.7. IR (KBr) 3410, 3090, 3036, 2985, 2908, 2584, 2411, 1715, 1667, 1574, 1490, 1471, 
1412, 1393, 1371, 1346, 1323, 1289, 1263, 1216, 1198, 1162, 1134, 1116, 1066, 1035, 1006 
cm-1. HRMS (ESI+) m/z 316.1154 (316.1161 calculated for C15H19NO5Na+ [M + Na]+). 
 
2,2-dimethyl-4-oxo-5-(2-oxo-5-(piperidin-1-ium-1-yl)cyclopent-3-en-1-yl)-4H-1,3-
dioxin-6-olate (91): Following General Procedure B, the title compound was obtained as a 
white solid (108 mg, 88%). 1H NMR (500 MHz, D2O) δ 7.86 (dd, J = 6.1, 1.8 Hz, 1H), 6.65 
(dd, J = 6.1, 1.4 Hz, 1H), 4.62 – 4.52 (m, 1H), 3.58 – 2.94 (m, 4H), 2.24 – 1.71 (m, 6H), 
1.67 (s, 6H). 13C NMR (125 MHz, D2O) δ 208.4, 154.5, 137.6, 103.7, 73.0, 70.7, 44.3, 24.5, 
23.1, 21.1. IR (KBr) 3420, 3049, 2989, 2968, 2940, 2877, 2645, 2327, 2274, 1717, 1682, 
1576, 1521, 1469, 1446, 1413, 1375, 1365, 1345, 1330, 1321, 1291, 1261, 1235, 1215, 
1201, 1190, 1179, 1149, 1116, 1081, 1048, 1038, 1005 cm-1. HRMS (ESI+) m/z 330.1318 
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(330.1317 calculated for C16H21NO5Na+ [M + Na]+). Due to it’s sparing solubility in D2O, 
and reversion to 17 in organic solvents, the structure of 72 was confirmed by single crystal 
x-ray analysis. The crystal structure data for 2,2-dimethyl-4-oxo-5-(2-oxo-5-(piperidin-1-
ium-1-yl)cyclopent-3-en-1-yl)-4H-1,3-dioxin-6-olate (91) can be obtained free of charge 
from the Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif  
CCDC 844845 
 
5-(2-(benzyl(methyl)ammonio)-5-oxocyclopent-3-en-1-yl)-2,2-dimethyl-4-oxo-4H-1,3-
dioxin-6-olate (99): Following General Procedure B, the title compound was obtained as a 
white solid (137 mg, 80%). 1H NMR (500 MHz, D2O) δ 7.86 (s, 1H), 7.51 (m, 5H), 6.69 
(dd, J = 6.1, 1.9 Hz, 1H), 4.22 (s, 1H), 3.76 (d, J = 3.6 Hz, 1H), 2.87 (s, 3H), 2.73 (s, 2H), 
1.67 (m, 6H). 13C NMR (125 MHz, D2O) δ 208.1, 138.04, 130.6, 130.2, 129.6, 129.6, 129.4, 
129.2, 129.0, 105.0, 103.8, 52.3, 32.0, 30.2, 25.1, 24.5. IR (KBr) 3080, 3037, 2988, 2938, 
2901, 2646, 2461, 1726, 1717, 1673, 1576, 1498, 1476, 1458, 1415, 1375, 1349, 1290, 
1262, 1212, 1199, 1173, 1159, 1120, 1040 cm-1. HRMS (ESI+) m/z 366.1320 (366.1317 cal-
culated for C19H21NO5Na+ [M +Na]+). Due to it’s sparing solubility in D2O, and reversion in 
organic solvents, the structure of 99 was confirmed by single crystal x-ray analysis. The 
crystal structure data for 5-(2-(benzyl(methyl)ammonio)-5-oxocyclopent-3-en-1-yl)-2,2-
dimethyl-4-oxo-4H-1,3-dioxin-6-olate (99) can be obtained free of charge from the Cam-
bridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif  CCDC 
851860 
 
2,2-dimethyl-4-oxo-5-(2-oxo-5-(1,2,3,4-tetrahydroisoquinolin-2-ium-2-yl)cyclopent-3-
en-1-yl)-4H-1,3-dioxin-6-olate (100): Following General Procedure B, the title compound 
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was obtained as a white solid (151 mg, 85%). 1H NMR (500 MHz, D2O) δ 7.96 (dd, J = 6.1, 
2.0 Hz, 1H), 7.37 – 7.27 (m, 3H), 7.21 – 7.15 (m, 1H), 6.68 (dd, J = 6.2, 1.9 Hz, 1H), 4.71 
(s, 1H), 3.70 (d, J = 3.4 Hz, 1H), 3.62 (dq, J = 12.3, 6.3 Hz, 1H), 3.54 (t, J = 6.6 Hz, 1H), 
3.21 (q, J = 6.4 Hz, 2H), 3.13 (t, J = 6.4 Hz, 1H), 3.02 (t, J = 6.7 Hz, 1H), 1.67 (s, 6H). 13C 
NMR (125 MHz, D2O) δ 207.3, 155.2, 137.6, 133.1, 128.7, 128.2, 128.0, 127.7, 127.0, 
126.8, 126.6, 103.7, 69.5, 51.4, 47.9, 44.8, 41.6, 25.1, 24.5. IR (KBr) 3433, 3019, 2994, 
2944, 2722, 2509, 2400, 1926, 1726, 1667, 1568, 1504, 1479, 1457, 1440, 1426, 1411, 
1394, 1373, 1346, 1323, 1288, 1275, 1259, 1231, 1200, 1181, 1152, 1115, 1087, 1070, 
1056, 1026, 1008 cm-1. HRMS (ESI+) m/z 378.1314 (378.1317 calculated for 
C20H21NO5Na+ [M +Na]+). Due to it’s sparing solubility in D2O, and reversion in organic 
solvents, the structure of 100 was confirmed by single crystal x-ray analysis. The crystal 
structure data for 2,2-dimethyl-4-oxo-5-(2-oxo-5-(1,2,3,4-tetrahydroisoquinolin-2-ium-2-
yl)cyclopent-3-en-1-yl)-4H-1,3-dioxin-6-olate (100) can be obtained free of charge from 
the Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif  
CCDC 844846 
 
1,3-dimethyl-2,6-dioxo-5-(2-oxo-5-(pyrrolidin-1-ium-1-yl)cyclopent-3-en-1-yl)-1,2,3,6-
tetrahydropyrimidin-4-olate (104): Following General Procedure B, the title compound 
was obtained as a white solid (235 mg, 77%).  1H NMR (600 MHz, D2O) δ 7.85 (dd, J = 5.8, 
1.8 Hz, 1H), 6.67 (dd, J = 6.3, 1.6 Hz, 1H), 4.53 (d, J = 1.9 Hz, 1H), 3.78 (d, J = 3.4 Hz, 
1H), 3.48 (s, 4H), 3.20 (d, J = 61.7 Hz, 6H), 2.06 (s, 4H). 13C NMR (125 MHz, D2O) δ 
208.7, 164.4, 163.7, 154.8, 154.1, 137.7, 85.5, 69.1, 52.4, 46.9, 28.0, 27.2, 22.8. IR (ATR) 
3006, 2990, 2747, 2619, 1716, 1667, 1567, 1435, 1361, 1275, 1260, 1189, 750 cm-1. HRMS 
(ESI+) m/z 328.1273 (328.1273 calculated for C15H19N3O4Na+ [M + Na]+). 
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1,3-dimethyl-2,6-dioxo-5-(2-oxo-5-(piperidin-1-ium-1-yl)cyclopent-3-en-1-yl)-1,2,3,6-
tetrahydropyrimidin-4-olate (105): Following General Procedure B, the title compound 
was obtained as a white solid (259 mg, 81%).   1H NMR (600 MHz, D2O) δ 7.69 (dd, J = 
6.2, 2.0 Hz, 1H), 6.50 (dd, J = 6.3, 1.9 Hz, 1H), 4.46 – 4.32 (m, 1H), 3.71 (d, J = 3.6 Hz, 
1H), 3.49 – 2.85 (m, 10H), 1.93 – 1.24 (m, 6H). 13C NMR (125 MHz, D2O) δ 208.7, 164.4, 
163.8, 154.3, 154.1, 137.5, 86.1, 70.7, 67.8, 50.8, 44.7, 23.0, 22.1, 21.4, 21.1. IR(ATR) 
3006, 2989, 2918, 2861, 1718, 1673, 1604, 1575, 1473, 1440, 1370, 1319, 1275, 1260, 
1191, 1153, 1117, 1016, 951, 707 cm-1. HRMS (ESI+) m/z 342.1424 (324.1430 calculated 
for C16H21N3O4Na+ [M + Na]+). 
 
1,3-dimethyl-2,6-dioxo-5-(2-oxo-5-(1,2,3,4-tetrahydroisoquinolin-2-ium-2-yl)cyclopent-
3-en-1-yl)-1,2,3,6-tetrahydropyrimidin-4-olate (112): Following General Procedure B, the 
title compound was obtained as a white solid (320 mg, 87%). 1H NMR (600 MHz, D2O) δ 
7.84 (dd, J = 6.3, 1.9 Hz, 1H), 7.20 – 7.00 (m, 3H), 6.89 – 6.75 (m, 1H), 6.55 (dd, J = 6.2, 
1.9 Hz, 1H), 4.59 (dt, J = 3.8, 2.0 Hz, 1H), 4.45 – 4.29 (m, 2H), 3.78 (d, J = 3.6 Hz, 1H), 
3.67 (dt, J = 11.9, 5.7 Hz, 1H), 3.57 (dt, J = 5.5, 2.0 Hz, 1H), 3.19 – 2.78 (m, 8H). 13C NMR 
(125 MHz, D2O) δ 208.0, 164.4, 163.6, 153.9, 153.7, 137.8, 130.2, 128.9, 128.7, 128.4, 
128.0, 126.8, 126.5, 85.5, 67.8, 51.3, 47.7, 45.8, 28.0, 27.1. IR (ATR) 3006, 2989, 1716, 
1668, 1568, 1435, 1374, 1318, 1275, 1260, 1187, 1062, 967, 907, 824, 764, 750 cm-1. 
HRMS (ESI+) m/z 390.1418 (390.1430 calculated for C20H21N3O4Na+ [M + Na]+). 
 
2-(2-(furan-2-ylmethylene)-3-oxo-2,3-dihydro-1H-inden-1-ylidene)malononitrile (64): 
Following the procedure out lined by Bello et al.,3 the title compound was isolated as a 
bright orange solid (882 mg, 81%). 1H NMR (500 MHz,  CDCl3) δ 8.73 – 8.68 (m, 2H), 8.57 
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(s, 1H), 7.93 (dd, J = 7.5, 1.5 Hz, 1H), 7.84 (d, J = 1.6 Hz, 1H), 7.82 – 7.74 (m, 2H), 6.80 – 
6.75 (m, 1H). 13C NMR (125 MHz,  CDCl3) δ 187.1, 160.5, 150.9, 150.2, 139.8, 137.3, 
135.3, 134.8, 130.4, 127.3, 125.4, 124.4, 124.0, 115.5, 114.2, 113.8, 71.2. IR (ATR): 3166, 
3147, 3129, 3079, 2218, 1708, 1595, 1576, 1543, 1451, 1357, 1231, 1146, 1091, 1025, 933, 
764, 718 cm-1. HRMS (EI+) m/z 272.0589 (272.0586 calculated for C17H8N2O2 [M]+). 
 
3-(diethylamino)-1-(furan-2-yl)-9-oxo-2,9-dihydro-1H-indeno[2,1-c]pyridine-4-
carbonitrile (65): Following General Procedure A the title compound was isolated as a dark 
blue solid (332 mg, 96%). 1H NMR (600 MHz,  CD2Cl2) δ 8.36 (d, J = 7.6 Hz, 1H), 7.61 – 
7.40 (m, 4H), 7.31 (s, 1H), 6.95 (d, J = 12.8 Hz, 1H), 6.32 (s, 1H), 5.33 (s, 1H), 3.59 (dq, J = 
29.4, 7.3 Hz, 4H), 1.36 (dt, J = 14.6, 7.3 Hz, 6H). 13C NMR (125 MHz,  CD2Cl2) δ 191.7, 
160.0, 159.8, 152.8, 148.4, 141.1, 136.6, 133.7, 132.2, 127.3, 123.8, 122.1, 118.2, 118.1, 
113.4, 106.3, 53.2, 45.7, 14.6, 12.9. IR(ATR): 3325, 2979, 2935, 2874, 2196, 2179, 1666, 
1616, 1602, 1579, 1498, 1436, 1367, 1344, 1243, 1185, 1111, 1068, 974, 912, 821, 759, 712 
cm-1. HRMS (EI+) m/z 345.1483 (345.1477 calculated for C21H19N3O2 [M]+). 
 
2,2'-(2-(furan-2-ylmethylene)-1H-indene-1,3(2H)-diylidene)dimalononitrile (67): Fol-
lowing the procedure out lined by Bello et al.,3 the title compound was isolated as a bright 
orange solid (1.17 g, 91%). 1H NMR (600 MHz,  CDCl3) δ 8.62 (d, J = 7.8 Hz, 1H), 8.51 (d, 
J = 7.8 Hz, 1H), 8.21 (s, 1H), 7.91 – 7.70 (m, 3H), 7.24 (d, J = 3.6 Hz, 1H), 6.72 (dd, J = 
3.9, 1.8 Hz, 1H). 13C NMR (150 MHz,  CDCl3) δ 161.7, 160.7, 149.7, 148.6, 138.3, 136.6, 
135.3, 134.6, 127.8, 127.4, 126.7, 126.2, 125.3, 115.3, 113.3, 113.1, 112.1, 78.8, 71.9. 
IR(ATR): 3139, 3121, 2222, 1608, 1551, 1527, 1460, 1396, 1349, 1025, 880, 772. 715 cm-1. 
HRMS (EI+) m/z 320.0693 (320.0698 calculated for C20H8N4O [M]+). 
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2-(4-cyano-3-(diethylamino)-1-(furan-2-yl)-1,2-dihydro-9H-indeno[2,1-c]pyridin-9-
ylidene)malononitrile (68): Following General Procedure A the title compound was isolat-
ed as a dark blue solid (315 mg, 80%).  1H NMR (600 MHz,  CD2Cl2) δ 8.19 – 8.09 (m, 2H), 
7.42 – 7.34 (m, 3H), 6.49 (s, 1H), 6.36 – 6.30 (m, 2H), 6.20 (d, J = 3.3 Hz, 1H), 3.63 (ddt, J 
= 42.7, 15.2, 7.5 Hz, 4H), 1.31 (t, J = 7.1 Hz, 6H). 13C NMR (125 MHz,  CD2Cl2) δ 158.1, 
155.6, 155.2, 152.9, 144.0, 137.9, 137.6, 131.4, 130.8, 124.0, 123.1, 119.2, 117.5, 116.9, 
111.0, 108.4, 48.0, 46.2, 30.3, 13.6. IR(ATR) 3312, 3108, 2937, 2206, 2188, 1581, 1546, 
1504, 1396, 1380, 1347, 1242, 1219, 1164, 1143, 1079, 1015, 920, 882, 749 cm-1. HRMS 
(EI+) m/z 393.1583 (393.1590 calculated for C24H19N5O [M]+). 
 
1,3-dibutyl-5-(furan-2-ylmethylene)pyrimidine-2,4,6(1H,3H,5H)-trione (69): Following 
the procedure outlined by Deb and Bhuyan,2 the title compound was obtained as a pale yel-
low solid (10.93g, 63%) 1H NMR (500 MHz,  CDCl3) δ 8.62 (d, J = 3.8 Hz, 1H), 8.41 (d, J 
= 0.7 Hz, 1H), 7.83 (dd, J = 1.7, 0.6 Hz, 1H), 6.72 (ddd, J = 3.8, 1.6, 0.8 Hz, 1H), 4.04 – 
3.87 (m, 4H), 1.75 – 1.51 (m, 4H), 1.50 – 1.29 (m, 4H), 0.95 (td, J = 7.4, 3.4 Hz, 6H). 13C 
NMR (125 MHz,  CDCl3) δ 162.4, 160.8, 151.4, 151.1, 150.4, 141.0, 128.0, 115.2, 112.1, 
42.5, 41.8, 30.4, 30.3, 20.4, 20.4, 14.0, 14.0. IR (ATR) 3120, 2957, 2933, 2873, 1724, 1659, 
1578, 1445, 1428, 1409, 1376, 1308, 1250, 1203, 1157, 1128, 1091, 1036, 1022, 962, 915, 
884, 791, 760, 734 cm-1. HRMS (ESI+) m/z 341.1479 (341.1477 calculated for 
C17H22N2O4Na+ [M + Na]+). 
 
5-(furan-2-ylmethylene)-1-methyl-3-octylpyrimidine-2,4,6(1H,3H,5H)-trione (73): 1-
methyl-3-octylpyrimidine-2,4,6(1H,3H,5H)-trione: A solution of methylamine-HCl (0.12 g, 
1.79 mmol) in anhydrous DCM (15 mL) was treated with n-octyl isocyanate (0.30 mL, 1.70 
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mmol) under argon. Triethylamine (0.35 mL, 2.56 mmol) was then added and the mixture 
was heated to reflux. After 1 h, malonyl dichloride (0.17 mL, 1.70 mmol) was added under 
argon and heated to reflux for an additional hour. The mixture was cooled to rt and 
quenched with 1N HCl. The crude product was extracted with DCM (3 x 10 mL), washed 
with H2O (10 mL), dried over MgSO4 and filtered. The solvent was removed in vacuo and 
the product was purified by column chromatography (hexane:EtOAc= 9:1 to 1:1) to afford 
clear oil (302 mg, 67%). 1H NMR (500 MHz,  CDCl3) δ 3.91 – 3.78 (m, 2H), 3.65 (s, 2H), 
3.29 (s, 3H), 1.62 – 1.52 (m, 2H), 1.34 – 1.18 (m, 10H), 0.86 (t, J = 7.0 Hz, 3H). 13C NMR 
(125 MHz,  CDCl3) δ 165.0, 164.7, 151.8, 42.4, 39.7, 32.0, 29.4, 29.3, 28.6, 28.2, 27.0, 22.8, 
14.3. IR (ATR) 2956, 2924, 2855, 1685, 1519, 1433, 1409, 1389, 1364, 1334, 1268, 1168, 
1121, 1005, 936, 758, 723, 685 cm-1. HRMS (EI+) m/z 254.1641 (254.1630 calculated for 
C13H22N2O3+ [M]+). This material was subjected to the conditions of Deb and Bhuyan2 to 
give the title compound as a pale yellow solid (228 mg, 83%) 1H NMR (500 MHz,  CDCl3) 
δ 8.63 (d, J = 3.7 Hz, 1H), 8.42 (s, 1H), 7.84 (d, J = 1.5 Hz, 1H), 6.72 (ddd, J = 3.9, 1.8, 0.9 
Hz, 1H), 3.98 – 3.92 (m, 2H), 3.40 (s, 3H), 1.68 – 1.61 (m, 2H), 1.39 – 1.24 (m, 10H), 0.89 
– 0.85 (m, 3H). 13C NMR (125 MHz,  CDCl3) δ 162.7, 160.7, 151.4, 151.3, 150.4, 141.1, 
128.1, 115.3, 111.9, 42.1, 32.0, 29.5, 29.4, 29.1, 28.3, 27.2, 22.8, 14.3. IR (ATR) 3145, 
2915, 2851, 1728, 1658, 1575, 1543, 1450, 1423, 1407, 1366, 1327, 1252, 1201, 1166, 
1129, 1115, 1095, 1029, 988, 962, 921, 882, 789, 756, 719 cm-1. HRMS (ESI+) m/z 
355.1627 (355.1634 calculated for C18H24N2O4Na+ [M + Na]+) 
 
5-(furan-2-ylmethylene)-1,3-diphenylpyrimidine-2,4,6(1H,3H,5H)-trione (75): Follow-
ing the procedure out lined by Deb and Bhuyan,2 the title compound was isolated as a bright 
yellow solid (1.22 g, 85%). 1H NMR (600 MHz,  CDCl3) δ 8.66 (d, J = 3.9 Hz, 1H), 8.59 (s, 
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1H), 7.88 (d, J = 1.5 Hz, 1H), 7.56 – 7.41 (m, 6H), 7.36 – 7.30 (m, 4H), 6.71 (ddd, J = 3.9, 
1.7, 0.8 Hz, 1H). 13C NMR (150 MHz,  CDCl3) δ 162.5, 151.3, 151.1, 142.4, 135.0, 134.7, 
129.5, 129.4, 129.2, 129.1, 128.8, 128.6, 115.6, 111.4. IR (ATR) 3348, 3146, 3124, 3070, 
1736, 1668, 1570, 1490, 1455, 1416, 1356, 1326, 1236, 1199, 1149, 1030, 948, 882, 786, 
691 cm-1. HRMS (ESI+) m/z 381.0851 (381.0851 calculated for C21H14N2O4Na+ [M + Na]+). 
 
5-(furan-2-ylmethylene)-1,3-bis(4-methoxyphenyl)pyrimidine-2,4,6(1H,3H,5H)-trione 
(66): Following the procedure out lined by Deb and Bhuyan,2 the title compound was isolat-
ed as a bright yellow solid (1.46 g, 87%).  1H NMR (600 MHz,  CDCl3) δ 8.66 (d, J = 3.9 
Hz, 1H), 8.57 (s, 1H), 7.86 (d, J = 1.6 Hz, 1H), 7.25 – 7.20 (m, 4H), 7.04 – 6.98 (m, 4H), 
6.70 (ddd, J = 4.0, 1.6, 0.8 Hz, 1H), 3.84 (d, J = 2.6 Hz, 6H). 13C NMR (150 MHz,  CDCl3) 
δ 162.8, 161.3, 159.9, 159.8, 151.3, 151.2, 151.0, 142.3, 129.7, 129.6, 129.3, 127.6, 127.2, 
115.5, 114.8, 114.7, 111.6, 55.6. IR (ATR) 3139, 3116, 3002, 2964, 2835, 1733, 1674, 1607, 
1568, 1509, 1455, 1349, 1325, 1239, 1156, 1027, 951, 828, 808, 779, 752 cm-1. HRMS 
(ESI+) m/z 441.1049 (441.1063 calculated for C23H18N2O6Na+ [M + Na]+). 
 
1,3-bis(4-chlorophenyl)-5-(furan-2-ylmethylene)pyrimidine-2,4,6(1H,3H,5H)-trione 
(68): Following the procedure out lined by Deb and Bhuyan,2 the title compound was isolat-
ed as a bright yellow solid (1.32 g, 77%). 1H NMR (600 MHz,  CDCl3) δ 8.57 (d, J = 3.8 
Hz, 1H), 8.49 (s, 1H), 7.81 (d, J = 1.5 Hz, 1H), 7.39 (dd, J = 13.3, 8.6 Hz, 4H), 7.17 (dd, J = 
12.5, 8.6 Hz, 4H), 6.70 – 6.61 (m, 1H). 13C NMR (150 MHz,  CDCl3) δ 162.2, 160.7, 151.7, 
151.2, 150.4, 142.8, 135.2, 135.1, 133.3, 133.0, 130.2, 130.0, 130.0, 129.8, 129.7, 115.8, 
110.8. IR(ATR) 3136, 3118, 2925, 2855, 1735, 1672, 1564, 1489, 1454, 1418, 1399, 1346, 
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1324, 1233, 1154, 1087, 1028, 1014, 949, 920, 826, 801, 783, 751 cm-1. HRMS (ESI+) m/z 
449.0066 (449.0072 calculated for C21H12N2O4Cl2Na+ [M + Na]+). 
“On water” synthesis of DASAs: 
General Procedure C: The active methylene compound (1 mmol, 1 eq) was suspended in 
20 mL DI H2O. To this suspension was added 2-furaldehyde (1 mmol, 1 eq). The reaction 
mixture was stirred at the temperature indicated in Scheme 3 of the main text, for two hours, 
developing a bright yellow precipitate. The reaction mixture was then cooled to room tem-
perature if necessary. The secondary amine (1 mmol, 1 eq) was then added, neat, to the reac-
tion mixture, rapidly converting the precipitate from yellow to red or purple. This mixture 
was stirred at room temperature for two hours. The reaction was diluted with 10 mL 1M 
HCl, and 30 mL of dichloromethane, and stirred for 10 min. The organic layer was separated 
and the aqueous layer extracted twice with 30 mL fresh dichloromethane. The organics were 
combined, dried over MgSO4, and evaporated in vacuo to give the target DASA. If neces-
sary the target can be purified by column chromatography (SiO2) eluting with a gradient 
from 100% DCM to 9:1 DCM:MeOH. 
Considerations: If the amine nucleophile employed contains fewer than 6 carbons, the 
DASA is prone to adopting its zwitterionic form, hindering isolation as described in Gen-
eral Procedure C. In these instances, in lieu of the above work-up procedure, the resulting 
heterogeneous reaction mixture is stripped of water by evaporation. The resulting residue is 
dissolved in hot DCM, and after cooling to room temperature, concentrated then purified by 
chromatography as described above. 
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5-(3-azido-2-oxo-5-(piperidin-1-yl)cyclopent-3-en-1-yl)-6-hydroxy-2,2-dimethyl-4H-1,3-
dioxin-4-one (25): 5-((3-azidofuran-2-yl)methylene)-2,2-dimethyl-1,3-dioxane-4,6-dione 
(86): 3-azidofuran-2-carbaldehyde, prepared by reaction of sodium azide with 3-
bromofuran-2-carbaldehyde according to the procedure of Gronowitz et al.,4 was reacted 
with Meldrum’s acid according to the procedure of Bigi, et al. to afford 5-((3-azidofuran-2-
yl)methylene)-2,2-dimethyl-1,3-dioxane-4,6-dione as a pale yellow solid.1 According to 
General Procedure A, 5-((3-azidofuran-2-yl)methylene)-2,2-dimethyl-1,3-dioxane-4,6-dione 
(42 mg, 0.16 mmol, 1 eq) was dissolved in 5 mL tetrahydrofuran. To this solution was added 
piperidine (19 mL, 16 mg, 0.2 mmol, 1.2 eq). The mixture was stirred at 23 oC for 10 
minutes followed by cooling at 0 oC for 20 minutes. The reaction mixture was then filtered 
to collect the precipitated solid, the solid was washed with cold diethyl ether, and dried in 
vacuo to afford 5-(3-azido-2-oxo-5-(piperidin-1-yl)cyclopent-3-en-1-yl)-6-hydroxy-2,2-
dimethyl-4H-1,3-dioxin-4-one 86 (42 mg, 75%) as a white solid. 1H NMR (600 MHz, d2o) δ 
5.85 (d, J = 3.0 Hz, 1H), 3.65 (s, 1H), 2.74 (d, J = 3.8 Hz, 1H), 2.49 (d, J = 12.2 Hz, 1H), 
2.11 (d, J = 11.3 Hz, 1H), 1.70 (t, J = 12.3 Hz, 1H), 0.87 (d, J = 13.2 Hz, 2H), 0.73 (s, 0H), 
0.66 (d, J = 38.1 Hz, 6H), 0.40 – 0.23 (m, 1H). 13C NMR (151 MHz, d2o) δ 194.42, 169.58, 
168.19, 164.52, 163.60, 143.42, 127.34, 106.86, 66.34, 65.27, 64.70, 63.96, 52.07, 47.71, 
43.34, 42.29, 21.36. IR (KBr) 3438, 3058, 2988, 2943, 2866, 2661, 2518, 2412, 2119, 1729, 
1668, 1632, 1571, 1473, 1457, 1413, 1391, 1375, 1348, 1333, 1295, 1259, 1216, 1198, 
1177, 1146, 1121, 1059, 1022 cm-1. MS (ESI) m/z 349.16 (349.14 calcd for C16H21N4O5+ [M 
+H]+). 86 was characterized by single crystal x-ray analysis, the crystal structure data for 5-
(3-azido-2-oxo-5-(piperidin-1-yl)cyclopent-3-en-1-yl)-6-hydroxy-2,2-dimethyl-4H-1,3-
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dioxin-4-one (86) can be obtained free of charge from the Cambridge Crystallographic Data 
Centre via www.ccdc.cam.ac.uk/data_request/cif  CCDC 851859 
5-(3-bromo-2-oxo-5-(piperidin-1-yl)cyclopent-3-en-1-yl)-6-hydroxy-2,2-dimethyl-4H-
1,3-dioxin-4-one (88): 3-bromofuran-2-carbaldehyde, prepared by formylation of 3-
bromofuran, was reacted with Meldrum’s acid according to the procedure of Bigi, et al. to 
afford 5-((3-bromofuran-2-yl)methylene)-2,2-dimethyl-1,3-dioxane-4,6-dione as a pale yel-
low solid.1 According to General Procedure A, 5-((3-bromofuran-2-yl)methylene)-2,2-
dimethyl-1,3-dioxane-4,6-dione (151 mg, 0.5 mmol, 1 eq) was dissolved in 5 mL tetrahydro-
furan. To this solution was added piperidine (59 mL, 51 mg, 0.6 mmol, 1.2 eq). The mixture 
was stirred at 23 oC for 10 minutes followed by cooling at 0 oC for 20 minutes. The reaction 
mixture was then filtered to collect the precipitated solid, the solid was washed with cold 
diethyl ether, and dried in vacuo to afford 5-(3-bromo-2-oxo-5-(piperidin-1-yl)cyclopent-3-
en-1-yl)-6-hydroxy-2,2-dimethyl-4H-1,3-dioxin-4-one 88 (193 mg, 99%) as a white solid. 
1H NMR (600 MHz, d2o) δ 6.55 – 6.50 (m, 1H), 2.47 (d, J = 4.1 Hz, 1H), 2.29 (p, J = 2.9, 
2.4 Hz, 2H), 2.19 (dd, J = 34.6, 11.0 Hz, 2H), 1.86 (t, J = 12.0 Hz, 2H), 1.37 (dd, J = 12.9, 
9.7 Hz, 1H), 0.56 (t, J = 14.1 Hz, 3H), 0.33 (d, J = 40.0 Hz, 6H). 13C NMR (151 MHz, d2o) 
δ 194.52, 169.52, 168.03, 149.04, 130.02, 106.82, 67.44, 66.25, 52.18, 48.19, 42.56, 41.59, 
25.39, 23.17, 21.47, 19.09. IR (KBr) 3461, 3072, 2990, 2955, 2867, 2661, 2505, 2405, 1736, 
1682, 1661, 1571, 1486, 1446, 1408, 1391, 1375, 1363, 1326, 1299, 1259, 1214, 1199, 
1178, 1145, 1119, 1063, 1040, 1020, 1005 cm-1. MS (ESI) m/z 386.07/388.07 
(385.05/387.05 calcd for C16H21BrNO5+ [M +H]+). 
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6-hydroxy-2,2-dimethyl-5-(2-oxo-5-(piperidin-1-yl)-3-(p-tolylthio)cyclopent-3-en-1-yl)-
4H-1,3-dioxin-4-one (87): 2-(3-bromofuran-2-yl)-1,3-dioxolane was prepared from 3-
bromofuran-2-carbaldehyde by the method of Wishka et al.5 3-(p-tolylthio)furan-2-
carbaldehyde was prepared from 2-(3-bromofuran-2-yl)-1,3-dioxolane by the method of 
Hartman et al. followed by dioxolane hydrolysis.6 2,2-dimethyl-5-((3-(p-tolylthio)furan-2-
yl)methylene)-1,3-dioxane-4,6-dione was prepared from 3-(p-tolylthio)furan-2-carbaldehyde 
by the method of Bigi et al.1 According to General Procedure A, 2,2-dimethyl-5-((3-(p-
tolylthio)furan-2-yl)methylene)-1,3-dioxane-4,6-dione (95 mg, 0.23 mmol, 1 eq) was dis-
solved in 5 mL tetrahydrofuran. To this solution was added piperidine (34 mL, 29 mg, 0.34 
mmol, 1.5 eq). The mixture was stirred at 23 oC for 10 minutes followed by cooling at 0 oC 
for 20 minutes. The reaction mixture was then filtered to collect the precipitated solid, the 
solid was washed with cold diethyl ether, and dried in vacuo to afford 6-hydroxy-2,2-
dimethyl-5-(2-oxo-5-(piperidin-1-yl)-3-(p-tolylthio)cyclopent-3-en-1-yl)-4H-1,3-dioxin-4-
one 27 (78 mg, 79%) as a white solid. 1H NMR (600 MHz, d2o) δ 6.21 – 5.99 (m, 2H), 5.99 
– 5.89 (m, 2H), 5.21 (d, J = 1.3 Hz, 1H), 3.35 (s, 1H), 2.59 (d, J = 4.0 Hz, 1H), 2.49 – 2.36 
(m, 2H), 2.16 (d, J = 8.5 Hz, 2H), 1.71 (t, J = 12.6 Hz, 1H), 1.25 (dd, J = 23.6, 12.0 Hz, 1H), 
0.99 (s, 3H), 0.85 (d, J = 1.4 Hz, 2H), 0.62 (d, J = 14.9 Hz, 2H), 0.47 (d, J = 37.6 Hz, 6H). 
13C NMR (151 MHz, d2o) δ 196.54, 169.82, 168.37, 164.70, 163.73, 151.24, 150.65, 140.19, 
132.88, 132.73, 129.53, 121.26, 106.78, 67.25, 66.44, 66.33, 47.46, 44.70, 44.57, 43.55, 
23.25, 18.35, 18.26. IR (KBr) 3432, 3058, 2946, 2864, 2661, 2508, 1724, 1679, 1575, 1492, 
1449, 1413, 1389, 1373, 1327, 1297, 1261, 1201, 1180, 1149, 1121, 1064, 1019 cm-1. MS 
(ESI) m/z 430.17 (430.16 calcd for C23H28NO5S+ [M +H]+). 
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6.4. Chapter 4 
General Methods:  
All commercially obtained solvents and reagents were used without further purification. An-
alytical thin-layer chromatography (TLC) was carried out on Merck silica gel 60 F254 glass 
plates and flash column chromatography was performed on Merck silica gel 60 (70 – 230 
mesh) or on a Biotage SP1 Flash Purification System using FLASH 40+M cartridges and 
FLASH 40+ sample cartridges. 1H and 13C solution-state NMR were recorded on a Varian 
VNMRS 600 (600 MHz for 1H and 150 MHz for 13C) spectrometer or Varian Inova-500 
(500 MHz for 1H, and 125 MHz for 13C). Chemical shifts are reported relative to residual 
solvent peaks (δ 7.26 for CDCl3 in 1H NMR and δ 77.2 for CDCl3 in 13C NMR). IR spectra 
were obtained using a Thermo-Nicholet Avatar-330 IR spectrometer with 1single-bounce 
attenuated total reflection (ATR) (Ge crystal) accessory (Smart MIRacle). Gel permeation 
chromatography (GPC) was performed in chloroform (with 0.25% triethylamine) on a Wa-
ters 2695 Separation Module equipped with a Waters 2414 Refractive Index Detecter and a 
Waters 2996 Photodiode Array Detector. Molecular weights of polymers were calculated 
relative to linear polystyrene standards unless otherwise noted. Mass spectral data were col-
lected on a Micromass QTOF2 Quadrupole/Time-of Flight Tandem mass spectrometer (ESI-
MS). 
Synthetic methods 
tert-butyl (4-(prop-2-yn-1-yloxy)cyclohexyl)carbamate: To a flame dried 250 mL round 
bottom flask equipped with a magnetic stir bar was added 1.80 g (8.37 mmols) of tert-butyl 
(4-hydroxycyclohexyl)carbamate and 100 mL dry THF. The solution was cooled to 0 °C and 
301 mg (12.6 mmols) of NaH was added slowly. The solution was subsequently allowed to 
  178 
warm to room temperature and stir for 1 hour. The solution was cooled back to 0 °C and po-
tassium iodide (1.66 g, 10.0 mmols) and catalytic 18-crown-6 were added before the drop-
wise addition of propargyl bromide (1.12 mL of 80 wt. % solution in toluene, 12.6 mmols). 
The solution was allowed to warm to room temperature and stirred for 12 hours. The reac-
tion was quenched into 100 mL of 1.0 M HCl and extracted ×3 with 40 mL EtOAc. The or-
ganic layers were combined, washed with brine and dried over anhydrous Na2SO4. Column 
chromatography on silica gel (0 to 10 % EtOAc:Hexane) yielded the product as a crystalline 
solid (1.38 g, 65 % yield). 1H NMR (600 MHz, CDCl3) δ 4.39 (m, 1H), 4.15 (d, 2H, J=6 
Hz), 3.43 (m, 1H), 2.38 (t, 1H, J=6 Hz), 2.01 (m, 4H), 1.41 (s, 9H), 1.34 (q, 2H, J=12 Hz), 
1.14 (q, 2H, J=12 Hz); 13C-NMR (150 MHz, CDCl3) δ 155.4, 80.4, 79.4, 76.1, 74.1, 55.4, 
49.1, 31.1, 30.4, 28.6; IR (ATR) 3305, 3285, 2979, 2939, 2862, 1694, 1670, 1534, 1454, 
1364, 1314, 1274, 1174, 1082, 1051, 992, 895, 670 cm-1; MS (TOF-ESI) calcd for 
C14H23NO3Na [M+Na]+: 276.1576, found [M+Na]+: 276.1582. 
 
4-(prop-2-yn-1-yloxy)cyclohexaneamine: To a 100 mL round bottom flask equipped with 
a magnetic stir bar was added 30 mL of dry dichloromethane and 690 mg (2.73 mmols) of 
tert-butyl (4-(prop-2-yn-1-yloxy)cyclohexyl)carbamate. The solution was cooled to 0 °C and 
1.25 mL (16.4 mmols) trifluoroacetic acid was added dropwise. The reaction mixture was 
allowed to warm to room temperature and stirred until all starting material was consumed as 
judged by TLC (~5 hours). The reaction mixture was quenched into 20 mL 1.0 M HCl and 
extracted ×2 with EtOAc. The aqueous layer was made basic by the addition of NaHCO3, 20 
mL brine was added, and extracted ×3 with dichloromethane. The organic layers were com-
bined, dried with anhydrous Na2SO4, and the solvent removed to yield the desired product as 
a crystalline solid (310 mg, 74 % yield). 1H NMR (600 MHz, CDCl3) δ 4.14 (d, 2H, J=6 
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Hz), 3.41 (m, 1H), 2.66 (m, 1H), 2.37 (t, 1H, J=6Hz), 2.00 (m, 2H), 1.85 (m, 2H), 1.38 (s, 
2H), 1.27 (q, 2H, J=12 Hz), 1.11 (q, 2H, J=12 Hz); 13C-NMR (150 MHz, CDCl3) δ 80.5, 
76.7, 73.9, 55.4, 49.9, 34.5, 30.59; IR (ATR) 3286, 2930, 2858, 2112, 1575, 1452, 1356, 
1260, 1084, 1013, 931, 799 cm-1; MS (TOF-EI) calcd for C9H14NO [M-H]+: 152.1075, 
found [M-H]+: 152.1072. 
 
1-(3,5-bis(trifluoromethyl)phenyl)-3-(4-(prop-2-yn-1-yloxy)cyclohexyl)thiourea (1): To 
a 50 mL round bottom flask equipped with a magnetic stir bar was added 10 mL of dry di-
chloromethane and 205 mg (1.33 mmols) of 4-(prop-2-yn-1-yloxy)cyclohexaneamine. The 
solution was cooled to 0 °C and 0.243 mL (1.33 mmols) of 3,5-bis(trifluoromethyl) phenyli-
sothiocyanate was added dropwise. The reaction mixture was allowed to warm to room tem-
perature and stirred for 12 hours. The solvent was removed and the solid was recrystallized 
from a hexanes:DCM mixture to yield the product as a crystalline solid (537 mg, 95 % 
yield). 1H NMR (600 MHz, CDCl3) δ 8.30 (bs, 1H), 7.75 (s, 2H), 7.70 (s, 1H), 5.99 (bs, 1H), 
4.21 (m, 1H), 4.18 (d, 2H, J=6 Hz), 3.49 (m, 2H), 2.40 (t, 1H, J=6 Hz), 2.18 (m, 2H), 2.05 
(m, 2H), 1.44 (q, 2H, J=12 Hz), 1.27 (q, 2H, J=12 Hz); 13C-NMR (150 MHz, CDCl3) δ 
179.8, 139.0, 133.3 (q, J=33 Hz), 124.1, 122.9 (q, J=271.5 Hz), 119.7, 80.2, 75.6, 74.4, 55.6, 
53.5, 30.1, 30.0; IR (ATR) 3273, 3218, 3044, 2947, 2859, 2112, 1543, 1531, 1455, 1379, 
1273, 1165, 1127, 1076, 896, 699, 681 cm-1; MS (TOF-ESI) calcd for C18H18F6N2OSNa 
[M+Na]+: 447.0942, found [M+Na]+: 447.0916. 
 
Azide-dimethylbarbitiuc acid DASA photoswitch (3): To a 20 mL scintillation vial 
equipped with a magnetic stir bar was added 463 mg (2.72 mmols) of 6-azido-N-ethylhexan-
1-amine and 1.50 mL THF. A solution of 5-(furan-2-ylmethylene)-1,3-dimethylbarbitiuc 
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acid (637 mg, 2.72 mmols) in 1.50 mL THF was added dropwise at room temperature. The 
reaction mixture was allowed to stir for 6 hours. The THF was removed and column chro-
matography (3 % MeOH:DCM) provided the product as a purple solid (837 mg, 76 % 
yield). 1H NMR (600 MHz, CDCl3) δ 12.51 (d, 1H, J=6 Hz), 7.22 (m, 1H), 7.11 (d, 1H, J=6 
Hz), 6.73 (d, 1H, J=12 Hz), 6.04 (dt, 1H, J=12 & 12 Hz), 3.46 (qn, 2H, J=6 Hz), 3.40 (q, 
2H, J=12 Hz), 3.33 (s, 3H), 3.32 (s, 3H), 3.27 (t, 2H, J=6 Hz), 1.67 (m, 2H), 1.58 (m, 2H), 
1.42-1.30 (m, 4H), 1.31 (t, 3H, J=6 Hz); 13C-NMR (150 MHz, CDCl3) δ 165.0, 163.3, 156.8, 
156.7, 151.9, 150.9, 146.5, 139.2, 139.0, 102.8, 102.5, 98.4,57.0, 52.1, 51.1, 49.1, 44.3, 
28.9, 28.6, 28.4, 28.2, 27.0, 26.5, 26.3, 26.2, 26.0 14.5, 12.2; IR (ATR) 3288, 3047, 2937, 
2861, 2094, 1691, 1615, 1594, 1559, 1495, 1462, 1412, 1364, 1203, 1135, 1076, 968, 775 
cm-1; MS (TOF-ESI) calcd for C19H28N6O4Na [M+Na]+: 427.2070, found [M+Na]+: 
427.2065. 
 
DASA-thiourea organic catalyst (4): To a 50 mL round bottom flask equipped with a 
magnetic stir bar was added 10 mL of THF, 312 mg (0.771 mmols) of azide-
dimethylbarbitiuc acid DASA photoswitch, 327 mg alkyne thiourea (0.771 mmols), and 7.0 
mg (0.386 mmols) of pentamethyldiethyltriamine. The reaction mixture was subjected to 
three freeze-pump-thaw cycles, backfilled with argon, and 5 mg CuBr was added. The reac-
tion mixture was stirred for 5 hours, the solvent removed, and column chromatography (5 % 
MeOH:DCM) provided the product as a purple solid (423 mg, 67 % yield). 1H NMR (600 
MHz, CDCl3) δ 12.51 (d, 1H, J=24 Hz); 9.12 (s, 1H), 8.07 (d, 2H, J=6 Hz), 7.59 (d, 1H, 
J=24 Hz), 7.55 (s, 1H), 7.42 (bs, 1H), 7.28 (m, 1H), 6.98 (d, 1H, J=6 Hz), 6.72 (dd, 1H, J=6 
& 12 Hz), 6.04 (dt, 1H, J=12 & 24 Hz), 4.63 (s, 2H), 4.35 (q, 2H, J=6 Hz), 4.27 (bs, 2H), 
3.46 (q, 2H, J=6 Hz), 3.44-3.35 (m, 4H), 3.32 (s, 6H), 2.19 (bs, 2H), 2.04 (bs, 2H), 1.90 (q, 
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2H, J=12 Hz), 1.64 (m, 2H), 1.42-1.28 (m, 12H), 1.26 (t, 3H, J=6 Hz); 13C-NMR (150 MHz, 
CDCl3) δ 180.1, 164.9, 163.6, 158.0, 157.6, 152.1, 151.8, 151.7, 146.5, 145.8, 140.8, 137.4, 
131.6 (q, J=33 Hz), 123.1 (q, J=271.5 Hz), 123.1, 122.7, 103.4, 103.3, 97.6, 61.7, 56.9, 53.4, 
52.4, 50.2, 50.1, 49.1, 44.5, 30.9, 30.5, 30.0, 29.9, 29.8, 28.6, 28.5, 28.3, 26.8, 26.0, 25.9, 
25.9, 25.7, 14.4, 12.2; IR (ATR) 3293, 3053, 2927, 2856, 1692, 1609, 1594, 1557, 1458, 
1412, 1348, 1273, 1201, 1115, 1070, 960, 880, 773, 679 cm-1; MS (TOF-ESI) calcd for 
C37H46F6N8O5SNa [M+Na]+: 851.3114, found [M+Na]+: 851.3098. 
 
1,3-dioctylpyrimidine-2,4,6(1H,3H,5H)-trione: To a solution of n-octyl amine (2.00 g, 
15.48  mmol) in 100 mL dichloromethane was added a solution of n-octyl isocyanate (2.73 
mL, 15.48 mmol) in 30 mL dichloromethane under argon. The mixture was stirred at room 
temperature for 1 h. After malonyl chloride (1.51 mL, 15.48 mmol) was added, the mixture 
was heated at reflux for 1 h. The mixture was allowed to cool to room temperature and was 
quenched with 1 N HCl (60 mL). The crude product was extracted with dichloromethane (3 
x 70 mL) and the combined organic phases were washed with H2O (1 x 50 mL), dried over 
MgSO4 and filtered. Solvent was removed under vacuo. Purification by flash column chro-
matography (hexane:EtOAc = 9:1 to 4:1) gave 4.80 g (88% yield) of the product as yellow 
oil. 1H NMR (500 MHz, Methylene Chloride-d2) δ 3.84 – 3.81 (m, 4H), 3.61 (s, 2H), 1.68 – 
1.48 (m, 4H), 1.40 – 1.19 (m, 20H), 0.88 (t, J = 6.6 Hz, 6H); 13C NMR (126 MHz, cd2cl2) δ 
165.2, 152.0, 42.5, 40.4, 32.4, 29.8, 29.8, 28.5, 27.4, 23.2, 14.4. IR (NaCl) 2957, 2926, 
2856, 1707, 1682, 1443, 1413, 1369, 1320, 1286, 1227, 1167, 937, 760, 723 cm-1. HRMS 
(EI+) m/z 352.2725 (352.2726 calc’d for C20H36N2O3+ [M]+).   
 
  182 
5-(Furan-2-ylmethyl)-1,3-dioctylpyrimidine-2,4,6(1H,3H,5H)-trione: 1,3-
dioctylpyrimidine-2,4,6(1H,3H,5H)-trione (4.80 g, 13.6  mmol) in H2O (27 mL) was treated 
with 2-furaldehyde (1.13 mL, 13.6 mmol). The mixture was stirred at room temperature for 
2 h. The yellow waxy solid was extracted by dichloromethane (3 x 30 mL). Combined or-
ganic phases was dried over MgSO4, filtered and the solvent was removed in vacuo to give 
1.55 g (26 % yield) of 5-(Furan-2-ylmethyl)-1,3-dioctylpyrimidine-2,4,6(1H,3H,5H)-trione 
as a light yellow powder. 1H NMR (500 MHz, Methylene Chloride-d2) δ 8.52 (d, J = 4.0 Hz, 
1H), 8.27 (s, 1H), 7.77 (dd, J = 1.7, 0.6 Hz, 1H), 6.66 (ddd, J = 3.8, 1.7, 0.8 Hz, 1H), 3.87 – 
3.82 (m, 4H), 1.53 (m, 4H), 1.33 – 1.11 (m, 20H), 0.85 – 0.73 (m, 6H). 13C NMR (126 MHz, 
cd2cl2) δ 162.6, 161.2, 151.8, 150.7, 140.7, 127.8, 115.5, 112.8, 42.9, 32.4, 29.9, 29.8, 28.6, 
27.5, 23.2, 14.4. IR (NaCl) 3145, 3115, 2955, 2922, 2853, 1725, 1670, 1660, 1580, 1466, 
1449, 1432, 1410, 1386, 1361, 1334, 1297, 1270, 1256, 1201, 1164, 1128, 1095, 1031, 883, 
792, 754 cm-1. HRMS (EI+) m/z 430.2834 (430.2832 calc’d for C25H38N2O4 [M]+).   
  
(Z)-5-((2Z,4E)-5-((6-azidohexyl)(ethyl)amino)-2-hydroxypenta-2,4-dien-1-ylidene)-1,3-
dioctylpyrimidine-2,4,6(1H,3H,5H)-trione: To a solution of 5-(Furan-2-ylmethyl)-1,3-
dioctylpyrimidine-2,4,6(1H,3H,5H)-trione (1.00 g, 2.32  mmol) in 2.6 mL tetrahydrofuran 
was added a solution of 6-azido-N-ethylhexan-1-amine (0.43 mL, 2.44 mmol) in 2.0 mL tet-
rahydrofuran. The mixture was stirred at room temperature for 17 h. Purification by flash 
column chromatography gave 1.09 g of (Z)-5-((2Z,4E)-5-((6-azidohexyl)(ethyl)amino)-2-
hydroxypenta-2,4-dien-1-ylidene)-1,3-dioctylpyrimidine-2,4,6(1H,3H,5H)-trione as purple 
viscous oil in 78 % yield. 1H NMR (500 MHz, Methylene Chloride-d2) δ 12.54 (s, 1H), 7.26 
(dd, J = 27.9, 12.2 Hz, 1H), 7.08 (s, 1H), 6.79 (dd, J = 12.4, 1.4 Hz, 1H), 6.06 (t, J = 12.3 
Hz, 1H), 3.99 – 3.75 (m, 4H), 3.56 – 3.34 (m, 4H), 3.28 (m, 2H), 1.70 (m, 2H), 1.65 – 1.51 
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(m, 6H), 1.41 (m, 4H), 1.37 – 1.19 (m, 23H), 0.88 (m, 6H). 13C NMR (126 MHz, cd2cl2) δ 
165.5, 157.6, 151.8, 151.1, 146.9, 139.1, 139.0, 102.8, 42.1, 42.0, 32.4, 32.2, 30.0, 29.8, 
29.2, 28.8, 28.7, 28.7, 27.6, 27.2, 23.2, 23.2, 14.4, 14.4. IR (NaCl) 2956, 2930, 2857, 2096, 
1694, 1623, 1599, 1557, 1498, 1459, 1429, 1407, 1368, 1341, 1266, 1226, 1204, 1144, 
1110, 1088, 970, 907, 839, 780, 760, 730, 687 cm-1. HRMS (ESI+) m/z 623.4234 (623.4261 
calc’d for C33H56N6O4Na+ [M + Na]+).  
 
Donor-Acceptor Stenhouse Adduct appended to poly(ethylene glycol) (DASA-PEG) 
(6a): To a stirring mixture of poly(ethylene glycol) (112 mg, 0.037 mmol), CuSO4-5H2O 
(1.0 mg, 0.0037 mmol) and sodium ascorbate (1.5 mg, 0.0074 mmol) in 1.0 mL water was 
added (Z)-5-((2Z,4E)-5-((6-azidohexyl)(ethyl)amino)-2-hydroxypenta-2,4-dien-1-ylidene)-
1,3-dioctylpyrimidine-2,4,6(1H,3H,5H)-trione (67 mg, 0.112 mmol) dissolved in minimum 
amount of acetone. The mixture was heated to 50 ⁰C in a water bath for 19 h. After the mix-
ture was cooled to room temperature, the product was extracted with dichloromethane (4 x 
20 mL). The crude product was precipitated twice into diethyl ether, yielding 83 mg (62 % 
yield) of DASA-PEG 6a as a purple solid. 1H NMR (600 MHz, Methylene Chloride-d2) δ 
12.54 (d, J = 11.2 Hz, 1H), 7.67 (s, 1H), 7.24 (dd, J = 28.9, 12.2 Hz, 1H), 7.09 (s, 1H), 6.77 
(dd, J = 12.4, 4.6 Hz, 1H), 6.10 – 5.99 (m, 1H), 4.62 (dd, J = 4.8, 2.1 Hz, 2H), 4.34 (dd, J = 
8.7, 6.9 Hz, 2H), 3.86 (dt, J = 15.0, 7.6 Hz, 4H), 3.60 (s, 259H), 3.34 (s, 3H), 2.92 (s, 2H), 
2.80 (s, 2H), 2.07 – 1.86 (m, 8H), 1.36 – 1.19 (m, 27H), 0.87 (dt, J = 7.2, 3.4 Hz, 6H). IR 
(NaCl) 2879, 2095, 1679, 1467, 1359, 1343, 1279, 1147, 1113, 1061, 842, 597 cm-1. 
Polymerization: 
To a dry 1 dram vial equipped with a magnetic stir bar and a Teflon cap was added D,L-
lactide (30 mg, 0.208 mmols), 4 (17 mg, 0.0208 mmols), and pyrene butanol (0.5 mg, 
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0.00208 mmols) and evacuated and backfilled with argon. Dry CDCl3 (175 µL, 1.2 M) and 
dry pentamethyldiethylenetriamine (9 µL, 0.0416 mmols) were added under inert atmos-
phere and the reaction mixture was allowed to stir for 48 hours at 30 °C.  
Recycling procedure:  
The CDCl3 was removed under vacuum and the mixture was dissolved in 0.2 mL THF and 
diluted with 4.8 mL benzene. The solution was layered over 10 mL deionized H2O, placed 
in a light box and irradiated for 1 hour with visible light (578 nm peak wavelength) while 
stirring. The water layer was removed, 10 mL fresh DI water was added, and the solution 
was again irradiated for one hour. The water layer was removed and combined with the pre-
vious extraction, made acidic by the addition of 5 mL 1 N HCl, and extracted ×3 with 20 mL 
dichloromethane. The organic layers were combined, washed with brine, dried over Na2SO4, 
concentrated, and run over a plug of silica (5% MeOH:DCM) to yield the pure catalyst as a 
dark red solid (11.6 mg, 70% recovery). 
1H-NMR titration experiments 
This procedure constitutes a slightly modified version from previous studies.7 C6D6 was 
stirred over CaH2 for 24 hours and distilled. Stock solutions of thiourea, caprolactone, and 
the diethyl DASA photoswitch were prepared in dry C6D6. The chemical shift of the thiou-
rea N–H protons was found to be independent of concentration between 0.05 and 0.01 M; 
thus, those all spectra were obtained within that concentration range.  
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Figure S9. NMR spectra of D2O layer after photoswitching and phase transfer of 4 
 
Figure S10. Comparison of 4 before and after recycling. 
 
Preparation of micelle solutions with Nile Red:  
The stock solutions were prepared according to the procedure used by Fréchet and cowork-
ers.8 Briefly, 12.5 µL of Nile Red stock solution in dichloromethane (0.05 mg/mL) was add-
ed to a 4 mL vial. This vial was placed under vacuum until the solvent was completely re-
moved. An aqueous DASA-PEG amphiphile (6a) stock solution at concentration of 2 
mg/mL was prepared and added to this vial. Deionized water was added to dilute the solu-
tion to 2 mL with desired concentration. This solution was stirred vigorously for 10 minutes 
and then allowed to equilibrate at room temperature for 1 hour. 
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Critical Micelle Concentration Studies:  
Fluorescence measurements were obtained using a Cary Eclipse spectrophotometer (Varian, 
Inc.) with a quartz fluorescence cuvette (1 x 1 x 0.2 cm) with the following settings: excita-
tion wavelength of 550 nm, excitation slit width = 5 nm, emission slit width = 10 nm, range 
= 560 nm to 700 nm and scan speed = 30 nm/min. 
Kinetic Studies:  
A set of micelle solutions of same concentration containing Nile Red was prepared as de-
scribed above and transferred to vials. All vials were transferred to a Rayonet photoreactor 
RPR-200, irradiated at 575 nm for desired amounts of time and taken out for fluorescence 
measurement. Same settings were used for fluorescence measurement. 
 
Figure S11. Fluorescence emission spectrum of Nile red with varying concentrations of 
DASA-PEG amphiphile (6a) in water. At low concentrations, maximum emission occurs 
around 660 nm. As concentrations increase, maximum emission blue shifts indicating en-
capsulation of Nile red within the core of micelles. 
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Figure S12. A plot of relative intensity as a function of log of concentration of 6a. Non-
linear relationship suggests that the inflection point (28 µM) is the critical micelle concentra-
tion (CMC). 
 
Figure S13. Fluorescence emission spectra of Nile Red in (A) 0.50 mg/mL and (B) 0.05 
mg/mL of 6a in water at various times of visible light irradiation. A noticeable red shift and 
decrease in emission intensity were observed as light irradiation continued (left), whereas 
minimum change occurred at the concentration below CMC (right). 
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Figure S14. UV-Vis spectra of 6a at 0.50 mg/mL in water at various time points of visible 
light (570 nm) irradiation Almost complete structural conversion from the extended form to 
the closed form is observed after 30 minutes of irradiation, This data corresponds to the min-
imum change that occurred in the emission spectrum of Nile red after the same time of irra-
diation. 
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